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iABSTRACT 
The central nervous system (CNS) is made up mainly of neurones, the signalling 
cells, and glia. The main types of glia are astrocytes and oligodendrocytes. 
Astrocytes are multifunctional cells with vital homeostatic roles, whereas 
oligodendrocytes are highly specialised to form axonal myelin sheaths, which are 
essential for rapid neuronal communication. Although glia are involved in every 
neurodegenerative disease, they have been less well studied as drug targets than 
neurones. Lithium has been used for decades as a mood stabilising agent and may 
have major therapeutic potential as a treatment in diverse neurodegenerative 
diseases. The mode of action of lithium is generally attributed to its potent 
inhibitory effect on glycogen synthase kinase 3 (GSK3), an enzyme that regulates 
the Wnt/-catenin pathway. The aim of this study was to examine the effects of 
lithium and Wnt signalling in glial cells of the adult CNS. First, I developed an 
organotypic culture model of the adult mouse optic nerve that maintains cellular, 
axon and myelin integrity in vitro. This model was used to examine the effects of 
lithium and Wnt on adult glial cells, using confocal microscopy, 
immunohistochemistry, microarray, western blot and qRT-PCR. A key finding was 
that lithium acts through the canonical Wnt/-catenin pathway to stimulate 
gliogenesis in the adult optic nerve, acting via diverse cell-cycle and cytoskeletal 
remodelling mechanisms. Lithium profoundly increased oligodendrocytes by 
downregulating inhibitors of differentiation, such as Wnt, bone morphometric 
protein (BMP) and inhibitor of differentiation (ID)4. Furthermore, lithium also acted 
through non-GSK3 targets, including Cxcl1 and leukemia inhibitory factor (LIF), 
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which promote oligodendrocyte differentiation. An important finding was that 
lithium, and to a lesser extent Wnt, induced the generation of a novel astrocyte 
morphology, with highly polarised morphology and axon growth promoting 
phenotype. Notably, I identified a number of novel glial genes in the optic nerve 
and provide evidence that lithium induces astrocyte polarisation through the 
inhibition lysyl oxidase and upregulation of the cell-cell adhesion molecule 
corneodesmosin. In summary, this PhD has demonstrated for the first time that 
Wnt regulates gliogenesis in the adult CNS and indicates that glial cells are a 
potential target of lithium in neurodegenerative diseases. 
iii
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1.1  Overview of Glial Cells 
The centrl nervous system (CNS) contins two mjor cell types  neurons nd gli. 
The term neurogli is thought to be coined by Rudolf Ludwig Krl Virchow (1821-
1902), where he described them s something slimy or sticky which served s 
connective tissue (Verkhrtsky nd Butt, 2013). However, this vision of gli is fr 
from true s they perform  plethor of homeosttic functions tht re essentil for 
the norml functioning of the CNS. This homeosttic role of gli is executed t mny 
different levels from defensive homeostsis to metbolic nd cellulr homeostsis. 
There re three mjor clsses of gli in the CNS: strocytes, oligodendrocytes nd 
microgli s shown in Figure 1.1. Astrocytes nd oligodendrocytes comprise the 
mcrogli nd re neurl cells derived from  common linege with neurons. 
Microgli re non-neuronl cells tht hve  mcrophge linege nd enter the CNS 
prior to birth, before the blood-brin brrier (BBB) forms (Verkhrtsky nd Butt, 
2013). In the norml CNS, microgli re resting nd become ctivted in response 
to n insult, regining their mcrophge sttus nd becoming phgocytic nd 
immune responsive (Hnisch nd Kettenmnn, 2007; Kim nd de Vellis, 2005). 
Microgli re chrcterised by  highly mobile rmified morphology tht scns the 
environment round the cell (Hnisch nd Kettenmnn, 2007; Kim nd de Vellis, 
2005). Although ctivtion of microgli in response to injury is beneficil, it cn lso 
led to  destructive profile ssocited with the clssicl ctivtion or M1 
phenotype. However, ctivted microgli cn lso hve  more tolernt ctivtion 
known s lternte ctivtion or M2 phenotype (Boche et l., 2013). Astrocytes 
(from the Greek for str cells) re the most diverse glil cells in the CNS. The most 
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clssic definition is bsed on their stellte (str-like) morphology nd their 
expression of the intermedite filment glil fibrillry cidic protein (GFAP). In 
truth, most strocytes do not hve  str-like morphology nd mny strocytes do 
not express GFAP (Butt et l., 1994b; Kimelberg, 2004). Astrocytes re lso defined 
by their loclistion in the CNS: protoplsmic strocytes reside in the grey mtter, 
while fibrous strocytes re observed in the white mtter. Astrocytes hve diverse 
functions tht spn from homeosttic mintennce, neurogenesis nd neurl cell 
migrtion, formtion of the glil scr, nd regultion of blood flow (Alvrez-Buyll 
et l., 2001; Alvrez-Buyll et l., 1988; Cmpbell nd Gotz, 2002; Goldmn, 2003; 
Gubert et l., 2009; Hrtfuss et l., 2001; Kettenmnn, 1999; Mltest et l., 2003; 
McDermott et l., 2005). Oligodendrocytes (from the Greek for cell with few 
processes) re highly specilised to form the myelin sheets tht insulte xons, 
enbling slttory conductnce of ction potentils (Butt, 1991; Butt nd Rnsom, 
1989; Rnsom et l., 1991). Myelinting oligodendrocytes re prevlent in the 
white mtter, lthough they re lso prominent in grey mtter, nd  subclss of 
non-myelinting oligodendrocytes known s perineuronl oligodendrocytes re 
lso observed in the grey mtter (Szuchet et l., 2011; Tkski et l., 2010). This 
PhD focuses on the mcrogli - strocytes nd oligodendrocytes  in the optic 
nerve,  typicl CNS white mtter trct. 
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Figure 1.1 Glil cells in the CNS.  Astrocytes provide homeostsis by communicting 
with synpses nd blood vessels, oligodendrocytes myelinte xons for rpid 
conduction, while microgli re the immune system of the CNS.  From (Allen nd 
Brres, 2009).  
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1.2  Oligodendrocytes 
Oligodendrocytes re cells with the specific function of forming the insulting 
myelin sheths round CNS xons. The myelin sheth is  ftty insulting lyer tht 
llows rpid slttory ction potentil propgtion in mmmls. Filure of the 
correct formtion of myelin (dysmyelintion) or the disruption of its mintennce 
(demyelintion) results in n impirment of neuronl ctivity, s observed in 
neurodegenertive diseses, such s Multiple Sclerosis (MS). Oligodendrocytes cn 
myelinte up to 30 xons within  short distnce of their cell bodies (Butt nd 
Rnsom, 1989; Rnsom et l., 1991). Myelin sheths re interrupted t the nodes of 
Rnvier, where the ction potentil occurs, nd the myelinted segments between 
two nodes of Rnvier re clled internodes. Internodl myelin sheths re 
connected to the oligodendrocyte som, giving the oligodendrocytes their 
symmetricl ppernce (Figure 1.2). 
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Figure 1.2  Confocal images of dye-filled oligodendrocytes in the mouse optic nerve 
illustrating their whole-cell morphology. The parallel arrays are the individual 
internodal myelin sheaths, connected to the cell body by fine process. Each 
oligodendrocyte in the mouse optic nerve myelinates up to 30 axons within 20 mm 
of the cell body. From (Butt et al., 1994a). 
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1.2.1  Oligodendrocyte development 
Oligodendrocytes in the brain and optic nerve are derived from oligodendrocyte 
precursor (or progenitor) cells (OPCs) that arise from multipotent neural stem cells 
(NSC) in the subventricular zone (SVZ) of the lateral ventricle (Richardson et al., 
2006). OPCs migrate to their final destination where they undergo local expansion 
by proliferation and terminal differentiation into myelinating oligodendrocytes. 
However, a small population persist after development as adult OPCs or NG2-glia 
that generate oligodendrocytes throughout life and in response to insults (Kang et 
al., 2010). In the adult optic nerve, NG2-glia (OPCs) comprise approximately 5% of 
the overall cell population (Butt et al., 1999). The regulation of oligodendroglial 
proliferation and differentiation is tightly regulated by the interplay of extrinsic and 
intrinsic factors such as Notch, platelet derived growth factor (PDGF), Sonic 
hedgehog (Shh), bone morphogenic proteins (BMP), Wnt, fibroblast growth factor 
(FGF2), and insulin-like growth factor (IGF-I) (Adachi et al., 2007; Azim and Butt, 
2011; Barres et al., 1993; Chandran et al., 2003; Fancy et al., 2009; Kim et al., 2009c; 
Lu et al., 2000; Wang et al., 1998; Wu et al., 2012; Yung et al., 2002). A range of 
specific markers and transcription factors allow the characterisation of specific 
stages that OPCs undergo before becoming myelinating oligodendrocytes (Figure 
1.3). OPCs can be defined by their expression of PDGF receptors alpha (PDGFR
and the chondroitin sulphate proteoglycan (CSPG) neuron-glial 2 (NG2) (Butt et al., 
1997a; Butt et al., 1997b; Mudhar et al., 1993; Nishiyama et al., 1996a, b; Raff et al., 
1988). While PDGFR mediate the proliferative effect of PDGF, the precise 
function/s of NG2 in OPCs is still unknown. In addition, OPCs may also express 
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Prominin-1 and A2B5, however they not glial-restricted and expressed by NSC and 
glial-precursor cells, respectively. OPCs differentiate directly from NSCs and express 
the basic helix-loop-helix (bHLH) transcription factors Olig1/2, Sox10 and Nkx2-2 
(Arnett et al., 2004; Marshall et al., 2005; Talbott et al., 2005; Zhou and Anderson, 
2002). Mash1 is also expressed by migratory OPCs (Parras et al., 2004; Parras et al., 
2007), which then gain the expression of the antigen O4, without losing PDGFR or 
NG2 (Bansal, 2002; Bansal and Pfeiffer, 1989, 1994). Premyelinating OPCs lose the 
expression of PDGFR and NG2, but not O4, and gain the expression of 
galactocerebroside (GalC), adenomatous polyposis coli (APC), and 2',3'-cyclic 
nucleotide phosphohydrolase (CNPase). Mature myelinating oligodendrocytes are 
characterised by expressing myelin related proteins, such as myelin basic protein 
(MBP), proteolipid protein (PLP), myelin-associated glycoprotein (MAG) and myelin-
oligodendrocyte glycoprotein (MOG) (Verkhratsky and Butt, 2013). 
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Figure 1.3 Stages of oligodendrocyte differentiation. OPCs are derived from NSCs 
and undergo a series of stage specific modifications that can be identified by the 
expression of different markers.  From (Verkhratsky and Butt, 2013), see text for 
definition of abbreviations. 
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1.2.2 Trophic factors and regulation of oligodendrocyte differentiation 
Many growth factors regulate oligodendrocyte generation and differentiation in 
vitro and in vivo (Hinks and Franklin, 1999). PDGF is a major factor regulating OPC 
proliferation and is produced by both astrocytes and neurons acting via PDGFR on 
OPC that are lost at later stages of differentiation (Bogler et al., 1990; Frost et al., 
2003; Frost et al., 2009; Noble et al., 1990; Raff et al., 1988). FGF2 is also a potent 
mitogen for OPC by maintaining the expression PDGFR and inhibiting their 
differentiation (Bansal, 2002). IGF-1 stimulates proliferation of early and late OPCs 
and promotes cell survival in vitro (Saneto et al., 1988). In vivo, IGF-1 stimulates the 
number of myelinating oligodendrocytes and increases the amount of myelin 
produced (Carson et al., 1993; Saneto et al., 1988). Many cytokines and chemokines 
regulate OPC proliferation and differentiation, e.g. the interleukins IL-6 and IL-11 
(Gurfein et al., 2009; Pizzi et al., 2004), and astrocytic CXCL1 direct OPC migration 
through the interaction with CXCR2 (Omari et al., 2006). Specification of OPC 
development is strongly regulated by Shh and FGF2 during development (Kessaris 
et al., 2004).  Postnatally, OPC fate specification from NSCs in vivo is regulated by 
BMPs, Wnt and FGF2 (Azim and Butt, 2011; Azim et al., 2014a; Azim et al., 2012; 
Azim et al., 2014b; Fancy et al., 2009; Samanta and Kessler, 2004; Vallstedt et al., 
2005; Wu et al., 2012). Olig1 and Olig2 are required for OPC specification from NSC 
through Sox9 and Notch expression (Appel et al., 2001; Finzsch et al., 2008; Park 
and Appel, 2003; Park et al., 2005; Wu et al., 2012).  
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In addition, OPC are highly migratory in response to growth factors (Mitew et al., 
2013), and OPC migration is also dependent on components of the extracellular 
matrix (ECM), such as Tenascin-C and Fibronectin (Garwood et al., 2004). OPC 
migration, proliferation, survival and differentiation are regulated through multiple 
intracellular pathways, including the phosphatidylinositol 3-kinase (PI3K)/Akt 
signalling pathway, which inhibits negative regulatory pathways such as glycogen 
synthase kinase 3 (GSK-3) (Fingar and Blenis, 2004; Frederick et al., 2007; 
Guardiola-Diaz et al., 2012; Jossin and Goffinet, 2007; Pang et al., 2007; Rickle et al., 
2006). Cell cycle progression is tightly regulated by the cyclin-dependent kinases 
(Cdks) and their inhibitors. Proliferating OPCs show high expression of Cyclin D1, 
Cyclin E-Cdk2 and Cdk4/6 (Chew et al., 2011; Chung et al., 2006; Diehl et al., 1998; 
Ghiani and Gallo, 2001). Cell cycle exit is essential for terminal differentiation and 
myelination. The transcription factors Yin Yan 1 (YY1) and Sox17 interact to inhibit 
cell cycle re-entry (Chew et al., 2011; Rylski et al., 2008a; Rylski et al., 2008b; Sohn 
et al., 2006). YY1 interacts specifically with the inhibitor of myelin expression T-cell 
factor4/lymphoid enhancer factor1 (TCF4/LEF1) and inhibitor of DNA (ID)4 by 
recruiting histone deacetylase (HDAC) 1/2 to their promoter during OPC 
differentiation (Chen et al., 2012a; Du and Yip, 2011; Marin-Husstege et al., 2002; 
Swiss et al., 2011). HDAC1 and 2 are required for oligodendrocyte differentiation by 
competing with -catenin and BMP signalling, which negatively regulate 
oligodendrocyte differentiation (Chen et al., 2012a; Samanta and Kessler, 2004; Ye 
et al., 2009). 
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1.3 Astrocytes 
Astrocytes are the most heterogeneous glial population in the CNS, which reflects 
their numerous functional roles (Figure 1.4) . Identification of astrocytes requires a 
complex set of criteria based on their morphology, localisation, developmental 
stage and function. Protoplasmic astrocytes are present in the grey matter and are 
characterised by large primary processes with a very complex branching 
arborisation that gives them a spongiform appearance. Some processes contact 
synapses while others contact blood vessels and there is very little overlap between 
the process arborisations of neighbouring cells (Bushong et al., 2002; Sosunov et al., 
2014). Fibrous astrocytes are present in the white matter tracts of the brain, spinal 
cord, optic nerve and retina (Bernardos et al., 2007; Butt et al., 1994b; Butt et al., 
1994c). Fibrous astrocytes form the glia limitans of the pia and blood vessels, and 
send processes to contact axons at the nodes of Ranvier (Butt et al., 1994c). 
Contrary to protoplasmic astrocytes in grey matter, fibrous astrocytes form 
overlapping domains with neighbouring cells. Fibrous astrocytes have a diverse 
morphology and in the optic nerve there are three main phenotypes: stellate, 
transverse and longitudinal (Figure 1.5) (Butt et al., 1994b; Butt et al., 1994c). 
Polarised astrocytes are another class of astrocytes, characterised by one or two 
long processes that travel across the superficial cortical layer (Figure 1.4) (Oberheim 
et al., 2012). The retina contains a specialised set of astrocytes called Müller glia 
which contact retinal neurons and have a characteristic radial or polarised 
morphology, extending longitudinal processes along the line of rods and cones. The 
cerebellum also has a specialised class of radial astrocytes called Bergmann glia, 
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which are characterised by small somata and extend their processes from the 
Purkinje cell layer to the pia. The study of astrocytes has benefited considerably 
from the generation of reporter mice, such as the one used in this PhD, in which 
GFAP drives the expression of enhance green fluorescent protein (EGFP). The range 
of astrocyte morphologies observed in the brains of GFAP-EGFP mice is illustrated 
in Figure 1.6. 
Figure 1.4 Diverse morphologies of astrocytes in the CNS. From (Verkhratsky and 
Butt, 2013). 
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Figure 1.5 Camera Lucida drawings illustrating the diverse morphologies of 
astrocytes in the optic nerve. From (Butt et al., 1994b). 
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Figure 1.6 Diverse morphologies of astrocytes observed in the CNS of GFAP-EGFP 
reporter mice, ranging from the spongiform appearance of protoplasmic astrocytes 
of the cortex (H), CA region of the hippocamous (P) and dorsal horn of the spinal 
cord (X), to highly polarised radial astrocytes of the SVZ (I), third ventricle (J, O) 
and dentate gyrus (Q). From (Verkhratsky and Butt, 2013). 
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1.3.1 Physiology  of astrocytes 
Astrocytes perform many physiological functions that are dependent on their 
morphological associations with synapses, blood vessels and the pia, and their 
expression of a wide complement of receptors, channels, transporters and 
intracellular signalling mechanisms. These have been comprehensively reviewed 
elsewhere (Verkhratsky and Butt, 2013) and are summarised in Figure 1.7. Key 
features of astrocytes are their expression of plasmallemal proteins that determine 
their physiological functions. Two primary functions of astrocytes are the uptake of 
potassium and glutamate released during neuronal activity. Potassium regulation is 
dependent on inward rectifying potassium channels (Kir), mainly of the subtype 
Kir4.1, whereas glutamate homeostasis is dependent on the excitatory amino acid 
transporters (EAAT) 1 and 2, or GLAST and GLT1. Astrocytes are also responsible for 
water homeostasis through their expression of aquaporins (AQP), primarily the 
AQP4 subtype. A key feature of astrocytes is their expression of neurotransmitter 
receptors, most notably ionotropic and metabotropic (G-protein coupled receptors, 
GPCR) receptors for glutamate (principally GluR1-5, or AMPA-type, and mGluR5 
receptor subtypes) and ATP (principally P2X2/3, P2X7 and P2Y1 receptor subtypes). 
In most cases, activation of these receptors evokes a rise in intracellular Ca2+, which 
is the substrate for astrocyte calcium excitability. Astrocytes are also characterised 
by a high degree of functional coupling via gap junctions formed from connexins, 
mainly of the Cx30 and Cx45 subtypes. Disruption of any of these physiological 
attributes of astrocytes results in CNS dysfunction and ultimately neuronal loss, for 
example changes in Kir4.1, EAAT1/2, glutamate receptors, purinoceptors, and 
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connexins are involved in the astrocyte response to injury and ischemia, and are 
implicated in most if not all CNS diseases, including epilepsy, multiple sclerosis 
(MS), amyotrophic lateral sclerosis (ALS), Parkinsons disease (AD) and Alzheimers 
disease (AD) (Matute and Cavaliere, 2011; Matute et al., 2006; Olsen and 
Sontheimer, 2008; Orellana et al., 2012; Van Den Bosch and Robberecht, 2008). 
Figure 1.7 Astrocytes have diverse physiological functions that are characterised by 
their expression of specific plasmalemmal proteins. From (Verkhratsky and Butt, 
2013). 
1.3.2 Reactive astrogliosis and glial scar formation 
Reactive astrogliosis is a defence mechanism of the CNS defined by a series of 
physiological and genetic changes in response to an insult, manifested by astrocyte 
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hypertrophy and increased proliferation (Sofroniew, 2009). The function of this 
mechanism is to increase neuronal protection and insulate the damaged area to 
avoid secondary degeneration due to an increased apoptotic response and, in 
ultimis, facilitate remodelling and repair. Reactive astrogliosis can be classified into 
isomorphic and anisomorphic. Isomorphic astrogliosis is characterised by 
hypertrophic astrocytes, elevated expression of GFAP and vimentin. These changes 
are not detrimental to the structure of the tissue and allow axonogenesis and 
synaptogenesis. In anisomorphic astrogliosis, however, there is a dramatic increase 
in astrocyte proliferation and hypertrophy. Moreover, these astrocytes lose their 
spatial domain and produce chondroitins and keratins, which are inhibitory to 
axonal regeneration. Anisomorphic astrogliosis results in an irreversible change in 
cytostructure known as the glial scar (Sofroniew, 2009). Astrogliosis is triggered by 
damaged cells in the insulted area with the release of neurotransmitters, 
glutamate, blood, growth factors and ATP. The combination of these factors 
determines the severity of astrogliosis. It is not known if mature astrocytes enter a 
proliferative state or if this is the function of astrocyte precursor cells dispersed 
through the parenchyma. Recent studies suggested that it could be a combination 
of both (Annalisa Buffo, 2009; Bardehle et al., 2013). Reactive astrogliosis is 
associated with disruption of astrocyte physiological properties and downregulation 
or loss of key physiological processes, such as potassium and glutamate 
homeostasis (Figure 1.7). 
19
1.4  Neurogenesis and gliogenesis in the developing CNS
All neural cells (neurons and glia) are of ectodermal origin and derive from 
neuroepithelium of the neural tube. For many decades it was thought that neurons 
derive from specialised progenitors called neuroblasts, while glia derived from 
spongioblasts. It was also taken for granted that the stem cell pool was depleted 
after birth and almost no proliferation occurred in the adult brain. This description 
has been changed by the discovery that radial glia and a subpopulation of 
astrocytes with stem cell properties give rise to neurons (Kriegstein and Alvarez-
Buylla, 2009). Neurons and glia derive from the multipotent stem cells - the 
neuroepithelial cells. Morphologically, these cells are highly polarised extending a 
single process between the pia and the ventricle. During embryogenesis these cells 
acquire features associated with radial glial cells (Figure 1.8), and begin to express 
markers associated with astrocytes, such as brain lipid-binding protein (BLBP), 
Tenascin C and the astrocyte-specific glutamate transporter (GLAST), as well as 
Nestin, Vimentin and GFAP (Campbell and Gotz, 2002; Hartfuss et al., 2001; 
Malatesta et al., 2000; Pinto et al., 2008). The endfeet of radial glia are anchored to 
each other through adherens junctions, which are critical for the ventricular 
structure and their stem cell behaviour (Kuo et al., 2006; Rasin et al., 2007). When 
the small Rho-GTPase Cdc42 is deleted, adherens junctions are lost and cells 
differentiate into intermediate progenitor cells (IPCs) (Cappello et al., 2006). Radial 
glia can generate neural cells through asymmetric division or through the 
generation of several IPCs with restricted linage fate, such as astrocyte IPCs (aIPCs), 
oligodendrocyte IPCs (oIPCs) and neuronal IPCs (nIPCs) (Alvarez-Buylla et al., 2001; 
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Alvarez-Buylla et al., 1988; Kriegstein and Alvarez-Buylla, 2009). These different 
IPCs coexist during development. During development, neuronal precursors migrate 
through the neural tube along the radial glia process. Gliogenesis starts after 
neurogenesis, astrocytes arising first, followed by oligodendrocytes. Finally, radial 
glia retract their primary processes and become parenchymal astrocytes (as 
described by Ramon y Cajal) and astrocyte-like stem cells. 
Figure 1.8  Neurogenesis and gliogenesis in the CNS. Neuroepithelial cells give rise 
to radial glia, which are the source of neurons and glia, via intermediate precursors 
cells for neurons oligodendrocytes and astrocytes. From (Kriegstein and Alvarez-
Buylla, 2009).  
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1.5  Adult neurogenesis and gliogenesis 
NSCs persist throughout life in restricted neurogenic regions, namely the SVZ of the 
lateral ventricle and dentate gyrus (DG) of the hippocampus, where they give rise to 
neurons and glia (Alvarez-Buylla et al., 2001; Doetsch et al., 1999; Kriegstein and 
Alvarez-Buylla, 2009). Neuroblasts that arise in the SVZ migrate along the rostral 
migratory stream (RMS) to the olfactory bulb to replace interneurons, whereas DG 
neuroblasts migrate a short distance to the hippocampus. In both neurogenic 
niches, new cells are derived from astrocyte-like stem cells (Doetsch et al., 1999; 
Kriegstein and Alvarez-Buylla, 2009; Tong and Alvarez-Buylla, 2014). These stem 
cells have phenotypic and genotypic features of astrocytes, as they express GFAP, 
form vascular end feet and have a negative resting membrane potential. However, 
they express the intermediate filament Nestin and some of them form a single 
primary cilium (Doetsch et al., 1999). These cells are also known in the SVZ as B-
cells that give rise to C-cells, which are IPCs and can generate neuroblasts 
(Kriegstein and Alvarez-Buylla, 2009). In contrast to neurogenesis, gliogenesis is not 
restricted to the SVZ, and glia appear to be generated everywhere from 
parenchymal IPCs present are the oIPCs or OPCs, which appear to be restricted to 
generating oligodendrocytes throughout life (Kang et al., 2010). 
1.6  Wnt signalling 
Wnt proteins were firstly identified as developmental morphogens in Drosophila 
and comprises of at least 19 members in mammals (Malaterre et al., 2007; Wodarz 
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and Nusse, 1998). These ligands are secreted cysteine-rich glycoproteins that 
activate signal transduction through their G-protein coupled receptor Frizzleds 
(FZDs) (Figure 1.9). Many studies have focussed on canonical Wnt signalling, which 
is the dynamic balance of -catenin ubiquitination and stabilisation, and its 
subsequent nuclear translocation. The canonical Wnt/-catenin signalling pathway 
has been implicated in many cellular processes involving cellular proliferation and 
differentiation (Jamora et al., 2003; Lie et al., 2005; Lindsley et al., 2006; 
Lyuksyutova et al., 2003; McWhirter et al., 1999; Nusse, 2008; Rochat et al., 2004; 
Sato et al., 2004; Seidensticker and Behrens, 2000; Shimizu et al., 2005; Ueno et al., 
2007). Wnt binding to the receptor FZD leads to the activation of Dishevelled (DVL) 
and subsequent degradation of the negative regulator complex constituted by APC, 
AXIN and GSK3. Under resting conditions, GSK3  induces the phosphorylation of 
-catenin, resulting in its subsequent degradation by ubiquitination. Inhibition of 
GSK3, on the other hand, leads to the stabilisation and accumulation of cytosolic 
-catenin, which then translocates to the nucleus and binds to TCF/LEF 
transcription factors leading to the transcription of target genes, such as Cyclin D1 
(Figure 1.9a) (Lindsley et al., 2006; Malaterre et al., 2007). Activation of FZD 
requires the interaction of co-receptors LRP5 and 6, which can induce Wnt 
activation by degradation of AXIN. Complex regulation occurs extracellularly to 
inhibit the Wnt pathway, including Dickkopf Wnt Inhibitory Factor (WIF) and the 
secreted FZD-related proteins (Hu et al., 2008; Malaterre et al., 2007). Furthermore, 
other pathways interact with Wnt and participate in the regulation of brain 
development, such as Notch, cadherins and BMP (Appel et al., 2001; Das et al., 
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2006; Park and Appel, 2003; Rajan et al., 2003; Samanta and Kessler, 2004; Shimizu 
et al., 2008; Xu et al., 2011; Yung et al., 2002).  
Figure 1.9  Wnt signalling, illustrating the canonical -catenin pathway (a) and non-
canonical Ca2+ and planar cell polarity (PCP) pathways (b). See text for definition of 
main abbreviations. From (Cohen and Frame, 2001). 
The non canonical Wnt pathways involve the release of intracellular calcium and 
the activation of Planar Cell Polarity (PCP) (Figure 1.9b, c). In the Wnt/calcium 
pathway, FZD activates phospholipase C (PLC) and phosphodiesterase (PDE) 
promoting the mobilisation of intracellular calcium (Figure 1.8b). This in turn results 
in a cascade of events that trigger the activation of downstream targets such as the 
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calcium-calmodulin-dependant kinase (CamKII) and Protein Kinase C (PKC) 
(Malaterre et al., 2007; Marchetti and Pluchino, 2013). However, few target genes 
have been characterised in the Wnt/calcium pathway and its role is still under 
investigation. Recent studies showed that Wnt5a can induce an increase of 
intracellular calcium regulating the dorso-ventral axis patterning (Keeble et al., 
2006). Moreover, Tomsig et al. (Tomsig et al., 2003) have identified a new class of 
calcium-dependant membrane-binding proteins called copines, which are capable 
of interacting with many target proteins, such as MEK1 and Cdc42. Wnt can also 
stimulate the PCP pathway by activating the small Rho GTPase through FZD. When 
FZD is activated it leads to its interaction with the Jun-N-terminal kinase (JNK) 
pathway, which in turn enables the interaction of DVL with Daam1 to activate Rho 
or Cdc42 (Figure 1.8c). The PCP pathway has a critical role during development in 
cytoskeletal remodelling and cell polarisation (Cappello et al., 2006; Etienne-
Manneville and Hall, 2003; Liu et al., 2013).  
1.7  Canonical Wnt signalling in neurogenesis and gliogenesis 
Stem cells require Wnt pathway activation to maintain a number of cellular 
characteristics, such as the capacity for self-renewal (Kim et al., 2009c; Lie et al., 
2005; Lindsley et al., 2006; Nusse, 2008; Zacharias and Gage, 2010). Wnt signalling 
has been found to regulate neurogenesis in the embryo and found to be still 
expressed in the adult mammalian brain (David et al., 2010; Kalani et al., 2008; Kelly 
et al., 1993; Krawetz and Kelly, 2008; Lie et al., 2005; Malaterre et al., 2007; Ohta et 
al., 2011). Furthermore, Wnt signalling is critical for correct oligodendrogenesis in 
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the developing SVZ, where its activation induces an expansion of NPs and OPCs 
(Azim and Butt, 2011; Azim et al., 2014a; Fancy et al., 2009; Fancy et al., 2011; 
Feigenson et al., 2009; Shimizu et al., 2005; Wu et al., 2012; Ye et al., 2009). The 
role of Wnt signalling on astrogliogenesis is unclear, but an increase of -catenin 
has been associated with increased gliosis and migration (Etienne-Manneville and 
Hall, 2003; White et al., 2009). 
While Wnt signalling during development has been well characterised, not much is 
known of its role in the adult brain. Wnt expression has been identified in the 
subgranular layer of the adult hippocampal DG and in the lateral wall of the SVZ 
(Adachi et al., 2007; Malaterre et al., 2007). Expression of Ccd1, a positive regulator 
of Wnt/ -catenin signalling, has been identified in embryonic as well as adult brain 
(Shiomi et al., 2005). Wnt7a, Wnt5a, Wnt6, Wnt10 and Wnt3 and Wnt3a expression 
have been shown in different brain regions (David et al., 2010; Huang and Qin, 
2010; Lucas and Salinas, 1997; Shimogori et al., 2004; Topol et al., 2003; Tsukiyama 
and Yamaguchi, 2012), and other components of the Wnt pathway, such as Lef-1 
and Axin, are expressed by progenitor cells in the neurogenic niches (Azim et al., 
2014a; Azim et al., 2014b; Barolo, 2006; Shimizu et al., 2008; Zacharias and Gage, 
2010). All these molecules participate in the tight control of NSC proliferation and 
at the same time avoid uncontrolled differentiation that would result in the 
depletion of the neurogenic pool. 
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1.8  The different roles of b-catenin 
B-catenin is a multitasking conserved molecule that is involved in many 
developmental and homeostatic cellular processes (Figure 1.10).-catenin was 
firstly characterised by Heasman et al. for its role as a cell-cell adhesion molecule 
and later as a nuclear effector in the canonical Wnt pathway.  (Giampuzzi et al., 
2003; Heasman et al., 1994; Valenta et al., 2012). The Drosophila -catenin ortholog 
Armadillo gene was discovered for the similarity of its null-phenotype in wingless-
null mutants (Orsulic and Peifer, 1996; Wieschaus and Riggleman, 1987). However, 
-catenin is not just a component of the Wnt signalling cascade and its functions 
can be summarised in its dual role as a signalling and structural factor (Orsulic and 
Peifer, 1996; Valenta et al., 2012). -catenin protein consists of a central region 
made of 12 imperfect repeats that are flanked by a distinct N- terminal (NTD) and C-
terminal (CTD) domain (Valenta et al., 2012). While the central region is structurally 
rigid, the proximal parts CTD and NTD are not. The scaffold properties of the central 
region allow interaction with binding partners in the cytosol and nucleus (Orsulic 
and Peifer, 1996; Valenta et al., 2012). Each Armadillo repeat (ARM) in the central 
region forms a superhelix characterised by a positively charged groove. Crystal 
structure identified that all the binding partners share overlapping binding site in 
the groove, thus avoiding multiple binding at the same time. This is reflected in its 
mode of action as a binding partner for cell adhesion molecules (E-cadherins), for 
the degradation complex (APC) and nuclear factors (TCF/LEF) (Huber and Weis, 
2001; Poy et al., 2001; Valenta et al., 2012).  
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Figure 1.10  Multiple functions of -catenin. -catenin binds to cadherins and 
translocates to the plasma membrane where it forms adherens junctions. It may 
also interact with -catenin and indirectly modulate the actin cytoskeleton. In the 
cytosol, -catenin can be released by protein kinases from cadherins, and is 
immediately destroyed by ubiquitination. In response to Wnt activation, the 
destructive complex (APC/GSK3/AXIN) is inhibited and cytosolic -catenin can 
translocate to the nucleus, where it binds to the transcription factor TCF/LEF to 
induce transcription of target genes. (CTTA, C-terminal transcriptional activators, 
NTTA, N-terminal transcriptional Activators). From (Valenta et al., 2012). 
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Genetic ablation of -catenin in embryonic stem cells results in impaired 
differentiation of the mesodermal layer, which is associated with defective cell-cell 
junctions (Valenta et al., 2012). The majority of -catenin is located at the 
cytoplasmic side of the membrane as a component of cadherin cell-cell 
connections. Cadherins are transmembrane glycoproteins that engage in calcium 
dependent interactions between their extracellular tail and -catenin at the 
cytoplasmic level. Many cells can co express different type of cadherins, but the 
most studied is the -catenin interaction with E-cadherin (Stepniak et al., 2009). 
inding of -catenin to E-cadherins takes place in the cytoplasm, where they 
translocate together to the plasma membrane, thus avoiding -catenin binding to 
the degradation complex (APC/Axin/GSK3) (Stepniak et al., 2009; Valenta et al., 
2012). The -catenin-cadherin complex binds to -catenin to inhibit the 
polymerisation of actin bundle filaments (enjamin et al., 2010; Yamada et al., 
2005). The -catenin-cadherin complex form highly dynamic adherens junctions. An 
important developmental process is the epithelial mesenchymal transition (EMT) 
that is modulated by a change in cell-cell adhesion. The Wnt pathway is one of the 
signals that control EMT by directly or indirectly controlling cell adhesion. The 
transcription factor Twist is a bHLH that is critical for mesodermal characterisation 
(Howe et al., 2003), and Twist directly down-regulates the expression of E-
cadherins, while inducing the expression of N-cadherin and fibronectin (Yang et al., 
2006). Recent studies have shown that lysil oxidase (Lox) can actively sequester 
cytosolic -catenin to the plasma membrane (Giampuzzi et al., 2003; Sanchez-
Morgan et al., 2011). Furthermore, Lox has a high affinity toward fibronectin (Fn1) 
(Fogelgren et al., 2005) and has been shown to be critical for cross-linking of elastin 
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fibres to collagen fibrils and the maintenance of ECM integrity (Kagan and Li, 2003). 
Genetic ablation of Lox results in perinatal death, due to aberrant cardiovasculature 
development (Maki et al., 2002). Lox is enriched in polarised epithelial cells (Jansen 
and Csiszar, 2007). 
1.9  GSK3 signalling 
GSK3 is a serine/threonine protein kinase that is encoded by two genes that yield 
two related proteins : GSK3 and GSK3. oth isoforms are ubiquitously expressed, 
although their proportion may vary according to the cell type (Doble et al., 2007; 
Doble and Woodgett, 2003; Kockeritz et al., 2006). GSK3 is 47kDa and GSK3 is 
5kDa larger, due to a glycine-rich extension at the N-terminus (Woodgett, 1990). 
The phosphorylated N-terminus of GSK3 serves as a pseudosubstrate that binds to 
the positively charged pocket, competing with primed substrates for binding to the 
catalytic groove (Doble and Woodgett, 2003; Meijer et al., 2003). GSK3 was first 
identified as an enzyme involved in glycogen synthesis, but it has been shown to 
interact with various substrates (Doble et al., 2007; Kockeritz et al., 2006), and 
generally acts as a negative regulator of various cellular processes (Grimes and 
Jope, 2001b). Unlike many proteins, GSK3 is active at resting condition and its 
activity is regulated by its inactivation (Grimes and Jope, 2001b; Jope et al., 2007). 
Inhibition of GSK3 is mediated by its phosphorylation at Ser9 in response to 
external stimuli. In contrast to the inhibitory effects of serine phosphorylation, 
direct phosphorylation of the tyrosine residue (Tyr216) located within the catalytic 
domain is associated with an increase in kinase activity, although it is not strictly 
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required, and the mechanisms regulating this modification are not well-understood 
(Doble and Woodgett, 2003; Hughes et al., 1993). Canonical Wnt signalling is the 
most characterised inhibitor of GSK3 activity (Azim and utt, 2011; Lindsley et al., 
2006; Saneyoshi et al., 2002; Sato et al., 2004). However, it was recently shown that 
GSK3 can be inactivated by phosphorylation by Cdc42 in response to PCP activation 
(Cappello et al., 2006; Etienne-Manneville and Hall, 2003). The PI3K/Akt pathway is 
a major regulator of GSK3, as Akt can directly inactivate GSK3 activity in response to 
its activation by FGF2 or IGF-1 (Frederick et al., 2007; Rochat et al., 2004). Several 
other protein kinases can also inhibit GSK3 function, such as mammalian target of 
rapamycin (mTOR), PKC, PKA, among others (ain et al., 2007; Cohen and Goedert, 
2004; Grimes and Jope, 2001b; Thornton et al., 2008). 
1.10  Lithium and its role as a GSK3 inhiitor 
Lithium has been extensively used as a mood stabilizing agent for decades, since its 
first documented use in 1949, and is still considered the standard treatment for 
bipolar disorder (D) (Cade, 1949; Licht, 2012). Its mechanisms of action are not 
completely clear, however there is strong evidence that it actions are due to direct 
and indirect inhibition of GSK3 (Jope, 2003; Quiroz et al., 2010). Although lithium 
was firstly identified for its ability to inhibit GSK3 (Klein and Melton, 1996), it has 
been shown to interact with neurotrophic signals, such as the Nerve Growth Factor 
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 (NGF), rain-Derived Neurotrophic Factor (DNF), extracellular-regulated kinase 
(ERK), PI3K/Akt, Notch and cAMP response element binding (CRE), which are all 
important for cellular survival, proliferation and differentiation (Figure 1.11)  (Azim 
and utt, 2011; Grimes and Jope, 2001a; Lee et al., 2007; Lindsay, 1988; Narayanan 
et al., 2009; Zhou et al., 2004). The inhibition of GSK3 and other kinases by lithium 
is thought to be its direct competition with magnesium (Jope, 2003; Quiroz et al., 
2010). However, it also indirectly increases the phosphorylation of GSK3 (Jope, 
2003; Quiroz et al., 2010). The mood-stabilising effects of lithium are in part 
Figure 1. 11 Lithium affects diverse cellular pathways involved in proliferation, 
differentiation and survival. Many of the effects of li thium are associated directly or 
indirectly with its inhibitory action on GSK3, but it can also inh ibit other kinases and 
stimulate the activation of ERK/MAPK, PKC, CRE and CL-2. From (Quiroz et al., 2010).
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attributed to its GSK3 inhibitory properties, since other GSK3 inhibitors exert the 
same effect (Kaidanovich-eilin et al., 2004; O'rien et al., 2004).  
The diverse actions of lithium have been reported to have beneficial effects in 
multiple neurological diseases, including ischemia, injury, AD, ALS, PD, and MS (Chiu 
et al., 2013). Lithium has been shown to promote axonogenesis and ameliorate 
disease in experimental autoimmune encephalomyelitis (EAE), an animal model of 
MS (De Sarno et al., 2008; Dill et al., 2008; Huang et al., 2003). Furthermore, GSK3 
inhibition by lithium has been shown to increase OPC proliferation and myelination 
in vivo (Azim and utt, 2011). At therapeutic concentrations, lithium activates the 
ERK/MAPK signalling in vitro and in vivo (Einat et al., 2003; Quiroz et al., 2010). 
ERK/MAPK activation of CRE leads to the expression of DNF and the subsequent 
expression of CL-2 (Azim and utt, 2011; Chen et al., 1999). CRE is one of major 
targets of PKA in the CNS and plays a critical role in neuroplasticity (Afshari et al., 
2001; Gao et al., 2004; Grimes and Jope, 2001a; Liang et al., 2008; Saini et al., 
2004).  Chronic administration of lithium has been associated with the modification 
of other neurotrophic factors, such as NGF and vascular endothelial growth factor 
(VEGF) (Angelucci et al., 2003; Warner-Schmidt and Duman, 2008). Lithium also 
directly inhibits inositol monophosphatase (IMP) (Hallcher and Sherman, 1980). The 
decrease of IMPase results in a decrease of free myo-inositol and the subsequent 
production of dyacylglycerol (DAG) and the decrease of PKC activity. PKC is present 
in the brain where it controls oligodendrogenesis and axonogenesis, 
neurotransmission and myelination (Afshari et al., 2001; aron et al., 2000; Mitew 
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et al., 2013; Wolf et al., 2008). Several biochemical changes have been attributed 
for the neurotrophic properties of lithium against oxidative stress, apoptosis and 
inflammation (Chen et al., 1999; Goldstein et al., 2009; Huang et al., 2003; Nahman 
et al., 2012; Quiroz et al., 2010; Wada et al., 2005). Recent studies showed an 
association between chronic lithium treatment and gray matter volume in brain 
areas implicated with emotional and cognitive processes (Malhi et al., 2013; Phillips 
et al., 2008; Warsh J.J., 2004). Interestingly, lithium has been shown to stimulate 
neurogenesis and differentiation in subjects with ALS (Fornai et al., 2008).   
1.11  Hypothesis and Aims 
Lithium has major therapeutic potential in multiple neurodegenerative diseases, 
most often associated with its GSK3 inhibitory action. A major action of GSK3 is 
through Wnt/-catenin signalling, which is a major determinant of glial cell fate in 
the developing CNS. However, the actions of lithium on glial cells have been largely 
overlooked and the potential functions of Wnt/-catenin signalling in non-
neurogenic regions of the adult CNS are unresolved. The hypothesis underpinning 
this thesis is that lithium and Wnt/-catenin are central regulators of gliogenesis in 
the adult CNS as observed during development. The overall aim of the thesis is to 






Various ages of mice were used throughout this study, as indicated in the relevant 
sections. The wildtype mouse strain used was the C57/L6 or C57/L10, and 
transgenic mice were PLP1-DsRed, GFAP-EGFP and SOX10-EGFP strains. In these 
transgenic mice the fluorescent reporter is under the control of the PLP1, GFAP or 
SOX10 promoter respectively. The DsRed reporter fluoresces only in myelinating 
cells (Hirrlinger et al., 2005). The GFAP-EGFP mice consists in the human GFAP 
promoter sequence tagged to the enhanced green fluorescent protein (EGFP) 
(Nolte et al., 2001). Similarly, the construct for the generation of the Sox-10-EGFP 
transgenic mice was assembled by standard in vitro DNA cloning techniques 
followed by manipulation of a genomic PAC construct in bacteria, the gel purified 
DNA was injected into fertilized mouse eggs which were returned to a 
pseudopregnant female mother to generate mice carrying the PAC transgene, 
Sox10-loxP-EGFP-4xpolyA-loxP-DTA (Stolt et al., 2006). GFAP-EGFP and PLP1-DsRed 
mice were kindly donated by Prof. Frank Kirchhoff while the GFAP-EGFP transgenic 
mice were donated by Prof. W.D. Richardson. The transgenic mice used in this study 
did not exhibit any external phenotype, appeared to be normal, and able to breed 
normally . Transgenic mice were used for all the biological experiments, while 
wildtype mice were used for all the genetic and proteomic studies. All animals were 
killed humanely by schedule 1 procedure in accordance with Home Office 
instruction (Animals Scientific Procedures Act 1984). 
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2.2 Chemicals and Solutions 
All chemicals and solutions were obtained through Sigma or Fisher, unless 
otherwise stated. Lithium Chloride, the Lox inhibitor -Aminopropionitrile and the 
Lox activator Suramin were dissolved in sterile dH2O at a stock concentration 
indicated by manufacturers instructions and diluted accordingly in culture medium. 
The Wnt3a agonist (2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-
methoxyphenyl)pyrimidine), the GSK3 inhibitor AR-A014418 were dissolved in 
dymethyl sulphoxide (DMSO) following manufacturers instructions. The Wnt3a 
agonist has been shown to activate the Wnt canonical pathway without inhibiting 
the activity of GSK3 (Liu et al., 2005). Furthermore, it has been shown to stimulate 
the Wnt pathway in oligodendrocytes, therefore any subsequent references to 
Wnt3a in the manuscript refers to this agonist (Azim and Butt, 2011). 
2.3 Ex vivo optic nerve culture 
GFAP-GFP, PLP-DsRed and Sox10-GFP mice aged postnatal day (P)35-45 were killed 
by cervical dislocation followed by decapitation. The skull was removed and the 
brain retracted. The optic nerves (ONs) were cut at the chiasmal end and dissected 
free with the eyeball attached. The tissue was then gently drawn from the cavity 
intact and placed immediately in ice chilled oxygenated artificial CSF composing of: 
NaCl 133 mM, KCl 3 mM, CaCl2 1.5 mM, NaH2PO4 1.2 mM,  HEPES buffer 10 mM, 
pH 7.3 0.5% penicillin and streptomycin (Invitrogen). To counteract glutamate 
activation caused by the dissection, Kynurenic Acid (Sigma) 0.1 mM was added to 
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the aCSF. ONs were cleaned under the dissecting microscope; residual tissue such 
as the arachnoid membrane, muscle, and peripheral nerves that were attached to 
the eye were removed. Tissue were washed once in clean aCSF and placed on 
semiporous culture membrane inserts (Millipore 0.4 µm), using 1  ml of serum 
based media consisting of 25% horse serum (Invitrogen), 49% OptiMEM 
(Invitrogen), 25% Hankss balanced salt solution (Invitrogen), 0.5% 25 mM glucose, 
0.5% penicillin and streptomycin (Invitrogen), and incubated at 37°C, 95%O2, 5% 
CO2 for up to 7 days in vitro (DIV) maximum.  To enhance survival and promote 
interaction between media and the ON-retina, 50 µl of culture media was added 
directly over the ON-retina unit to slightly submerge the tissue.  The effects of the 
GSK3 inhibitors and the Lox inhibitors were added at the desired concentration in 
the media. Media was changed every two days. At the end of the culture period, 
the ON and the eye were separated and optic nerve tissue was prepared for protein 
or RNA extraction, or fixed in paraformalhdehyde (PFA) for 1 hour at RT.  
2.4 Western Blotting 
2.4.1 Tissue Lysis 
Optic nerves were separated from the eye and transferred in ice-cold lysis buffer 
(50 mM Tris, pH 8.0, 150mM NaCl, 1.0 % Triton X-100, 0.5% sodium deoxycholate, 
0.1 % SDS, 0.5M phenylmethylsulfonyl fluoride, Roche protease/phosphatase 
inhibitor cocktail tablets). Tissue was mechanically disrupted using 3 cycles of 10 
seconds each with 20 seconds rest on ice at maximum speed using the Precellys 
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MiniLys homogeniser (Bertin Technologies). Homogenates were transferred in a 
sterile Eppendorf and centrifuged for 15min at 4 ° C. 
2.4.2 BCA Assay for Determination of Protein Content 
The protein concentrations of samples were determined using Bradford assays.  
Protein standards 1 mg bovine serum albumin (BSA) /ml in 0.15M NaCl, 0.05% NaN3
(Sigma-Aldrich) serial dilution were made up with sterile distilled H2O.  Samples 
were analysed using a plate reader (POLAR star OPTIMA, BMG LabTech) and 
samples were diluted with lysis buffer to obtain equal protein content.  
2.4.3 Protein Separation, Transfer and Detection 
SDS polyacrylamide gel electrophoresis (PAGE) of 8-10% and 5% stacking gels were 
prepared. The cell lysates in Laemli buffer (Biorad) and -mercaptoethanol (Sigma) 
were heated for 5 min at 95 ° C. The prestained protein molecular weight marker 
(Biorad) was used for protein size indication. 30µg protein was loaded into each gel 
lane. The electrophoretic separation was carried out at a constant voltage of 100V 
(vertical slab gel, 1.5 mm x 14 cm x 14 cm). Following this, gels were subjected to 
wet transfer to a polyyinylidene fluoride (PVDF) membrane (GE healthcare). The gel 
and membrane were sandwiched between two stacks of filter paper that had been 
pre wetted with transfer buffer containing: 25mM Trizma Base, 192 mM Glycine, 
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20% Methanol, and ran for 1 hour at constant Amperage of 75mA for each 
sandwich. To control protein transfer, the PDVF membrane was stained in Ponceau 
S (Sigma) following manufacturer instructions. Membranes were washed in distilled 
water (dH20) to remove any staining and washed twice for 10 min in TRIS buffered 
saline (TBS) at pH 7.4 and incubated for 1h at room temperature (RT) or overnight 
at 4 ° C in blocking solution containing 5% BSA in TBS and 0.1% Tween or 5% Milk 
powder in TBS with 0.1% Tween. Membranes were incubated overnight at 4°C in 
primary antibody. After primary incubation, membranes were washed three times 
in TBS and Tween 0.1% for 10 min and incubated in HRP-conjugated antibodies 
(DAKO) for anti-mouse or rabbit as appropriate. Membranes were washed twice in 
TBS and 0.1% Tween for 10 min each cycle. An enhanced chemiluminescent (ECL) 
detection (GE healthcare) was prepared by mixing enhanced luminal to oxidising 
agent in ration 1:1. The reagent was spread on the membrane and incubated for 5 
min at RT.  After removing the excess of reagent, the membrane was exposed to an 
ECL detection system (Amersham Biosciences) coupled to a PC and images captured 
digitally. A list of antibodies used is given in Table 2.1. 
Table 2.1 Antibodies used for Western Blot analysis 
Antiody 
Target Raised in Dilution Source
PDGFR Rabbit 1:300 Santa Cruz
PCNA Mouse 1:1000 Sigma
-actin Mouse 1:10000 Sigma
SOX10 Rabbit 1:300 Abcam
OLIG2 Rabbit 1:400 Millipore
HRP Goat -mouse 1:10000 DAKO
HRP Goat -Rabbit 1:10000 DAKO
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2.5  RNA extraction 
Optic nerves were separated from the eye and placed in 500 µL of ice-chilled Trizol 
(Sigma). Tissue was mechanically disrupted with a sterile plastic pestle. 
Homogenate was passed through a 19 gauge syringe needle 10 times and rested for 
5 min. 100µL of Chloroform (Sigma) was added and samples were vigorously shaken 
for 15 sec and rested for 3 min at RT. Samples were then centrifuged at 14000 g for 
15 min at 4°C. The clear aqueous phase containing the RNA was carefully separated 
and added to 70% ethanol (Sigma) at the ratio 1:1. RNA was then loaded to a 
RNeasy MinElute spin column (Qiagen) and processed following manufacturers 
instructions using a RNeasy Micro kit (Qiagen). RNA concentration was determined 
by spectrophotometry at A260 using Nanodrop ND-1000 spectrophotometer. 
Samples were then stored at -80°C for subsequent experiments. 
2.6 Microarray preparation and analysis 
1µg of RNA was converted to double stranded cDNA using the Bioarray Single 
Round RNA amplification and Labelling Kit (Enzo Life Science). After second strand 
synthesis, cDNA was purified using the cDNA purification kit (Enzo Life Science). 
Double stranded cDNA was used to generate multiple copies of biotinylated cRNA 
using the Bioarray Highyield RNA transcription Labelling Kit (Enzo Life Sciences). 
Quality control on the biotinylated cRNA produce included the determination of the 
A260/280 ratio.  
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For microarray chip hybridisation, 10µg of each biotinylated cRNA samples was 
hybridised on an Affymetrix GeneChip Mouse Genome 430 2.0 for 16 h at 45°C. 
Subsequently, arrays were washed and stained using the Affymetrix GeneChip 
Fluidics Station and scanned using an Affymetrix GeneChip Scanner 3000. Quality 
control analysis and data analysis produced .CEL image and .CHP image files for 
further analysis using an Affymetrix GeneChip Operating Software. All samples 
passed quality control as advised from the ATLAS-Biolabs company, Germany. 
Data analysis was performed using the GeneSpring GX 12 software (Agilent). Data 
normalisation was carried out using the MAS-5 algorithm and to visualise the data, 
baseline transformation to the mean of all samples was carried out. GeneSpring GX 
software was used to prolife genes of interest and obtains datasets form samples. 
Further microarray analysis including functional analysis and pathway analysis was 
performed using the Ingenuity Pathway Analysis (IPA) software (Ingenuity). In brief, 
after statistical analysis performed in GeneSpring GX 12, datasets containing Fold 
Change and P values were uploaded onto IPA for subsequent analysis. 
42
2.7 qRT-PCR 
500 ng of Total RNA of each sample were converted to single stranded cDNA using 
the RT2 First Strand Kit (Qiagen) following manufacturers instructions. 
Subsequently, cDNA was added to SYBR mastermix (Qiagen) and 25µL was added to 
each well of the optimised PCR Array RT2 WNT signalling Pathway (Qiagen). 
Samples were run using a Roche Lyghtcycler 96 (Roche) instrument. Reaction 
consisted of one cycle at 95°C for 15 s followed by 45 cycles at 60°C for 1 min each. 
Data normalisation for this array was performed using the housekeeping gene 
Hsp90ab1. Analysis was performed using t-test statistical analysis and volcano plots 
analysis as shown in Section 6.  
For specific gene analysis, cDNA was added to a mixture of FAM dye-labelled primer 
and FastStart mastermix (Roche) following manufacturers instructions. PCR 
amplification was performed as follows: 1 cycle at 95°C for 600 sec followed by 45 
cycles of two step amplification of 95°C for 10 sec and 60°C for 30 sec. Data 
normalisation was performed using Gapdh and Rpl13a or Hsp90ab1 housekeeping 
genes identified from the microarray samples data as the most stable using the 
Normfinder algorithm (Andersen et al., 2004). A list of primers and their sequence 
are shown in Table 2.2 
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2.8 Immunostaining techniques 
All antibodies used are listed in table 2.3 with the concentration at which they were 
applied. 
Table 2.3 Details of antibodies used for Immunostaining techniques  
Antibody 
Target Raised in Dilution Source 
GFAP Chicken 1:200 Chemicon 
MBP Rat 1:300 Chemicon 
NG2 Rabbit 1:400 Chemicon 
















Optic nerves were separated from the eye and fixed in 4% PFA in PBS for either 1 h 
at RT or overnight at 4°C. Tissue was placed in cryoprotectant (30 % sucrose in PBS) 
overnight at 4°C. The tissue was then orientated and embedded in Cryo-M-Bed 
(Bright Instruments Company Ltd) before rapid freezing at -80°C. 12µm transverse 
sections were cut with a Leica CM3050 S cryostat (with a chamber of -21°C) and 
transferred onto a Polysine coated slide (Thermo-Scientific). Prior to antibody 
incubations, tissue was washed in PBS for 30 min at RT and then blocked in 5% 
normal goat serum (NGS) in PBS with 0.1% Triton X-100 for one hour at RT. All 
antibodies were diluted into blocking solution and incubated overnight at 4°C. After 
three washes of 10 min each in PBS with gentle agitation, secondary antibodies 
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were incubated at RT for 1h. Samples were washed three times in PBS with gentle 
agitation and mounted with fluoromount G (Southern Biotech). Images were 
acquired using confocal microscopy. 
2.8.2 Confocal microscopy 
Images were captured maintaining the acquisition parameters constant to allow 
comparison between samples.  The brightness and contrast of flattened confocal 
sections was adjusted slightly to obtain clear visible images.  Unless stated, confocal 
flattened z-section micrograph of wholemounted optic nerves are presented 
throughout this thesis.  Confocal parameters were kept constant between all 
analysed samples, and controls flattened confocal micrographs are of equal 
thickness and magnification unless otherwise stated.   
2.9 Quantification of glia in the optic nerve 
SOX10-EGFP, GFAP-EGFP and PLP1-DsRed positive cells were identified by confocal 
microscopy and confocal micrographs obtained using constant parameters. Cells 
were counted in 1 constant Field of View (FOV) per optic nerve of 200µm x 200µm x 
20µm (x-y-z). Due to the high number of SOX10-EGFP cells, the FOV was reduced to 
200µm x 200µm x 5µm. Statistical analysis was performed using GraphPad Prism 
v3.02 for one way analysis of variance (ANOVA) followed by Bonferroni post-hoc 




Effects of Lithium on Macroglia 
in the Adult Mouse Optic 
Nerve
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3.1 INTRODUCTION AND AIMS 
GSK3b is a potent negative regulator of multiple signalling pathways in neuronal 
development, most notaly Wnt/b-catenin (Grimes and Jope, 2001a; Kim et al., 
2009c). Recent studies from our laoratory have shown that inhiition of GSK3b 
promotes genesis and differentiation of oligodendrocytes from OPCs derived from 
the SVZ in the developing forerain (Azim and Butt, 2011; Azim et al., 2014a; Azim 
et al., 2014). However, the role of GSK3b signalling in oligodendrocytes and 
astrocytes of the adult CNS are unresolved. This is important, ecause in adults 
several receptor-mediated pathways regulated y GSK3b are implicated in 
astrocyte reactivity and regeneration of oligodendrocytes in many neurological 
diseases, such as MS, injury and AD (Grimes and Jope, 2001a; Kim et al., 2009c). 
Lithium is a potent inhiitor of GSK3b and has een shown to have eneficial 
effects in a range of experimental models for injury, AD and MS (Chiu et al., 2013; 
Phiel and Klein, 2001). Therefore, the aim of this section was to examine the effects 
of lithium on adult oligodendrocytes and astrocytes using an ex vivo organotypic 
mouse optic nerve model. 
48
3.2  RESULTS 
3.2.1 Identification of glial cells in transgenic reporter mice
Brain slices from many different rain regions have een used in organotypic 
culture to study neuronal functions, most commonly hippocampus and cereellum 
(Gahwiler et al., 1997). However, most studies have focused on postnatal rodents, 
<P14, ecause adult tissues lose their integrity (Gahwiler et al., 1997; Stoppini et al., 
1991). Similarly, studies from our laoratory used the postnatal rodent optic nerve 
to examine the effects of GSK3b inhiition on oligodendrocytes during the peak 
period of their differentiation and myelination (Azim and Butt, 2011). However, 
care must e taken when extrapolating from the developing CNS to the adult. A 
major difference is that oligodendrogenesis is ongoing from aundant rapidly 
proliferating OPCs, whereas in the adult, OPCs are a small population of slowly 
proliferating cells (Kang et al., 2010).  Furthermore, astrocytes in the developing 
CNS have an immature phenotype and there is evidence they exhiit an attenuated 
reactive response to CNS insults (Jarlestedt et al., 2010). Hence, the first aim of this 
section was to develop model to study glial cells ex vivo in the adult optic nerve. A 
numer of different techniques were tested, ut the key to maintaining optic nerve 
survival and integrity was to carefully and rapidly dissect the optic nerve free with 
the eyeall intact, whilst maintaining the tissue moist with ice-cold aCSF containing 
kynurenic acid, to lock NMDA receptors. The tissue was cleaned of excess tissue 
(e.g. muscle and lood vessels) and the arachnoid carefully removed, efore 
transferring intact to interface culture in serum ased medium. Optic nerves from 
GFAP-EGFP and Sox10-EGFP Tg mice were maintained ex vivo for 1 to 7DIV and 
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qualitative examination of wholemounted optic nerves y confocal microscopy 
indicated glial integrity was maintained in culture for 7DIV, the longest period 
examined (see Figure 3.4). At 3DIV, the period used in previous experiments (Azim 
and Butt, 2011), there was no significant effect on astrocyte cytoarchitecture 
(Figure 3.1A, B) or cell numers (Figure 3.1E). In contrast, there was some 
disruption of oligodendrocyte cytoarchitecture (Figure 3.1C, D) and a significant 
decrease in the numer of Sox10-EGFP+ cells (Figure 3.1E); in controls, 
oligodendrocytes are arranged in interfascicular rows of 3-4 cells, and these rows 
were less evident after 3DIV for oth Sox10-EGFP (Figure 3.1C, D) and PLP1-DsRed 
(insets Figure 3.1C, D). Higher magnification confocal microscopy confirms that 
astrocyte and oligodendrocyte cellular integrity were maintained in culture (Figure 
3.2A, B), and immunohistochemistry demonstrates that myelin and axons persisted 
after 3DIV (Figure 3.2C, D). 
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Figure 3.1 Effects of tissue organotypic tissue culture on optic nerve glia. (A-D) 
Representative confocal images of optic nerves acutely isolated (A, C) or 
maintained in culture for 3DIV (B, D), from GFAP- and Sox10-EGFP mice, as 
indicated; insets in C and D are from PLP1-DsRed nerves; scale ar in D = 50 m in 
main panels and 100 m in insets. (E) Histogram of mean (+SEM) cell counts per 
constant FOV; tested for significance compared to acute nerves using t-tests, 
*p<0.05, ***p<0.001, n=6 optic nerves for each group. 
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Figure 3.2 Glial integrity is maintained in optic nerve organotypic tissue culture. (A, 
B) Representative confocal images of astrocytes (main panels) and 
oligodendrocytes (insets) from optic nerves acutely isolated (A) or maintained in 
culture for 3DIV (B), from GFAP- and Sox10-EGFP mice, as indicated. (C, D) Sections 
of optic nerves from GFAP-EGFP mice after 3DIV and immunolaelled for MBP (C) 
and neurofilament (D); inset in C is negative control, in which primary antiody is 
omitted. Scale ar in D = 20 m in all panels, except inset in  C, where it = 50 m in 
insets. 
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3.2.2 Lithium stimulates gliogenesis ex vivo  
Optic nerves from GFAP-EGFP mice were maintained ex vivo for 3 or 7DIV in control 
culture medium or medium containing 20 mM lithium chloride, a concentration 
which has een shown previously to effectively inhiit GSK3 in the optic nerve due 
to the interaction etween Lithium cations and GSK3 (Azim and Butt, 2011; Klein 
and Melton, 1996). Examination of whole-mounted optic nerves y confocal 
microscopy showed that lithium increased the numer of astrocytes primarily 
etween DIV1 and DIV 3 (Figure 3.3). The numer of astrocytes in lithium was 
significantly greater than controls at oth 3DIV (Figure 3.3A, B) and 7DIV (Figure 
3.3C, C); unpaired t-tests, p<0.01 and p<0.001, respectively (Figure 3.3F). There was 
no statistical difference of astrocyte cell numers etween 3DIV and 7DIV nerves 
treated with Lithium (Figure 3.3F; n=6), and there was no significant difference 
when lithium was removed at 3DIV and nerves examined at 7DIV (Figure 3.3E, F).  
The results indicate that lithium has a maximal effect after 3DIV, and to determine 
whether lithium was required for this entire culture period, nerves were incuated 
for 1, 2 or 3 days in lithium, and examined qualitatively y confocal microscopy at 
3DIV (Figure 3.4). Representative data (n=6 in all experimental groups) indicate that 
removal of lithium from the culture medium after 1 or 2 DIV appeared less effective 
than continued incuation in lithium for 3DIV in oth astrocytes (Figure 3.4Ai-Aiii) 
and oligodendrocytes (Figure 3.4 Ci-Ciii).  
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In addition, culture medium containing serum has een shown to affect oth 
astrocytes and OPC in vitro (Ffrench-Constant and Raff, 1986; Raff et al., 1984), and 
so nerves were incuated in low serum (0.5%) for 1, 2 or 3DIV, in the presence of 
lithium throughout (Figure 3.4B, C). Representative data (n=6 in all experimental 
groups) indicate that the presence of serum did not markedly alter the effects of 
lithium on astrocytes (Figure 3.4Bi-Biii) or oligodendrocytes (Figure 3.4Di-Diii), and 
so serum was used in all susequent experiments. 
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Figure 3.3 Effects of lithium on optic nerve astrocytes. (A-E) Representative 
confocal images from optic nerves maintained in culture for 3 or 7DIV, in 
control medium (A, B), with lithium continuously (C, D), and following 
removal of lithium at 3DIV (E); scale ar in E = 50 m in all panels. (F) 
Histogram of mean (+SEM) cell counts per constant FOV; tested for 
significance compared to controls using t-tests, **p<0.01, ***p<0.001.  
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Figure 3.4 Effects of lithium and serum removal on optic nerve glia. Representative 
confocal images from optic nerves maintained in culture for 3DIV (72h). (A, C) 
Nerves were treated with normal medium containing lithium for 24h, 48h or the 
entire period of 72h, as indicated. (B, D) Nerves were maintained in low serum 
(0.5%) medium for 24h, 48h or 72h, as indicated, in the presence of lithium 
throughout. Scale ar in Diii = 50 m in all panels. 
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3.2.3 Concentration- and time- dependent effects of lithium on glia 
The results presented aove indicated lithium promoted gliogenesis over 3DIV, 
using 20mM lithium as in previous studies (Azim and Butt, 2011). To test this 
further, a concentration curve was examined in GFAP-GFEC mice (Figure 3.5). 
Compared to control nerves at 3DIV (Figure 3.5A), there was no significant effect of 
10 mM lithium on astrocyte numers (Figure 3.5B), ut they were significantly 
increased (p<0.001, unpaired t-tests) following incuation in 20 mM (Figure 3.5C) 
and 30 mM lithium (Figure 3.5D). There was no significant difference etween 20 
mM and 30 mM lithium (Figure 3.5F), and so 20 mM lithium was used in all 
susequent experiments.  
The time-course of action of lithium was examined in nerves from GFAP-EGFP, 
Sox10-EGFP and PLP1-DsRed mice and lithium significantly increased astrocyte and 
oligodendrocyte cell numers etween 2DIV and 3DIV (Figures 3.6 and 3.7). The 
numer of astrocytes was not altered after 2DIV in control culture or lithium 
compared to acute nerves (Figure 3.6E), ut astrocyte numers were more than 
douled after 3DIV in lithium, compared to control and acute nerves (Figure 3.6C-E; 
p<0.001, unpaired t-test).  
In Sox10-EGFP nerves, which identifies all oligodendrocyte lineage cells (oth OPC 
and oligodendrocytes), there was a gradual loss of oligodendrocyte lineage cells in 
culture over 2DIV compared to acute nerves (Figure 3.7G; p<0.01, unpaired t-test), 
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which did not progress further after 3DIV (Figure 3.7G). The decrease in Sox10-
EGFP+ cells in culture was completely locked y lithium at 2DIV (Figure 3.7C, D, G; 
p<0.001; unpaired t-test), and this was followed y a significant increase in Sox10-
EGFP+ cells after 3DIV in lithium (Figure 3.7E, F, G; p<0.001, unpaired t-tests), and 
significantly greater than in acute nerves (Figure 3.7G, p<0.05, unpaired t-test).  
Examination of PLP1-DsRed nerves, which identifies differentiated oligodendrocytes 
and not OPC (although it should e noted that this reporter is expressed in <50% of 
oligodendrocytes), indicated that differentiated oligodendrocyte numers slowly 
decreased in control cultures and were more than douled at 3DIV in lithium 
(Figure 3.7H; p<0.001, unpaired t-test compared to control), ut not altered at 1 or 
2DIV.  
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Figure 3.5 Concentration-dependent effects of lithium on optic nerve 
astrocytes. (A-D) Representative confocal images from optic nerves 
maintained in culture for 3DIV, in control medium (A),10mM lithium (B), 
20mM lithium (C) or 30 mM lithium (D); scale ar in D = 50 m in all panels. 
(E) Histogram of mean (+SEM) cell counts per constant FOV; tested for 
significance compared to controls using t-tests, ***p<0.001.  
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Figure 3.6 Time-course of the effects of lithium on optic nerve astrocytes. (A-D) 
Representative confocal images from optic nerves maintained in culture for 2 
or 3DIV, in control medium (A, C) or 20 mM lithium (B, D), as indicated; scale 
ar in D = 50 m in all panels. (E) Histogram of mean (+SEM) cell counts per 
constant FOV; tested for significance at each time-point compared to controls 
using unpaired t-tests, ***p<0.001.  
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Figure 3.7 Time-course of the effects of lithium on optic nerve 
oligodendrocytes. (A-F) Representative confocal images of optic nerves 
from Sox10-EGFP mice maintained in culture for 1, 2 or 3DIV, in control 
medium (A, C, E), or 20mM lithium (B, D, F), as indicated (insets are 
representative images of nerves from PLP-DsRed mice); scale ar in E = 50 
m in main panels and 100 m in insets. (G, H) Histogram of mean (+SEM) 
cell counts per constant FOV for Sox10-EGFP+ cells (G) and PLP1-DsRed+ 
cells (H); tested for significance at each time-point compared to controls 
using unpaired t-tests, ***p<0.001.  
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3.2.4 Effects of lithium on cell proliferation 
The results show that lithium increases astrocytes and oligodendrocytes specifically 
etween 2 and 3DIV, indicating cell proliferation (oligodendrogenesis and 
astrogliogenesis) at this time-point. This was examined y EdU laelling, ut very 
few proliferating cells were detected in optic nerve sections (not illustrated). 
Western lot analysis demonstrated significant expression of PCNA (proliferating 
cell nuclear antigen), a marker of cell proliferation (Azim and Butt, 2011), ut there 
was no significant difference etween the experimental groups (Figure 3.8). The 
source of newly generated oligodendrocytes in the optic nerve is adult OPC, which 
comprise a small population (approximately 5%) of slowly proliferating cells in the 
CNS (Kang et al., 2010; Psachoulia et al., 2009). OPC express Sox10 and can express 
PLP1, and so the increase in cells expressing these reporters in lithium at 3DIV 
reflects an expansion of OPC y proliferation and/or their increased differentiation 
into myelinating oligodendrocytes. However, this could not e confirmed y 
immunolaelling for the OPC marker PDGFR and fate-mapping of EdU laelled 
cells (not illustrated). Unfortunately, 12 optic nerves were required for each lot 
and so it was not practicale to perform comprehensive analyses of cell 
proliferation and death. 
It is accepted dogma that OPC only generate oligodendrocytes in the adult CNS 
(Kang et al., 2010; Richardson et al., 2011), hence newly generated astrocytes in 
lithium are likely to arise from cell division of mature astrocytes, a possiility that is 
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supported y EdU laelling of GFAP-EGFP+ cells after 3DIV in lithium (Figure 3.9A-
C). Furthermore, the close proximity of astrocytes after lithium treatment at 3DIV 
has the appearance of sister cells (Figure 3.9E), which was not oserved in controls 
(Figure 3.9D); some of these closely associated sister cells were EdU positive, 
indicating they had recently divided (Figure 3.9B, C). However, EdU laelling, cell 
tracking, and live cell imaging were unale to provide accurate quantitative data or 
unequivocally resolve the source of newly generated astrocytes in lithium (not 
illustrated). Nonetheless, NG2+ OPC may generate astrocytes in pathology (Tripathi 
et al., 2010), and work from our la has previously reported that astrocytes 
expressing the GFAP-EGFP reporter ecome immunopositive for the OPC marker 
NG2 in organotypic rain slice cultures (Leoni et al., 2009). At 3DIV in lithium there 
was evident co-localization of the GFAP-EGFP reporter with NG2 immunolaelling 
(Figure 3.10A) and of the Sox10-EGFP reporter with GFAP immunolaelling (Figure 
3.10B).  The results support the possiility that oth astrocytes and OPC are sources 
of newly generated astrocytes in lithium. 
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Figure 3.8 Effects of lithium on cell proliferation and oligodendrocyte markers. 
Optic nerves (n=12 nerves for each lot) were analysed y western lot for 
expression of PCNA (proliferating cell antigen), a marker for cell proliferation, 
and data (mean and intensity relative to -actin + SEM, n=3 replicates for 
each data point) were tested for significance compared to controls using 
unpaired t-tests. 
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Figure 3.9 Effects of lithium on astrocyte proliferation. Optic nerves from 
GFAP-EGFP mice were maintained in lithium culture for 3DIV. (A-C) EdU 
injection laelled rows of astrocytes (arrows). (D, E) Rows of astrocytes were 
not evident in controls (D) ut were frequent at DIV3 in lithium as illustrated 
y a single z-section confocal micrograph (E), where GFAP-EGFP+ cells 
appeared as sister cells. Scale ar=50 m in A, and 10 m in other panels. 
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Figure 3.10 Effects of lithium on astrocyte phenotype. Optic nerves from GFAP-
EGFP mice (A) and Sox10-EGFP mice (B) were maintained in lithium culture for 
3DIV. (A) Immunolaelling of sections for the OPC marker NG2 identifies cells 
expressing the astrocyte reporter GFAP-EGFP (arrow). (B) Immunolaelling of 
sections for the astrocyte marker GFAP identifies rows of cells expressing the 
oligodendrocyte reporter Sox10-EGFP (inset illustrates low magnification 
image, with characteristic astrocyte processes). Scale ars = 10 m. 
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3.2.5  Lithium has different effects than the GSK3 inhibitor AR-A014418 
Lithium is a potent inhiitor of GSK3 and is used in this context in many 
experimental paradigms. To examine this, the effects of lithium were compared to 
the specific GSK3 inhiitor AR-A014418 (Figure 3.11). AR-A014418 and lithium had 
the same effects on Sox10-EGFP+ oligodendrocyte lineage cells, significantly 
increasing their numers in an equivalent manner (Figure 3.11B, D, E, H). In 
comparison, although oth AR-A014418 and lithium significantly increased 
astrocytes compared to controls (p<0.001, unpaired t-tests), astrocyte numers 
were increased to a far greater degree in lithium than in AR-A014418 (p<0.001, 
unpaired t-tests). However, the most marked difference etween lithium and AR-
A014418 was the effect on astrocyte morphology, wherey astrocytes in AR-
A014418 appeared stellate (Figure 3.11C), whereas astrocytes in lithium were 
strikingly polarised, appearing as a dense network of cells oriented transversely 
across the optic nerve (Figure 3.11E). The morphogenic effect lithium is clearly 
illustrated at high magnification, which also demonstrates the close affiliation of 
astrocytes, suggestive of cell proliferation (Figure 3.12). 
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Figure 3.11 Effects of lithium and AR-A014418 on optic nerve glia. (A-F) 
Representative confocal images of optic nerves from GFAP- and Sox10-EGFP 
mice maintained in culture for 3DIV, in control medium (A, B), 20 M AR-
A014418 (C, D), or 20mM lithium (E, F), as indicated; scale ar in F = 50 m 
in main panels and 100 m in insets. (G, H) Histogram of mean (+SEM) cell 
counts per constant FOV for GFAP-EGFP+ cells (G) and Sox10-EGFP cells (H); 
tested for significance compared to controls using unpaired t-tests, *p<0.05, 
***p<0.001.  
68
Figure 3.12 Morphogenic effects of lithium on optic nerve astrocytes. 
Representative confocal images of optic nerves from GFAP-EGFP mice 
maintained in culture for 3DIV, in control medium (A, B), or 20mM lithium 
(C, D), as indicated; scale ars = 20 m.  
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3.3  DISCUSSION 
The developing CNS is characterised y its high plasticity and is primed to respond 
to stimuli that control cell differentiation and proliferation. However little or no 
proliferation is present after development, as most of the cells have reached 
terminal differentiation (Butt and Ransom, 1993; Kang et al., 2010). Thus, the 
stimuli that regulate gliogenesis during development may have different effects in 
adults. To examine this, we devised an ex vivo model that would allow the study of 
glial cells in the adult CNS y careful dissection of the optic nerve with retina intact. 
After 3 to 7 DIV, we confirmed that the model maintain its integrity and did not 
undergo severe axon/myelin degeneration or astrogliosis. Pharmacological 
inhiition of GSK3 y lithium has een shown to promote myelination in the 
developing rain (Azim and Butt, 2011). Here, we demonstrate that lithium 
promotes oligodendrogliogenesis in the adult optic nerve and show for the first 
time that lithium induces astrogliogenesis and causes a dramatic change in 
astrocyte morphology. By comparing the effect of the specific GSK3 inhiitor AR-
A014418, the effect of lithium on oligodendrocytes is consistent with its inhiitory 
action on GSK3. In contrast, the morphogenic effect of lithium was highly specific 
and hence is unlikely to e mediated y inhiition of GSK3. In the asence of a 
neurogenic niche such as the SVZ, the source of newly generated oligodendrocytes 
is adult OPCs. Astrocytes also appeared capale of cell division in response to 
lithium, and we also oserved colocalisation of GFAP with the OPC marker NG2 and 
the SOX10 reporter, suggesting that lithium may have stimulated the generation of 
astrocytes from OPC. 
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3.3.1 The ex vivo optic nerve model  
Most studies have used rain and cereellum of young animals (<P14) for 
organotypic rain slice cultures, due to the irreversile loss of integrity oserved 
when adult tissue was used (Gahwiler et al., 1997; Stoppini et al., 1991). Similar 
studies on postnatal optic nerves have een successful in studying oligodendrocyte 
differentiation and myelination (Azim and Butt, 2011). However, most 
neurodegenerative diseases, such as AD and MS, are diseases of the adult CNS 
(Goldenerg, 2012). Hence, we wished to develop a model for studying glial cells in 
the adult optic nerve, where oligodendrocytes and astrocytes are terminally 
differentiated, and there is a small pool of slowly proliferating adult OPCs that is 
capale of generating oligodendrocytes throughout life (Butt et al., 1999; Butt and 
Ransom, 1993; Kang et al., 2010; Psachoulia et al., 2009; Young et al., 2013). This 
compares with the postnatal tissue, where OPCs predominate and are undergoing 
cell proliferation, death and differentiation under the control of multiple intrinsic 
and extrinsic factors (Barres et al., 1992). To successfully maintain the integrity of 
the adult optic nerve, it was necessary to alleviate or prevent degenerative changes 
in axons and myelin, which we achieved y keeping the retina intact and 
performing nerve isolation in ice-chilled aCSF containing kynurenic acid, to lock 
NMDA receptor activation. Immunohistochemical analysis confirmed the presence 
of axons and myelin after 3DIV, although neurofilament and MBP immunolaelling 
appeared punctate, indicative of some degenerative changes in culture. This 
possiility was confirmed a general decline in SOX-10+ and PLP+ cell numers, and 
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a disruption of their arrangement within distinct rows. Nonetheless, there was not 
a reactive astrogliosis in control cultured nerves, consistent with tissue 
maintenance, as evinced y the integrity of axons, myelin and oligodendrocytes in 
culture in the asence of a marked astrogliosis. These results indicate that the 
model is useful for studying glial cells in adult white matter, aleit with the caveat 
that the tissue displays some hallmarks of dyshomeostasis and care must e taken 
when extrapolating results to the in vivo situation. 
3.3.2 Lithium stimulates oligodendrogenesis in the adult optic nerve 
Lithium is a potent inhiitor of GSK3 and previous studies in our laoratory 
showed GSK3 inhiition y lithium or other agents dramatically increased OPCs 
and myelinating oligodendrocytes in the developing forerain and optic nerve 
(Azim and Butt, 2011). The results of this section show that lithium had the same 
effects in the adult optic nerve and promoted oligodendrogenesis from adult OPCs, 
as it does with postnatal OPCs. The generation of oligodendrocytes from OPCs is 
determined y the alance etween OPC proliferation, apoptosis and 
differentiation, under the control of multiple extrinsic and intrinsic factors (Barres 
et al., 1993). The douling of oligodendrocytes in lithium demonstrates it promotes 
OPC proliferation and differentiation, and most likely survival. However, despite 
attempts to measure these parameters, western lot proved impractical due to the 
numers of animals required, and staining of tissue sections did not detect 
significant numers of cells in S-phase or undergoing apoptosis. This is consistent 
with previous findings in the optic nerve, due to apoptotic cells eing rapidly 
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cleared, and proliferating cells passing through S-phase rapidly, so that multiple 
injections of cell cycle markers are required for accurate measurements of cell 
proliferation and fate mapping (Barres et al., 1992; Calver et al., 1998; Psachoulia et 
al., 2009), Nonetheless, since in the adult optic nerve the numer of OPC is less 
than 1/10th that of oligodendrocytes (Butt et al., 1999), it is evident that the 
population of OPCs must have expanded around 2IV in order to generate the 
douling in Sox10+ cells oserved at 3 DIV. Adult OPCs normally divide very slowly, 
with a cell cycle time as great as 70 days (Psachoulia et al., 2009). However, OPC 
proliferation increases to a cell cycle time of <24h in response to many factors, 
including traumatic injury, demyelination and treatment with FGF2 (Butt and 
Dinsdale, 2005; Tripathi et al., 2010). Hence, the rapid expansion of 
oligodendrocytes in lithium after 3 DIV could only occur y a marked decrease in 
OPC cell cycle time and increased differentiation, and most likely survival. These 
effects of lithium on oligodendrocytes were equivalent in AR-A014418, indicating 
that in oligodendrocytes lithium acts primarily through inhiition of GSK3. AR-
A014418 and lithium are used as Wnt mimetics, ecause of their GSK3 inhiitory 
actions. Wnt has een very well characterised in the developing CNS for its role in 
neurogenesis and oligodendrogliogenesis (Azim and Butt, 2011; Azim et al., 2014a; 
Azim et al., 2014; Fancy et al., 2009; Kim et al., 2009c; Lindsley et al., 2006; 
Lyuksyutova et al., 2003; White et al., 2009). However, in the developing optic 
nerve, Wnt inhiited oligodendrocyte differentiation (Azim and Butt, 2011), 
whereas our results show lithium and AR-A014418 increased PLP+ oligodendrocytes 
in the adult nerve, suggesting they mimic the actions of factors such as IGF-I and 
FGF2, which act via PI3K/Akt to inhiit GSK3 and promote OPC survival and 
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differentiation (Azim et al., 2012; Azim et al., 2014; Barres et al., 1993; Flores et 
al., 2008; Zeger et al., 2007). 
3.3.3 Lithium stimulates astrogliosis and morphogenesis 
Astrocytes did not exhiit a reactive astrogliosis typical of an injury response, as 
characterised previously in the optic nerve (Butt and Colquhoun, 1996; Butt and 
Kirvell, 1996). However, we show for the first time that lithium stimulates a 
dramatic increase in astrocytes in the adult optic nerve, generally referred to as 
astrogliosis, which is the characteristic astrocyte response to CNS insults 
(Sofroniew, 2009). A similar astrogliosis was oserved in AR-A014418, ut to a 
lesser extent, suggesting that GSK3 is not the only factor mediating the effects of 
lithium on astrocyte proliferation. In fact, GSK3 inhiition has een oserved in 
response to scratch injury in vitro (Etienne-Manneville and Hall, 2003). Removal of 
lithium at 24h or 48h in culture showed that lithium was required continuously 
during the first 72h to mediate its full effects on astrogliosis. Interestingly, however, 
removal of lithium after this point did not significantly affect astrocyte numers for 
at least 7DIV, indicating the effects of lithium were complete y 3DIV. By comparing 
the effect of lithium with the synthetic specific GSK3 inhiitor AR-A014418, we 
oserved a remarkale difference in their morphogenic effects. Astrocytes in AR-
A014418 appeared morphologically normal, whereas those in lithium were highly 
polarised and distinct from astrocytes descried in the normal adult mouse optic 
nerve (Butt et al., 1994a; Butt et al., 1994). In lithium, astrocytes undergo a 
profound morphogenesis and assumed a highly polarised morphology, forming 
rows of cells that extended long rarely ranching processes that had few collaterals 
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and spanned the diameter of the optic nerve. This was not oserved in AR-
A014418, indicating the morphogenic effects of lithium were either due to the 
different ways in which they inhiit GSK3 or involved other pathways. AR-A014418 
inhiits GSK3 y competing with ATP and y inding to its pocket (Bhat et al., 2003), 
whereas lithium has a dual inhiitory action on GSK3, y directly competing with 
Mg2+ and y increasing the phosphorylation of the inhiitory serine of GSK3 (Jope, 
2003). GSK3 has een shown to e involved in many signalling pathways and is 
phosphorylated y Cdc42 resulting in a change in cell polarity (Etienne-Manneville 
and Hall, 2003). Therefore, selective inhiition of the ATP inding pocket in GSK3
might lock the negative regulation of cell proliferation without affecting cell 
polarity. Alternatively, lithium affects other signalling pathways that regulate 
astrogliosis, such as TGF (Sandvig et al., 2004). 
A spectrum of changes that characterise astrogliosis have een defined (Sofroniew, 
2009): isomorphic astrogliosis when the morphology and cytoarchitecture is 
preserved, and anisomorphic astrogliosis when astrocyte morphology is altered. In 
this respect, GSK3 inhiition with AR-A014418 is isomorphic and lithium is 
anisomorphic. However, lithium did not cause an increase in GFAP immunostaining, 
which is characteristic of reactive astrogliosis (Pekny and Nilsson, 2005), and the 
polarised astrocytes in lithium were distinct from the morphology of reactive 
astrocytes descried in the optic nerve following injury, which are densely GFAP 
immunopositive (Butt and Colquhoun, 1996; Butt et al., 1996). Instead, astrocytes 
in lithium appeared similar to transverse astrocytes descried in the developing 
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optic nerve that have a highly polarised morphology akin to radial glia in the 
developing rain (Butt and Ransom, 1993). The results demonstrate that lithium 
induced the generation of a novel type of astrocyte in the adult optic nerve. 
Astrocyte proliferation due to re-entry into cell cycle is considered to e the source 
of newly generated astrocytes following CNS insults (Bardehle et al., 2013; Pekny 
and Nilsson, 2005; Sofroniew, 2009). Certainly, following lithium treatment, we 
oserved EdU laelling in astrocytes and the clonal appearance of rows of closely 
apposed astrocytes, consistent with what recently shown in vivo y live cell imaging 
(Bardehle et al., 2013). Furthermore, there was evidence of colocalisation of NG2 
and SOX10 with GFAP immunolaelling, suggesting that lithium may have 
stimulated the generation of astrocytes from OPCs. Although OPCs are considered 
to only generate oligodendrocytes in vivo in the adult rain (Kang et al., 2010), they 
are ale to generate astrocytes in the developing rain (Zhu et al., 2011a), and 
studies in transgenic NG2 and PDGFR reporter mice have shown adult OPC 
generate astrocytes following injury and demyelination, aleit to a small extent 
(Komitova et al., 2011; Tripathi et al., 2010). Furthermore, we have shown OPC 
generate astrocytes in cereellar rain slice cultures (Leoni et al., 2009) and in optic 
nerve cultures in vitro in the presence of serum (Kondo and Raff, 2000). Our results 
indicate the astrogliosis and morphogenesis oserved in lithium is not dependent 
on serum, similar to our findings in cereellar slice cultures (Leoni et al., 2009). 
Thus, lithium may affect fate decision in adult OPC to favour astrogliogenesis, which 
has een descried for the lithium target canonical Wnt/-catenin in NSC 
(Muroyama et al., 2004). 
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3.4 SUMMARY AND CONCLUSIONS
In this section, lithium is shown to promote gliogenesis in the adult optic nerve. 
Comparison with AR-A014418 indicates the GSK3 inhibitory action of lithium is a 
key mechanism by which it promotes the expansion and differentiation of 
oligodendrocytes. In contrast, AR-A014418 and lithium have markedly different 
effects on astrocytes, and a key finding is that lithium has striking morphogenic 
effect and induces the generation of a novel kind of astrocyte not previously 
observed in the adult optic nerve or brain. The astrocytes induced by lithium do not 
have the phenotypic characteristics of reactive scar astrocytes and may be derived 
from OPC. The effects of lithium on oligodendrocytes and astrocytes suggest it may 
be a useful treatment for protection and repair in CNS injury and demyelination.  
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Section 4
Microarray analysis of gene 
targets of Lithium in the adult 
mouse optic nerve
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4.1  INTRODUCTION AND AIMS 
In the previous section, I provided evidence that lithium promotes gliogenesis in the 
adult optic nerve ex vivo in an organotypic culture model. The effects of lithium on 
oligodendrocytes are consistent with lithium being a potent inhibitor of GSK3, 
which is a profound negative regulator of oligodendrogenesis (Azim and Butt, 2011; 
Azim et al., 2014a; Azim et al., 2014b). In contrast, the role of GSK3 in 
astrogliogenesis is undefined, although inhibition of GSK3 with lithium has been 
reported to stimulate neurogenesis and suppress astrogliogenesis from 
transplanted NSC in spinal cord injury (Zhu et al., 2011b). Inhibition of GSK3 by 
lithium affects several signalling pathways, most notably canonical Wnt/-catenin 
signalling, but also BDNF, VEGF, CREB, and HSF-1, and subsequent induction of 
major cytoprotective proteins, such as GDNF, HSP70, and Bcl-2 (Chiu et al., 2013; 
Phiel and Klein, 2001). Also, lithium is proposed to have multiple cellular targets in 
addition to GSK3, such as NMDA-R and ion channels, with downstream effects on 
p38, JNK and cell survival (Lenox and Wang, 2003; Malhi et al., 2013; Zhu et al., 
2011b). These proposed diverse actions of lithium are of wide-ranging therapeutic 
potential and beneficial effects of lithium have been reported in experimental 
models of multiple neurological diseases, including ischemia, injury, AD, ALS, PD, 
and MS (Chiu et al., 2013). The aim of this section of the thesis is to use Affymetrix 
GeneChip arrays to profile gene expression in the adult mouse optic nerve and 
identify the major glial targets of lithium. 
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4.2 RESULTS 
4.2.1 Microarray analysis of gene expression in the adult optic nerves 
The primary aim of this section is to identify the glial targets of lithium using the ex 
vivo optic nerve model. However, an important finding from previous astrocyte 
gene profiling studies is that culture results in major genotypic changes compared 
to acutely purified astrocytes (Cahoy et al., 2008; Foo et al., 2011; Zamanian et al., 
2012). Therefore, to better understand the potential effects of culture on the optic 
nerve, a three-way Affymetrix GeneChip analysis was used to profile mRNA isolated 
from acutely isolated nerves, compared to control cultured nerves and nerves 
treated with lithium. Following the protocol of Barres and colleagues (Zamanian et 
al., 2012), total RNA was extracted from P35-P45 optic nerves (pooled from 12 
animals for each sample) and run in quadruplicate. Total RNA concentration was 
determined by spectrophotometry and samples were sent to ATLAS Biolabs 
(Germany) for microarray analysis. Briefly, 1ug of Total RNA is converted to cDNA 
and then used to generate multiple copies of biotinylated cRNA samples. 
Subsequently, 10ug of cRNA was hybridised to a Genechip® Mouse Genome 
430_2.0 Arrays (Affymetrix) and visualised using a Affymetrix Genechip ® Scanner 
3000.  This platform contains oligonucleotide probe sets complimentary to the 3 
end of the mRNA transcripts (a 3-array), with each array containing 45,000 probe 
sets, corresponding to over 34,000 well characterised mouse genes. All samples 
passed quality control (QC), as reported by ATLAS Biolabs (Germany). Two 
replicates were performed for each experimental condition and each microarray 
analysis was run in duplicate (Zamanian et al., 2012). The generated CEL file was 
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analysed with Genespring GX 12 (Agilent) software, using the MAS-5 algorithm to 
generate expression values and absent/marginal/present (A/M/P) calls (Hubbell et 
al., 2002). Expression profiles were then analysed using fold change (FC), A/P calls, 
heat maps and profile plots, all within Genespring GX 12 software (Agilent). 
Statistical significance was determined using one-way ANOVA, with post-hoc tests, 
Tukey HSD and Benjamin-Hochberg FDR (false discovery rate, multiple testing 
correction). Pathway analysis was performed using the Ingenuity Pathway Analysis 
(IPA) software (Ingenuity Systems, www.ingenuity.com).  
Data analysis using the MAS-5 algorithm showed on average expression of 45,101 
entities (probe sets) per sample, of which on average 29,616 were present in one or 
more of the samples. Expression values (E, Absolute Value) are summarised by the 
box and whisker plot (Figure 4.1A) and hierarchical clustering of entities based on 
the similarity of their expression across the samples (Figure 4.1B). These data show 
that entities were more closely related within experimental groups and variation 
was greatest between experimental groups. The Venn diagram in Figure 4.1C shows 
the numbers of entities common and exclusive to the three experimental groups: 
50 % were present in only one of the samples, and 17 % were present in all three 
samples (Figure 4.1C). 
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Figure 4.1 Gene expression analysis of adult mouse optic nerves. Optic nerve 
transcripts were pooled from 12 nerves in each group (acutely isolated, 
control culture, and cultured with lithium for 3 DIV) and run in quadruplicates. 
Samples were assessed using a genome wide microarray and scanned 
intensity values were normalised using the MAS-5 algorithm. (A) Data is 
shown as a baseline transformation to the median of all samples for data 
representation on a log2 scale using a box and whisker plot to illustrates the 
variability between samples. (B) Hierarchical clustering of all entities and 
conditions based on expression profile across samples (with Euclidean 
similarity metric and centroid linkage rule). (C) Venn diagram demonstrates 
probes that are present in our datasets catalogued by their presence in each 
groups. 
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4.2.2 Macroglial genes predominate in optic nerve samples 
Astrocytes and oligodendrocytes make up the vast majority of cells in the optic 
nerve (>90%), and so the bulk of gene expression is expected to be specific to these 
cells, with low levels of entities from OPC, microglia, vasculature and axons (Salter 
and Fern, 2005). To test this, the expression levels of well described glial, neuronal, 
microglial (M1/M2) and endothelial specific markers were examined in acute 
nerves, control cultured nerves and lithium treated cultured nerves (Figure 4.2). 
The P/M/A calls for these entities are given in Error! Reference source not found.. 
Under the three different experimental conditions, the entities with highest levels 
of expression were for astrocyte and oligodendrocyte markers, the majority of 
microglial and non-glial markers either being called absent or present at negligible 
levels (E<50) (Table 4.1). Expression levels of the M1 (activated) 
microglia/macrophage markers Mrc1 (CD206), Fcgr3 (CD16), and Arg1 (Arginase 1) 
were present in acute and cultured nerves, indicating these are appropriate 
markers for identifying microglia in the optic nerve; there was a spike in expression 
of Arg1 and Fcgr3 (CD16) in control culture conditions (see below). Similarly, the 
results indicate Cldn5 (claudin 5) and von Willebrand factor (Vwf) are useful 
markers for endothelial cells in the adult optic nerve, and these were generally 
downregulated in culture. Neuronal/axonal markers were called absent or present 
at barely detectable levels, although Nefl (neurofilament, light polypeptide) was 
prominent, which is consistent with axonal mRNA being present at low levels in the 
optic nerve (Salter and Fern, 2005). 
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Figure 4.2 Gene expression of well described cell markers in adult mouse optic nerves. Optic nerve transcripts were pooled from 
12 nerves in each group (acutely isolated, control culture, and cultured with lithium for 3 DIV) and run in quadruplicates. 













Table 4.1 Gene expression of well described cell markers in adult mouse 
optic nerves (acutely dissected, cultured controls, and cultured with 
lithium). 
Gene Symbol Acute Control Lithium Name Cell Type
E Call E Call E Call
Kcnj10 717 P 658 P 501 P Kir4.1 Astrocyte
Aqp4 1595 P 1141 P 989 P aquaporin 4 Astrocyte
Gfap 2080 P 1591 P 1479 P GFAP Astrocyte
Gja1 1817 P 1326 P 1271 P Cx43 Astrocyte
Slc1a3 1454 A 895 A 949 A GLAST/EAAT1 Astrocyte
Cnp 1302 P 1302 P 1371 P Cnpase Oligodendrocyte
Mag 940 P 690 P 569 P MAG Oligodendrocyte
Plp1 2298 P 1700 P 1807 P PLP Oligodendrocyte
Mbp 2977 P 2343 P 2470 P MBP Oligodendrocyte
Mobp 2939 P 2292 P 2531 P MOPBP Oligodendrocyte
Mog 2007 P 1244 P 1268 P MOG Oligodendrocyte
Ugt8a 1813 P 999 P 954 P UDP glycosyltransferase Oligodendrocyte
Cspg4 62 P 13 P 68 P NG2 OPC
Pdgfra 576 P 522 P 182 P PDGFRa OPC
Nkx2-2 231 P 178 P 149 P Transcription Factor OPC
Sox10 958 P 640 P 678 P Transcription Factor OPC/OL 
Olig2 307 P 171 P 297 P Transcription Factor OPC/OL
Kcnq2 7 A 4 A 2 A Kv7.2, nodal K+ channel Axon
Scn8a 55 P 33 P 23 P Nav1.6, nodal Na+ channel Axon
Cntnap1 5 P 4 A 5 M Caspr/Contactin Axon
Ank3 38 P 24 P 35 P Ankyrin 3G, nodal protein Axon
Nefl 150 P 22 P 17 P Neurofilament, light chain Axon
Slc12a5 14 P 8 P 13 P K+/Cl- transporter Neuron
Sv2b 51 P 9 P 10 P synaptic vesicles Neuron
Syt1 10 A 4 A 1 A synaptotagmin I Neuron
Mrc1 119 P 54 P 28 P CD206 Microglia/M2
Arg1 6 P 1022 P 361 P Arginase 1 Microglia/M2
Fcgr3 309 P 790 P 444 P CD16 Microglia/M2
Nos2 1 A 8 M 7 M iNOS Microglia/M1
Cd86 29 P 37 P 42 P CD86 Microglia/M1
Fcgr2b 51 P 205 P 69 P CD32 Microglia/M1 
Cldn5 184 P 84 P 69 P Claudin5 (tight junctions) Endothelial
Ocln 82 P 15 P 8 P Occluding (tight junctions) Endothelial
Pecam1 9 P 12 P 14 P adhesion molecule Endothelial
Tek 111 P 39 P 33 P tyrosine kinase Endothelial
Vwf 210 P 61 P 17 P Von Willebrand factor Endothelial
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4.2.3  The main macroglial genes are unaltered in culture
Astrocytes and microglia in culture are considered to have a more reactive 
phenotype than cells in vivo or acutely isolated, although it is notable that few 
studies have considered this possibility in the case of oligodendrocytes, where 
in vitro studies predominate. Microarray of the optic nerve indicates that 
expression levels of the major oligodendrocyte myelin-related genes were 
unaffected by culture conditions, e.g. Mbp, Plp1, Cnp, Mobp, etc. (Table 4.1). 
Similarly, reactive astrocytes are generally associated with an upregulation of 
GFAP and vimentin, and downregulation of Kir4.1, AQP4 and GLAST, none of 
which was the case in optic nerves after 3DIV (Table 4.2); this was also true for a 
wide range of genes responsible for proteins that are critical for normal 
astrocyte homeostatic functions (Table 4.2). In comparison, analysis of 
microglial markers for the M1 (activated, or pro-inflammatory) and M2 
(alternatively activated or anti-inflammatory, involved in restoring tissue 
homeostasis) phenotypes (Kigerl et al., 2009) indicated a general upregulation 
of microglial entities (Table 4.3), most prominent being the M2 markers Arg1, 
CD14, and Gal3, together with the M1 markers CD16 and Cxcl10 whereas 
numerous important markers of microglial activation were called absent, 
including the M1 marker iNOS, and M2 markers Il10, Fizz1 and Tnf (Figure 4.3). 
Hence, astrocyte and oligodendrocyte genotypes appeared largely unaltered in 
culture, whereas microglia were in a state of activation, with the spike in Arg1, 
which was called absent in acute nerves, suggesting an overall M2 phenotype. 
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Table 4.2 Expression levels of major glial homeostatic genes. 
Gene Symbol Acute Control Lithium Comments
Vim 2574 2251 2459 Vimentin
Kcna1 817 772 901 Kv1.1,  Major glial Kv channel
Kcnj10 717 658 501 Kir4.1, Main glial Kir channel
Kcnb1 654 814 855 Kv2.1, Major glial Kv
Slc1a3 1453 895 949 GLAST1, EAAT1
Slc1a2 877 553 596 GLT-1, EAAT2
Slc38a1 1683 1044 1092 glutamine transporter
Slc6a1 835 310 306 GAT-1 
Slc6a9 1446 747 936 GlyT
Slc16a1 1356 1439 1227 MCT1
Slc2a1 1336 1506 1390 GLUT1
Car2 1908 1393 1680 CAII
Slc12a2 1475 1219 1041 main glial Na+-K+-Cl- co-transporter  
Slc9a3r1 963 852 902 Na+/H+ exchanger
Slc9a6 961 686 672 Na+/H+ exchanger
Slc4a4 806 500 358 Na+/HCO3- cotransporter
Atp1a2 2101 1479 1261 Na+/K+ pump
Atp1b2 1296 1136 874 Na+/K+ pump
Atp1b3 1002 733 959 Na+/K+ pump
Atp2a2 1185 1203 1264 Ca2+ pump
Gja1 2194 1485 1573 Cx43,  Main As GJ protein
Gjb1 287 194 122 Cx32,  Main OL GJ protein
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Table 4.3 Expression levels of M1/M2 phenotype microglial genes. 
Gene 
Symbol Acute Call Control Call Lithium Call Name
M1/M2
Scara5 42 P 75 P 16 P Scara5 M2
CD163 71 P 45 P 18 M CD163 M2
Arg1 6 P 1022 P 361 P ARG1 M2
CD14 104 P 525 P 541 P CD14 M2
MRC1 119 P 54 P 28 P MRC1 M2
Fcer2a 3 M 3 M 4 M CD23 M2
Scarb1 66 P 145 P 138 P Scarb1 M2
Chi3l3 7 P 15 P 2 A YM1 M2
Retnla 24 A 5 A 4 A FIZZ1 M2
Lgals3 528 P 1046 P 1349 P GAL3 M2
Cd200r1 4 P 14 P 8 P CD200R M2
IL10 1 A 3 A 3 A IL10 M2
Tgfb1 29 P 120 P 36 P TGF M2
iNOS 1 A 8 M 7 M iNOS M1
Fcgr3 309 P 790 P 444 P CD16 M1
CD86 29 P 37 P 42 P CD86 M1
Fcgr1 102 P 222 P 238 P CD64 M1
Fcgr2b 51 P 205 P 69 P CD32 M1
IL6 1 A 126 P 71 P IL6 M1
Il1b 5 P 18 P 33 P IL1 M1
Tnf 2 A 4 P 6 P TNF M1
Cxcl10 303 P 1012 P 1599 P CXCL10 M1
Cybb 22 P 36 P 21 P Gp91phox M1
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Figure 4.3 Major genes associated with M1 and M2 microglia/macrophages in 
acutely dissected nerves compared to nerves cultured for 3DIV in control 
medium or medium containing lithium. 
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4.2.4  Optic nerve genes altered in culture 
Although the main macroglial genes were not markedly altered in culture, 
significant differences (p<0.05) between the treatment groups were identified 
using One way ANOVA, with post-hoc tests Tukey HSD and Benjamini-Hochberg 
FDR  (Figure 4.4). Genes in the dataset were divided by Volcano plot (p<0.05; 
Fold Change > 2.0) to identify the most altered genes in the groups comparing 
acute versus lithium (Figure 4.4A) and control (Figure 4.4B), and a profile plot 
illustrates the expression profile of each probe in the different conditions 
(Figure 4.4C). Table 4.4 presents IPA analysis of the top 10 most significantly up- 
and down-regulated entities in culture compared to acute nerves, and how 
these were altered by lithium. The results indicate that many of the genes most 
altered in culture were rectified by lithium, i.e. genes upregulated or 
downregulated in control culture (e.g. Cxcl1 and Hba1/Hba2, respectively) 
recovered to acute levels in lithium (Table 4.4).
Genes upregulated by control culture are largely indicative of an inflammatory 
response and those that were rectified by lithium include the chemokines Cxcl1, 
Cxcl3 and Cxcl6, together with Mmp3 and Csf3 (colony stimulating factor 3 
(granulocyte). In contrast, genes upregulated in control cultures and not 
rectified or only partly rectified by lithium include the M1 marker Il6 (M1) and 
M2 marker Arg1 (M2), together with Ereg (Epiregulin) and Krt6A (Keratin 6A), 
which have no reported function in glia. 
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Genes downregulated by control culture compared to acute nerves were 
numerous and top of this list was Hba1/Hba2 (haemoglobin apha1/alpha 2), 
iron-containing proteins that are generally associated with oxygen transport, 
and which were completely rectified (upregulated) by lithium. In addition, 
lithium rectified Slco1A4, Slc22A6 and Slc22A8, which are organic anion 
transporters (OATs), Dpp4 (dipeptidyl-peptidase 4), which is involved in insulin 
receptor function, and Omd (osteomodulin), which is involved in keratin 
metabolism. With the exception of Kcnj13 (Kir7.1), which has been shown in 
optic nerve glia (Butt and colleagues, unpublished findings), the remaining most 
highly regulated genes in culture (Aifm3, Col25A1, Atp13A5) have no reported 
functions in glia and were not rectified or only partly rectified by lithium. 
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Figure 4.4  Gene expression analysis of adult mouse optic nerves. Optic nerve 
transcripts were pooled from 12 nerves in each group (acutely isolated, control 
culture, and cultured with lithium for 3 DIV) and run in quadruplicates. Genes 
altered in Acute and Lithium (A) and Acute and Control (B) were identified by 
Volcano plot (P<0.05 t-test followed by Benjamini-Hoechberg FDR, FC>2.0). 
Their expression values across the different samples are illustrated in C. 
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Table 4.4 Top 10 genes up- and down-regulated in control culture compared to 














Cxcl1 +8.9 -9.2 Hba1/Hba2 -7.8 +6.9 
Cxcl3 +8.7 -9.1 Slco1a4 -7.3 +7.5 
Mmp3 +7.5 -7.4 Slc22a6 -6.7 +6.4 
Cxcl6 +7.3 -6.9 Slc22a8  -6.4 +7.3 
Csf3 +7.3 -6.9 Dpp4 -6.3 +7.0 
Arg1  +7.9 - Omd -6.2 +6.4 
Ereg +7.4 - Kcnj13 -6.6 -
1600029D21Rik +7.1 - Aifm3 -6.4 -
Krt6a +7.0 - Col25a1 -6.3 -
Il6 +6.9 - Atp13a5 -6.1 -
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4.2.5  Effects of lithium on optic nerve genes 
IPA analysis shows the top 10 genes most up- and down-regulated by lithium 
(Table 4.5). The most altered gene was Saa1 (serum amyloid A1) (Table 4.5), 
which is notable because it is expressed in the brain in response to 
inflammation and was massively upregulated by culture compared to acute 
nerves and completely downregulated by lithium. A number of the other most 
altered genes are related to the cell cycle, namely Ccnb1, or Cyclin B1, which is 
involved in the cell cycle arrest, Mki67 (Ki67), a well-known marker of cell 
proliferation, Cdca3 (also known as Tome-1), which interacts with Cyclin B to 
activate mitotic entry (Ayad et al., 2003), Esco2, an acetyltransferase required 
for sister chromatid cohesion, Ckap2l (also known as Radmis), a microtubule 
associated protein that induces mitotic arrest and cell cycle exit. The remaining 
most downregulated genes are Hmmr (Hyaluronan-mediated motility receptor), 
which is involved in cell motility and remodelling of the extracellular matrix, and 
Kcne3, an ancillary protein that assembles as a beta subunit with Kcnc4/Kv3.4, 
and have no reported functions in glia. 
The gene most upregulated by lithium was Car3 (carbonic anhydrase 3, CAIII) 
which is a member of the family of metalloenzymes that catalyse the hydration 
of carbon dioxide, but it is not a prominent CA of the brain. Many of the 
remaining genes have reported expression in the brain (e.g. Barx2, which 
encodes a gene that is involved in cell adhesion, calcitonin-related polypeptide 
beta (Calcb), also known as Cgrp2, the chemokine Cxcl11 is found at the BBB, 
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Harakiri (Hrk) is involved in apoptosis. Notably, Rhce/Rhd, Lhfpl2, Plin5 (perilipin 
5), Rfx2 and Cdsn have no reported functions in the CNS. 
Figure 4.5 represents a three-way comparison of the top 20 genes that are most 
altered by lithium and sorting for those that are the most highly expressed 
(Absolute Value >1000v in one or more of the experimental groups). Car3, 
Calcb, Cdsn, and Cxcl11, together with Mmp10, Cox6a2, Ddit4l and Hspa1a, are 
notable because they were barely expressed in acute nerves and upregulated 
specifically by lithium, not in control culture (Figure 4.5). Cdk1 and Cdca3 were 
identified above as amongst the top 10 genes most downregulated by lithium, 
and the three-way analysis shows this represents rectification of their 
upregulation in culture, and also identifies Lox, Prga4, Clec7a and Col3a1 as 
additional major targets of lithium. These latter genes were almost completely 
ablated by lithium, together with Fzd2, Lbp, Foxc2, Mfap5, Cd248, and Smoc2, 
which were highly expressed in acute nerves.  
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Table 4.5 Top 10 genes up- and down-regulated by lithium compared to control 
nerves (IPA). 
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Figure 4.5 Three-way analysis of the top 20 genes most altered by lithium in 
comparison to acutely dissected nerves and control cultures. Genes were 
sorted for FC (>10-fold) and level of expression (>1000 absolute value) in one or 
other of the experimental groups. Data are presented as relative expression, to 
illustrate the proportional change in gene expression. 
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4.2.6  Pathway analysis of genes altered by lithium 
Analysis of the most altered canonical pathways revealed a number of 
interesting potential targets of lithium compared to acute and control nerves 
(Table 4.6). The IL-8 and IL-17F signalling pathways were reported in both 
controls and lithium (Table 4.6C), although IL-8 and IL-17F were called absent in 
all samples, and the major determinant in both pathways is Cxcl1 which was up-
regulated in culture and rectified by lithium (Table 4.4); Cxcl1 is induced by 
activation of Il-17RA and activates the IL-8 receptor Cxcr2 (not illustrated). The 
PPAR pathway was specific to controls (Table 4.6A, C), and regulates the 
expression of genes involved in lipid metabolism (Figure 4.5). The top canonical 
pathway specific to lithium was mitotic role of polo-like kinase (PLK) (Table 
4.6B, C), which executes several essential functions to promote cell division, 
ranging from centrosome maturation in late G2 phase to the regulation of 
cytokinesis (Figure 4.6; Bruinsma et al., 2012). The second major pathway 
affected by lithium concerned the role of osteoblasts, and on closer inspection 
the main element was Rankl (Rankl, receptor-activator of NF-B ligand) and its 
TNF-family receptor Rank (not illustrated). Similarly, the effect of lithium on 
retinol biosynthesis is related to changes in NAD+/NADH reactions (not 
illustrated). In comparison, lithium has multiple targets in the PTEN pathway 
(Figure 4.7) and RAN pathway (Figure 4.8), which are major regulators of cell 
proliferation, survival, differentiation and function. Lithium dramatically 
increased the expression of P21CIP1 (FC > 15), also known as Cyclin-dependent 
kinase inhibitor 1a (Cdkn1a), which is a potent inhibitor of cell growth and 
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maturation. Hence, the top pathways regulated by lithium are related to cell 
proliferation, survival and growth, with the exception of axon guidance 
signalling (Table 4.6B), which is of particular interest and is examined in greater 
detail later with respect to astrocytes (Section 6). In addition, other pathways 
significantly altered by lithium have resonance because they are proposed 
targets of lithium and/or GSK3 in neurological diseases (see below, Section 
4.2.7), and/or have functions in glia (Table 4.6D), including the Wnt/-catenin 
canonical pathway, which is a target of Gsk3 inhibition and profound regulator 
of oligodendrocytes (see Section 5). 
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Table 4.6. IPA top regulated canonical pathways (A) in controls versus acute, (B) 
in lithium versus control, (C) specific to control or lithium, and (D) specific to 
lithium.  
Top Canonical Pathways Control Lithium 
IL-8 Signalling  YES YES 
Role of IL-17F in Allergic Inflammatory Airway 
Diseases  
YES YES 
PPAR Signalling  YES NO 
RAN signalling NO YES 
PTEN signalling NO YES 
Role of Osteoblasts, Osteoclasts and 
Chondrocytes in Rheumatoid Arthritis 
NO YES 
Ingenuity Canonical Pathways  -log(p-value) Ratio 
BMP signalling pathway 1.45E00 4.42E-01 
Human Embryonic Stem Cell 
Pluripotency 
1.43E00 4.01E-01 
TGF- Signalling 1.43E00 4.79E-01 
PDGF Signalling 1.37E00 4.65E-01 
CREB Signalling in Neurons 1.35E00 3.86E-01 
Wnt/-catenin Signalling 1.35E00 4.57E-01 
CNTF Signalling 1.32E00 4.56E-01 
NGF Signalling 1.26E00 4.26E-01 
Integrin Signalling 1.24E00 4.38E-01 
VEGF Signalling 1.23E00 4.04E-01 
(A) Controls 
(B) Lithium 
(C) Control compared to Lithium 
(D) Pathways specific to Lithium 
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Figure 4.5. PPAR signalling genes altered in culture.  A complement system pathway generated by IPA. Proteins with increased 
expression are marked in red proteins with decreased expression are marked in green. Figure legend applies to all IPA pathways.
IPA Pathway Figure Legend 
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Figure 4.7 Polo-like kinase (PLK) signalling genes altered in lithium.  A complement 
system pathway generated by IPA. Proteins with increased expression are marked 
in red proteins with decreased expression are marked in green. The IPA legend is 
shown in Figure 4.5  
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Figure 4.8. PTEN signalling genes altered in lithium.  A complement system pathway 
generated by IPA. Proteins with increased expression are marked in red proteins 
with decreased expression are marked in green. The IPA legend is shown in The IPA 
legend is shown in Figure 4.5
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Figure 4.9 RAN signalling genes altered in lithium. A complement system pathway 
generated by IPA. Proteins with increased expression are marked in red proteins 
with decreased expression are marked in green The IPA legend is shown in Figure 
4.5.
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4.2.7  Principle diseases related to genes altered by lithium
IPA analysis indicated major effects of lithium on genes associated with mood 
disorders, MS and AD (Figures 4.10-4.12), which is relevant because lithium is the 
frontline treatment for bipolar disease and beneficial effects of lithium have been 
reported in experimental models of MS and AD (Chiu et al., 2013). Genes associated 
with BD that were altered by lithium were generally downregulated at the plasma 
membrane level compared to other cellular compartments (Figure 4.10). Glia are 
enriched with carbonic anhydrase (CA), and it is notable that Car3, Car6 and Car9 
were the most upregulated genes in the BD dataset, whereas Car4 was 
downregulated, suggesting changes in glial CA may be important in bipolar disease. 
Lithium also upregulated the melanin-concentrating hormone receptor 1 (Mchr1), 
which has no reported function in the optic nerve. The effect of lithium on genes in 
the MS dataset was generally upregulation (Figure 4.11), including the chemokine 
Cxcl1, which as noted above was the gene most altered by lithium (FC>+500), in 
addition to Ptgs2 (FC>+15), also known as cyclooxygenase 2 (Cox2) (FC>15). A novel 
finding was that one of the genes most regulated by lithium was Cdsn (FC>+30), or 
corneodesmosin, which is responsible for psoriasis and has not previously been 
identified in the CNS, but is a gene recently associated with MS (Calleja et al., 2006; 
Hafler et al., 2007; Leclerc et al., 2009; Oji et al., 2010). Interestingly, another gene 
detected in our dataset was the antiviral gene Rsad2 (Radical S-adenosyl 
methionine domain-containing protein 2), also known as Viperin, which is also 
increased in psoriasis and MS (Kulski et al., 2005; van Baarsen et al., 2008). 
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Lithium altered more genes associated with AD than any other disease, with a 
predominant effect of down-regulation at the plasma membrane level (Figure 4.12). 
Genes include Arg1, which as noted above was massively upregulated in control 
and rectified by lithium (Table 4.4), Ptgs2 (COX2), and Tgm1 (transglutaminase 1), 
which is the gene underlying ichthyosis (scaling of the skin) and has no reported 
function in glia or the CNS. The most down-regulated genes affected by lithium and 
associated with AD was Ogn (osteoglycin), also known as mimecan, an ECM protein, 
and Igfbp6 (insulin-like growth factor binding protein 6). In contrast, lithium 
dramatically upregulated the AD-associated gene Lcn2 (lipocalin 2), a protein 
involved in the transport of small hydrophilic molecules such as steroids and lipids 
into cells. Interestingly, the neuronal markers doublecortin (Dcx), neurofilament 
Light (Nefl) and heavy (Nefh) chains were present in our dataset, but on closer 
inspection their absolute expression values were minimal in all the groups (E < 50).  
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Figure 4.10 Bipolar Disorder related genes altered by Lithium.  A complement 
system pathway generated by IPA. Proteins with increased expression are marked 
in red proteins with decreased expression are marked in green. The IPA legend is 
shown in Figure 4.5
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Figure 4.11 Multiple Sclerosis related genes altered by lithium. A complement 
system pathway generated by IPA. Proteins with increased expression are marked 
in red proteins with decreased expression are marked in green. The IPA legend is 
shown in Figure 4.5. 
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Figure 4.12 Alzheimers Disease related genes altered by lithium.  A complement 
system pathway generated by IPA. Proteins with increased expression are marked 
in red proteins with decreased expression are marked in green. The IPA legend is 
shown in Figure 4.5.  
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4.3  DISCUSSION 
The aim of this section was to examine the genes and major pathways affected by 
lithium in the ex vivo adult mouse optic nerve organotypic culture preparation. 
Microarray analysis confirmed that the bulk of gene expression is specific to 
astrocytes and oligodendrocytes, which make up the vast majority of cells in the 
optic nerve, with minor levels of entities from OPC, microglia, vasculature and 
axons. Comparison of acutely dissected optic nerves with those maintained in 
organotypic culture for 3DIV indicated the major astrocyte and oligodendrocyte 
genes were not greatly affected by culture, supporting the microscopic evidence on 
astrocytes and oligodendrocytes in Section 3. Culture did appear to result in a 
general activation of microglia towards a M2 phenotype, consistent with a tissue 
protective response following isolation of the optic nerve. A key finding is that 
lithium rectified many of the inflammatory genes that were upregulated in control 
cultures and in this respect normalised the tissue towards an acute state. A number 
of genes and pathways that were specifically altered in lithium included targets of 
GSK3, most notably the Wnt pathway, but also CREB, VEGF, and HSF-1. In addition, 
novel genes altered by lithium treatment were identified, such as Saa1, Calcb, Car3, 
Cdk1, Lox and Cdsn, many of which have no reported function in glia or the CNS. 
Novel pathways altered by lithium treatment included the PLK and RAN signalling 
pathways, with downstream effects on cell proliferation, survival and growth. 
Furthermore, lithium treatment had major effects on genes associated with mood 
disorders, MS and AD, in particular the latter. The results indicate that glial targets 
of lithium treatment in the adult mouse optic nerve have therapeutic relevance to a 
number of neurodegenerative diseases, including MS and AD. 
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4.3.1 Major macroglial genes are unaltered ex vivo 
Expression profiling is a powerful approach to understanding the genetic changes 
that characterise the ex vivo optic nerve model, prior to testing the effects of 
therapeutic agents. An important finding is that the major macroglial genes were 
not greatly altered in culture. Oligodendrocytes/myelin are highly sensitive to CNS 
insults, and unaltered expression of the major myelin genes in culture is consistent 
with the biological findings in Section 3 indicating that oligodendrocyte and myelin 
integrity are maintained in this ex vivo model. In addition, astrocytes are known for 
their extensive genetic and morphological changes following injury (Zamanian et al., 
2012), marked by upregulation of GFAP, and the intermediate filaments vimentin 
and Nestin, together with changes to the actin cytoskeleton and binding proteins 
that modify the extracellular milieu to form the glial scar. The genetic profile of 
cultured optic nerves did not report any significant changes that would suggest a 
reactive astrocyte phenotype. However, many minor genes associated with reactive 
astrocytes were altered. For example, in controls there was increased expression of 
Serpina3n, which is associated with hypertrophic reactive astrocytes characterised 
by a stellate morphology (Zamanian et al., 2012). Interestingly, Serpina3n was 
downregulated by lithium, suggesting it may be involved in the lithium-induced 
morphological changes in astrocytes. In addition, there was upregulation of Mmp3 
and Csf3 (colony stimulating factor 3), which are hallmarks of reactive astrocytes 
and brain injury (Hua et al., 2011; Neria et al., 2013), together with the chemokines 
Cxcl1, Cxcl3 and Cxcl6, which are expressed and release by reactive astrocytes 
(Koyama et al., 2013; Lu et al., 2005). Notably, all of these genes were 
downregulated by lithium, indicating it has a general anti-inflammatory effect. 
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Interestingly, EREG (Epiregulin) and KRT6A (Keratin 6A) were upregulated in culture 
and have not been reported in glia, but their respective roles in EGF/ErbB signalling 
and cytoskeletal remodelling suggests they may be important in astrocyte 
remodelling in cultured nerves (Liu and Neufeld, 2007). In the case of microglia, 
there was clear evidence of activation in control cultured nerves (see below). 
4.3.2 Astrocyte homeostatic genes are maintained ex vivo 
A number of genes altered in culture and lithium were associated with reactive 
astrocytes. To dissect the extent of astrocyte changes, I examined genes associated 
with the known homeostatic functions of astrocytes, many of which are 
dysregulated in reactive astrocytes. The results indicated that astrocyte 
homeostatic functions were maintained in culture, but comparison of expression 
profiles in acute and control nerves also highlighted a number of genes related to 
astrocyte homeostatic genes that appear distinct to the optic nerve and would not 
otherwise have been identified. For example, the transporters involved in pH 
regulation SLC26A6 (Cl--HCO3- exchanger), SLC26A7 (Cl--HCO3- exchanger) and 
SLC4A10 (Na+-HCO3- co-transporter) are expressed in acute nerves and almost 
completely lost in culture; they have no reported functions in glia, although 
SLC4A10 is predominantly expressed in the brain and with AQP1 is a candidate gene 
in glaucoma (Liu et al., 2010a; Liu et al., 2010b), whereas SLC26A6 and SLC26A7 are 
important in the kidney and GI tract (Alper and Sharma, 2013). The expression of 
these transporters in the acute optic nerve is novel and suggests they play a role in 
glial electrolyte and acid-base homeostasis, although SLC13A4 was the main Na+-
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HCO3- co-transporter (NBC), and SLC9A3R1 and SLC9A6 were the main Na+-H+
exchangers (NHE) in all experimental groups. Car2 (CAII), is the most strongly 
expressed Car in the optic nerve (Absolute value 19000, and not altered by culture), 
and has been reported specifically in oligodendrocytes (Butt et al., 1995; Butt and 
Kirvell, 1996). However, Car9 (CA IX) was also called present in acute nerves and 
upregulated in cultured nerves, but has not been described in glia, although a study 
in Car9 KO mice indicated it has unresolved functions in the brain (Pan et al., 2012). 
Car11 and Car14 were also expressed in acute nerves and have been reported in 
the brain (Aspatwar et al., 2010; Makani et al., 2012), whereas all others were 
called absent or barely detectable in all groups, with the exception of Car3, which 
was massively upregulated in Lithium treated nerves (see below).  
The SLC6 family is normally referred to as the neurotransmitter transporter family, 
and a number are prominent in the optic nerve samples and regulated in culture 
(Table 4.2). A novel finding was the expression in acute nerves of Slc6a20, which is 
massively downregulated in culture, and is the transporter for proline, an amino 
acid with an essential role in primary metabolism and physiological functions 
(Broer, 2006; Wyse and Netto, 2011). GAT1 (SLC6A1) is the main GABA transporter 
in the optic nerve in all experimental groups, but Slc6a13 (GAT3), another astrocyte 
GABA transporter (Gadea and Lopez-Colome, 2001), is strongly expressed in acute 
nerves and downregulated in culture. In contrast, the low affinity monocarboxylate 
transporter Slc16a3 (MCT4) is strongly upregulated in culture, although SLC16A1 
(MCT1) is the primary MCT expressed in the optic nerve (not illustrated) in all 
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experimental groups, and is responsible for the lactate shuttle by which astrocytes 
supply the high energy demand of neurons (Bergersen, 2007; Hertz and Dienel, 
2005), which has been demonstrated in the mouse optic nerve (Tekkok et al., 
2005). Interestingly, GLAST (SLC12A3, EAAT1), GLT1 (SLCA1A2, EAAT2) and the 
glutamine transporter SLC28A1, which are responsible for the astrocyte glutamate-
glutamine shuttle, were amongst the most highly expressed transporters in the 
optic nerve (Abs Val > 1000), in all experimental groups. Similarly, GlyT was the 
third most abundant solute transporter in the optic nerve, indicating 
neurotransmitter homeostasis is maintained in culture. 
The main potassium channels in optic nerve glia in all experimental groups were 
Kir4.1 (Kcnj10) and Kv1.1 (Kcna1), which are ubiquitous in glia (Verkhratsky, 2013). 
However, there was a complete loss of Kcnj13 (Kir7.1) in culture (Table 4.2); Kir7.1 
is a potassium channel recently discovered in our lab to be important in optic nerve 
glia and its loss in culture might explain why this channel has been overlooked in 
other in vitro studies of glia. Other highly expressed glial potassium channels were 
Kir5.1 (Kcnj16), Kv1.6 (Kcna6), TREK-1 (Kcnk2), TWIK-1 (Kcnk1), Kv4.3 (Kcnd3), Kv2.1 
(Kcnb1) and THIK-1 (Kcnk13). 
The aquaporin water channels Aqp1 and Aqp5 were both similarly up-regulated in 
control cultured nerves, but were called absent in acute nerves. AQP1 and AQP5 
have been indicated in astrocytes during brain injuries (Chai et al., 2013), but there 
are no reports of these AQPs in oligodendrocytes, microglia, or brain endothelium 
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(Papadopoulos and Verkman, 2013; Verkhratsky, 2013; Verkman, 2002). This 
suggests AQP1 and AQP5 might be important water channels that are differentially 
expressed in optic nerve astrocytes in response to injury. Nonetheless, AQP4 is the 
principal member of this protein family in the optic nerve (Table 4.1) and 
throughout the CNS, where it is expressed in astrocytes and is involved in water 
movement, cell migration and neuroexcitation (Papadopoulos and Verkman, 2013). 
4.3.3 Novel optic nerve genes 
A number of entities that have not been described previously in glia or the optic 
nerve were identified because of their regulation in culture and strong expression in 
acute nerves. Top of the list is Hba1/Hba2 (haemoglobin apha1/alpha 2), iron-
containing proteins that are generally associated with oxygen transport in the 
blood, but which are co-localised with mitochondria in the brain and are 
significantly reduced in neurodegeneration (Shephard et al., 2014). Notably, 
Hba1/Hba2 was completely rectified by lithium. Other entities not previously 
identified in the optic nerve are implicated in neuroprotection, such as AIFM3, 
which reduces mitochondrial membrane potential and induces apoptosis through a 
caspase dependent pathway. In comparison, although neither COL25A1 nor DPP4 
(dipeptidyl-peptidase 4) have been reported in glia, the former is implicated in AD 
pathology (Tong et al., 2010), and the latter is involved in neuronal insulin receptor 
function (Pipatpiboon et al., 2013), suggesting their expression in  acute nerves may 
indicate unresolved functions in optic nerve glia worthy of further study. ATP13A5 
is belongs to the P5-ATPase group mutations underlie a form of PD. Similarly, 
115
SLCO1A4, SLC22A6 and SLC22A8, which are organic anion transporters (OATs), are 
not reported in glia, but are important for drug delivery across the BBB and their 
dysfunction may contribute to neurological diseases (Zhou and You, 2007). Notably, 
another top 10 gene downregulated by culture and rectified by lithium was OMD 
(osteomodulin), which is involved in keratan sulfate/keratin metabolism, consistent 
with the expression of keratin 6A and the keratan sulphate proteoglycan Ogn (also 
known as mimecan proteoglycan and osteoglycin), which have not been reported in 
the optic nerve, but are associated with macular dystrophy (Keenan et al., 2012), 
and suggest a previously unrecognised function for keratin in the optic nerve 
worthy of further study. 
LCN2 (lipocalin 2) is of interest because it is an iron-trafficking protein and iron has 
an essential function in oligodendrocytes (Badaracco et al., 2010; Todorich et al., 
2009); the iron-bound form of LCN2 is internalized following binding to the 
SLC22A17 receptor (which is also present in optic nerves (Asb Val = 520)), leading to 
release of iron and subsequent increase of intracellular iron concentration. 
Lipocalin 2 was also recently reported as a new marker of early reactive response of 
astrocytes to nerve injury and inflammation (Chia et al., 2011; Zamanian et al., 
2012). It was also reported to cause a polarisation of astrocytes which would fit 
with our biological findings (Bi et al., 2013; Jang et al., 2013; Jeon et al., 2013). 
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4.3.4 Ex vivo upregulation of genes associated with inflammation 
The modulation of inflammation in the CNS is important for decreasing 
neurodegeneration and favouring successful repair. A number of microglial genes 
were upregulated, and the large spike in the M2 marker Arg1, which was called 
absent in acute nerves, suggests an anti-inflammatory phenotype involved in 
restoring tissue homeostasis (Zhou et al., 2012). In addition, upregulation in culture 
of Csf3 (colony stimulating factor 3), a feature of brain injury (Hua et al., 2011), 
suggests it may act similar to CSF1 (MCSF, macrophage colony stimulating factor), 
which has a known function in microglia (Raivich et al., 1999). Further genes 
specifically upregulated in control cultures that were indicative of an inflammatory 
response include the chemokines Cxcl1, Cxcl3 and Cxcl6, which are expressed and 
released by reactive astrocytes (Koyama et al., 2013; Lu et al., 2005). These 
chemokines were called absent or barely detectable in acute nerves and were 
rectified by lithium, indicating it has an anti-inflammatory action. All three 
chemokines have been reported in the brain, where they may have complex 
functions in addition to their well-established functions in the immune system 
(Reaux-Le Goazigo et al., 2013). Interestingly, the most altered gene in cultured 
nerves CXCL1 has been shown to play a critical role in regulating the dispersal of 
oligodendrocyte progenitors during development (Vora et al., 2012), and genetic 
overexpression of CXCL1 has been indicated to promote remyelination and 
neuroprotection in EAE (Omari et al., 2009). CXCL3, the second most altered gene in 
cultured optic nerves and which was called absent in acute nerves, has been 
reported in astrocyte cell lines (Laureys et al., 2014; Lu et al., 2005), but otherwise 
the functions of CXCL3 in glia are undefined. In addition, the chemokine CXCL12 
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(SD-F) and its receptors CXCR4 and CXCR7 were called present, and are of interest 
because they are part of the astrocyte chemokine network (McKimmie and 
Graham, 2010), CXCL12 acting via CXCR4 to regulate survival and migration of 
OPC(Dziembowska et al., 2005), and via CXCR7 to promote their maturation acting 
(Gottle et al., 2010). CCL2 (MCP-1) and CCL7 (MCP3) are closely related and were 
barely detectable in acute nerves, but massively upregulated in culture. Astrocytes 
and microglia are sources of CCL2 (Reaux-Le Goazigo et al., 2013), but I could not 
find any reports of CCL7 in glia or the brain. 
The most altered pathway that was specific to control cultured optic nerves was the 
peroxisome proliferator-activated receptor pathway (PPAR) (Table 4.6). Alterations 
in PPAR signalling were related to specific upregulation of PPAR, and 
downregulation of HSP90. PPAR is repressed by forming a complex with hsp90, 
which was downregulated in cultured nerves. In addition, PPAR function is 
suppressed by cytokines, growth factors and insulin, which is consistent with 
downregulation of insulin signalling in cultured nerves and the low expression of IL-
1 and TNF, which were called absent. PPAR has been shown to regulate lipid and 
glucose metabolism, homeostasis and microglial macrophage activation following 
brain injury (Bernardo and Minghetti, 2006). Moreover, PPARs regulate the 
expression of genes involved in lipid metabolism, and gemfibrozil, a known 
activator of PPAR- and PPAR- (called present), has anti-inflammatory properties 
and stimulates the expression of myelin-specific genes in oligodendrocytes, by 
promoting the recruitment of PPAR- to the promoter of PLP and myelin 
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oligodendrocyte glycoprotein genes in human oligodendrocytes (Jana et al., 2012). 
These results indicate PPAR signalling is worthy of further study in the optic nerve. 
 Another key pathway regulated in culture was HIF1 signalling (Table 4.5), which is 
an important factor in hypoxic stress and was downregulated in optic nerve 
cultures; HIF1- also associates with the molecular chaperone HSP90 and p53 
protein, which were both downregulated. HIF1- accumulates under hypoxic 
conditions and contributes significantly to the pathophysiology of cerebral 
ischemia, and its downregulation in cultured nerves is consistent with these nerves 
being healthy. Another key pathway regulated in culture was IL-17F (Table 4.5B), 
although IL-17F (also known as IL-24) was called absent in all groups, its receptor IL-
17RA was called present and upregulated in culture, and this receptor is shared by 
IL-17A, which was called statistically present and binds IL-17RA with a far higher 
affinity than IL-17F. Signal transduction for both IL-17A and IL-17F requires the 
presence of a heterodimeric complex consisting of both IL-17RA and IL-17RC (both 
called present in all groups) and the absence of either receptor results in ineffective 
signal transduction. Activation of IL-17RA invokes an ACT-1/TRAF-6 mediated 
activation of NF-B and ERK signalling pathways to induce the expression of 
cytokines and chemokines such as IL-6 and CXCL-1, which were both increased in 
culture. Another member of the family, IL-17D is highly expressed in brain and was 
the most expressed in the optic nerve, and its receptor IL-17RD was called present. 
The most notable role of IL-17 is its involvement in inducing and mediating 
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proinflammatory responses, and it has been suggested as a target for anti-
inflammatory therapies to improve recovery post-stroke. 
4.3.5 Lithium downregulates genes associated with tissue inflammation 
A major effect of lithium was the downregulation of inflammatory markers 
upregulated by culture.  Lithium and GSK3 pathway has been implicated in many 
diseases and inflammation state in various tissues (Goldstein et al., 2009; Jope et 
al., 2007). Accumulating evidences suggest that lithium, together with other mood 
stabilizing agents, exhibits anti-inflammatory properties (Goldstein et al., 2009; Rao 
et al., 2008; Rapoport et al., 2009). The most regulated gene by lithium was Saa1 
(serum amyloid A1), which is expressed at trace levels in acute nerves and 
massively upregulated in control cultured nerves. Saa1 is one of the top genes 
associated with amyloidosis and chronic inflammatory diseases including 
atherosclerosis, rheumatoid arthritis, Crohn's and AD (Tucker and Sack, 2001). 
Microglia are the likely source of Saa1 in the optic nerve, since it has been shown to 
be induced in retinal microglia in response to gluacoma (Walsh et al., 2009), 
although Schwann cells have been shown to be a primary source of Saa1 after 
peripheral nerve injury (Jang et al., 2012), raising the possibility that astrocytes or 
oligodendrocytes may produce Saa1 in the optic nerve. Similarly, one of the top 
genes rectified by lithium was S100a8, which is a potential proinflammatory 
chemokine that is upregulated by activated microglia (Walker et al., 2006). Of the 
remaining top rectified genes, Ccnb1 (Cyclin B1) is involved in the cell cycle arrest 
and is regulated by PPAR pathway (Morse et al., 2009). Lithium also downregulated 
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a number of genes related to the cell cycle: Ccna2 (cyclin A2), Ccnb1 (cyclin B1) and 
Ccnb2 (cyclin B2) are involved in cell cycle and differentiation and mediate the 
actions of IGF1 in oligodendrocytes (Bellanger et al., 2007; Min et al., 2012); Cdca3 
is also known as Tome-1 and acts as a cytosolic protein interacting with Cyclin B for 
the activation of mitotic entry (Ayad et al., 2003); Esco2 is an acetyltransferase 
required for sister chromatid cohesion and shown to promote neuronal 
differentiation by suppressing the Notch pathway (Leem et al., 2011); Ckap2l, also 
known as Radmis, is a microtubule associated protein found in neural stem cells 
and expressed in the neurogenic niches throughout life, and its over expression 
induces mitotic arrest and cell cycle exit (Kuninger et al., 2004; Yumoto et al., 2013); 
Mki67 is a well-known marker of cell proliferation (Scholzen and Gerdes, 2000) that 
is also downregulated by lithium. The dramatic decrease of expression of Saa1 
together with the modulation of PPAR and the down regulation of Cox-2 could 
explain the potent anti-inflammatory effect that has been associated with lithium 
(Bernardo and Minghetti, 2006; Bosetti et al., 2002). 
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4.3.6 Novel gene targets of lithium treatment  
The microarray approach identified a great number of genes that have not been 
previously reported as targets of lithium and many have not been reported in the 
CNS. Lithium showed a remarkable upregulation of CAIII (Ca3) which is a member of 
a family of metalloenzymes that catalyse the hydration of carbon dioxide and has 
not been reported in the optic nerve or glia. Expression of CAIII is specific to skeletal 
tissue, cerebrospinal fluid, liver and kidney and associated with a plethora of 
diseases such as seizures, heart diseases, Alzheimers Disease (AD), Parkinson 
Disease (PD) and bipolar disorder (BD) (Lafon-Cazal et al., 2003; Staunton et al., 
2012; Winum et al., 2003). Barx2 is also of interest because it encodes a gene that 
has been shown to be expressed in various tissues, including muscles and brain, and 
is involved in the control of cell adhesion and remodelling of the actin cytoskeleton 
(Herring et al., 2001; Meech et al., 2012; Tsau et al., 2011), suggesting it may be 
important in the dramatic morphological changes in astrocytes induced by lithium. 
Barx2 has been shown to act downstream of BMP and regulates chondrogenesis 
together with the Sox proteins (in particular Sox9) during limb development (Meech 
et al., 2005).  Another major gene upregulated by lithium was calcitonin-related 
polypeptide beta (Calcb), also known as Cgrp2, which together with its alpha 
counterpart are mainly expressed in the brain, but found also in liver, kidney testis 
and heart (Rezaeian et al., 2009; Young et al., 2005). Calcb was shown to be 
expressed by degenerating spinal cord neurons in an ALS model while its receptor 
seems to be astrocyte specific, therefore suggesting a potential role of astrocyte 
activation in ALS (Ringer et al., 2009). Our results indicate lithium dramatically 
upregulates Calcb in optic nerve glia. Similarly, Harakiri (Hrk) gene is a protein 
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encoding the apoptosis of neurons during embryogenesis and also expressed during 
axotomy or NGF deprivation through the activation of caspase-3 (Imaizumi et al., 
2004; Imaizumi et al., 1997; Kanazawa et al., 1998). There are no neurons in the 
optic nerve and known neuronal markers are barely expressed, suggesting Hrk has 
an unidentified function in glia that is activated by lithium. In contrast, upregulation 
of the chemokine Cxcl11 is suggests increased endothelial expression, since it is 
involved in the passage of T cells across the BBB and thought to be a biomarker for 
MS (Feng et al., 2014; Jernas et al., 2013; Szczucinski et al., 2007).  
A key finding was that the major canonical pathway specific to lithium was the 
mitotic role of polo-like kinase (PLK), which is not a reported target of lithium, but 
has been implicated in oligodendrocyte cell death (Kragh et al., 2009) and Schwann 
cell proliferation (Schworer et al., 2003), and executes several essential functions to 
promote cell division, ranging from centrosome maturation in late G2 phase to the 
regulation of cytokinesis (Bruinsma et al., 2012). It is also of main importance 
because it is known to regulate neuronal and axonal remodelling and growth (Lin et 
al., 2012; Seeburg et al., 2005). The main downstream target of PLK was Cdkn1a, 
which was downregulated by lithium, and a loss of Cdkn1a has been shown to 
induce terminal differentiation of progenitor cells into mature astrocytes (Porlan et 
al., 2013). We also identified a link between the PLK and the PTEN pathways, as 
Plk3 was shown to be important in the stabilisation of PTEN and both pathways 
were down-regulated (Xu et al., 2010). PTEN is necessary for myelin formation and 
its inhibition can be deleterious in vivo (Harrington et al., 2010). 
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The pathway analysis showed that one of the main effects of lithium was to down-
regulate the cell cycle entry by affecting genes such as cyclin B together with Tome-
1, which are regulators of mitotic entry. The RAN pathway was another important 
finding that fits with this general hypothesis. RAN-GTPases have many roles that 
span from the regulation of cellular growth to the arrangement of the cytoskeleton. 
Furthermore, it was shown to be important in the cell maturation of stem cells 
(Lopez-Casas et al., 2002; Lopez-Casas et al., 2003; Wang and Gao, 2005). The 
general upregulation of the RAN pathway by lithium is indicative of its role as 
potentiator of cell maturation and remodelling.  
A number of other genes in the top 10 upregulated by lithium are of considerable 
interest because they are not reported to be expressed in the brain, most notably: 
Perilipin 5 (Plin5), which is involved in the lipolysis and it is mainly expressed in 
skeletal and muscle tissue and reported as being absent in the brain (Kuramoto et 
al., 2012; Yamaguchi et al., 2006); Rfx2, which is highly expressed in tissues rich in 
ciliated cells (McClintock et al., 2008); mimecan, a proteoglycan that has never 
been reported in the optic nerve and does not have a known function, but is 
suggested to have a role in collagen formation (Tasheva et al., 2002). Two surprising 
genes identified by lithium treatment are corneodesmosin (Cdsn) and Lox (Lysis 
oxidase). Cdsn is profoundly and specifically upregulated by lithium (not culture), 
but has never been reported in glia or the CNS, and is a protein found in 
corneodesmosomes that localise to the epidermis of the skin associated with 
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psoriasis, although Cdsn has been identified as a risk gene in MS (Calleja et al., 
2006; Hafler et al., 2007; Leclerc et al., 2009; Oji et al., 2010). In contrast, Lox is 
expressed in acute nerves and almost completely ablated by lithium (and notably 
upregulated in culture). Lox is involved in many pathologies and cellular activities, 
such as control of differentiation and oncogenic transformation (Dimaculangan et 
al., 1994; Hajnal et al., 1993), and is important for the oxidation of cell surface 
proteins and the chemotactic response in vitro (Lucero et al., 2011; Lucero et al., 
2008). Notably, however, Lox regulates cell-cell adhesion by its interaction with -
catenin, leading to an up-regulation of the down-stream activator Cyclin D1 
(Giampuzzi et al., 2003; Sanchez-Morgan et al., 2011). -catenin has two main 
function in the cell: it can localise at the plasma level compartment as a component 
of adherens junctions in order to stabilise adhesion and also activation of 
proliferation by translocating to the nucleus and interacting with T cell factor 
(TCF)/lymphoid enhancer factor (LEF) (Mann et al., 1999; Sanchez-Morgan et al., 
2011). Lox interacts with cytosolic -catenin and sequesters it to the plasma 
membrane, regulating its cytosolic availability. Hence, downregulation of Lox would 
alter -catenin mediated cell-cell adhesion, possible involving Cdsn, and at the 
same time increase availability of -catenin for the canonical Wnt/-catenin 
signalling pathway, which are likely to be important for the effects of lithium on 
oligodendrocytes and astrocytes (see Sections 5 and 6). 
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4.3.7 Lithium alters genes related to multiple neurodegenerative diseases 
Lithium is the gold standard choice for the treatment of BD (Cade, 1949; Licht, 
2012), but there is evidence that lithium may have wide-ranging beneficial effects in 
multiple neurological diseases, including MS and AD (Chiu et al., 2013). There is 
strong evidence that the direct and indirect modulation of GSK3 is an effect of 
lithium (Jope, 2003; Quiroz et al., 2010). However, the full mechanisms of action of 
lithium and its cellular targets are not completely clear in these diseases. IPA 
analysis of disease-related genes in the optic nerve showed that lithium down-
regulates a great number of components at the plasma membrane compared to 
any other compartment of the cell. Notably, CAIII was one of the most altered 
genes following lithium treatment and it was flagged in the BD dataset. Lithium 
increased the expression of CAIII, which is involved in pH regulation and cellular 
homeostasis (Supuran, 2011). It has been shown that inhibition of CA using 
Topimarate can be beneficial during acute depression, but their activation could be 
a novel therapy for AD (Supuran et al., 2011; Winum et al., 2003). CAIII is the only 
isoform that is not inhibited by sulphonamides and sulphamates (Supuran, 2011), 
whereas CAIV is sensitive and was inhibited by lithium, as well as being identified in 
astrocytes (Svichar et al., 2006). CAIV is also expressed by osteoclasts and its 
inhibition is currently investigated as a novel treatment for osteoporosis (Riihonen 
et al., 2007), which in turn could be related to identification of the osteoclast 
pathway as one of the top lithium regulated pathways in the optic nerve. 
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Bipolar disorder is associated with a higher risk of dementia and it has been 
suggested that chronic treatment of lithium could be beneficial against the effects 
of AD (Nunes et al., 2007). AD is characterised by dementia caused by the formation 
of amyloid plaques and neurofibrillary tangles, and through its inhibition of GSK3, 
lithium has been shown to inhibit amyloid plaque formation and 
hyperphopsphorylation of tau proteins in neurons (Munoz-Montano et al., 1997). 
One of the most downregulated genes in lithium was Arg1, which plays an 
important role in M2 macroglia/macrophage activation and also in vascular cell 
function (Liu et al., 2012; Tuppo and Arias, 2005), and has also been shown to be 
involved in AD pathology and wound healing (Campbell et al., 2013; Olivon et al., 
2013). The most down-regulated gene affected by lithium and associated with AD 
was osteoglycin, also known as mimecan, a small leucine-rich proteoglycan with 
unclear functions, that is expressed mainly in skeletal and muscle, but also found in 
the brain and retina (Ge et al., 2004; Kurpakus Wheater et al., 1999; Tanaka et al., 
2012), and found in cerebrospinal fluid of patients affected by AD (Zhang et al., 
2005). Another gene associated with AD that was down-regulated by lithium is 
Igfbp6, a polypeptide that modulates the expression of Igf-1 by regulating the 
bioavailability of Igf-1 and Igf- 2 protein (Cerro et al., 1993; Pollak et al., 2004; 
Putzer et al., 1998). Igfbp6 is of high relevance because it is expressed by astrocytes 
and oligodendrocytes and its decreasing levels are associated with a peak in OLs 
maturation (Kuhl et al., 2003; Larsen et al., 2006; Mewar and McMorris, 1997). 
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In section 3, I showed that lithium increased oligodendrogenesis in the adult mouse 
optic nerve, and so it is of interest that lithium regulated a great number of genes 
associated with MS (Figure 4.10). The gene for the chemokine CXCL1 was the most 
altered by lithium in our analysis (FC>500). CXCL1 acting via its receptor CXCR2 has 
been shown to be important for the development and maintenance of 
oligodendrocyte lineage cells and myelination (Padovani-Claudio et al., 2006). 
Similarly, regulation of genes by lithium that control cell cycle arrest and 
maturation, such as the RAN, PLK and PTEN pathways, Cdkn1a and Igfbp6, are 
consistent with lithium promoting gliogenesis, as observed in Section 3. Moreover, 
it was surprising to identify in the optic nerve genes for Corneodesmosin and 
Viperin that are reported exclusively in the epidermis, but recently have been 
associated in MS pathologies, suggesting a potential interaction between psoriasis 
and MS (Calleja et al., 2006; Hafler et al., 2007; Kulski et al., 2005; Leclerc et al., 
2009; Oji et al., 2010; van Baarsen et al., 2008). In this respect, it is interesting to 
note that a side-effect of lithium treatment is an exacerbation of pre-existing 
psoriasis or an induction of de novo psoriasis (Jafferany, 2008). In the optic nerve, 
corneodesmosin was specifcially upregulated by lithium treatment, suggesting a 
previously unrecognised function for this protein in the formation of desmosomal 
intercellular junctions in the mouse optic nerve that may be relevant to MS. 
Desmosomes contribute to cell-cell adhesion, signalling and differentiation and are 
a feature of CSF-contacting neurons (Vigh et al., 2004) and astrocytes in the fish 
optic nerve (Scholes, 1991), as well as having features in common with the post-
synaptic density in asymmetric synapses, which ensure maintenace of 
interneuronal communication (Klemann and Roubos, 2011). 
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4.4  SUMMARY AND CONCLUSIONS 
In this section I have used a genomic approach to identify the potential mechanisms 
by which lithium may have its profound effects on glial cells in the optic nerve. In 
addition, the results have provided a new insight into the genetic profile of the 
adult optic nerve and its response to culture. An important finding is that the ex 
vivo optic nerve is a good model for studying macroglial cells, which appeared 
largely unaltered in culture. Although a number of genes associated with reactive 
astrocytes were upregulated in control cultures, a prominent astrogliosis was not 
detected, suggesting limited tissue damage and maintenance of a relatively normal 
astrocyte phenotype in the ex vivo optic nerve. Unsurprisingly, there was evidence 
of microglial activation, with a number of M1 and M2 markers being increased, 
together with a range of genes associated with inflammation and injury. A key 
finding was the lithium had a general anti-inflammatory effect on genes 
upregulated by culture, with prominent novel targets including Arginase-1, Saa1 
and the PPAR pathway, as well as recognised targets of lithium, such as Wnt 
signalling. In addition, lithium treatment is shown to be a potent regulator of genes 
involved in the cell cycle, proliferation, maturation and cellular remodelling. 
Furthermore, numerous genes were identified that have not been reported in the 
optic nerve or glia, and in some cases have no known function in the CNS, including 
corneodesmosin, Lox, Saa1, Calcb, and Car3. Notably, many of the genes altered by 
lithium in the optic nerve are associated with mood disorders, MS and AD, 
suggesting that glial cells are targets of lithium treatment in these 
neurodegenerative diseases. 
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                                                    Section 5
Wnt signalling regulates 
oligodendrogenesis in the adult optic 
nerve 
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5.1  INTRODUCTION AND AIMS 
In Section 4, I identified a number of key genes and pathways that are altered by 
lithium and may underlie the profound effect of lithium on gliogenesis in the adult 
mouse optic nerve demonstrated in Section 3. One of the highlighted pathways was 
Wnt signalling, which is a key regulator of oligodendrocyte differentiation in the 
developing brain (Azim et al., 2014a; Fancy et al., 2009), and a recent study in the 
adult indicated a specific role for canonical Wnt signalling in stimulating 
proliferation within the oligodendrocyte lineage (Ortega et al., 2013).  Lithium is 
widely used as a Wnt mimetic due to its inhibitory effect on GSK3, which results in 
the translocation of -catenin to the nucleus to interact with LEF-1 (Detera-
Wadleigh, 2001; Williams and Harwood, 2000), which has been shown to have 
neuroprotective effects (Leng et al., 2008). The effects of lithium and Wnt on adult 
oligodendrocytes are unknown, but in the postnatal optic nerve, Wnt and GSK3 
inhibition had opposite effects, respectively inhibiting and promoting 
oligodendrocyte differentiation and indicating diverse mechanisms of action of 
lithium (Azim and Butt, 2011). The aim of this section was to compare the effects of 
lithium and Wnt on oligodendrocyte lineage cells in the adult optic nerve. 
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5.2  RESULTS 
5.2.1  Effect of Wnt3a on adult oligodendrocytes 
Canonical Wnt/-catenin signalling is a key regulator of oligodendrocyte 
differentiation and microarray analysis (n=12 optic nerves for each experimental 
group, run in triplicate) showed it was one of the pathways most altered by lithium 
treatment (Table 5.1). To test whether lithium acts as a Wnt mimetic, I compared 
the effects of lithium (20 mM) and the Wnt3a agonist 2-Amino-4-(3,4-
(methylenedioxy)benzylamino)-6-(3-methoxyphenyl) pyrimidine (2 M) ex vivo in 
adult optic nerves from Sox10-EGFP and PLP-DsRed mice (Figure 5.1). In the adult 
optic nerve, the vast majority of oligodendrocyte lineage cells are mature 
myelinating oligodendrocytes, with a small population (<5%) of adult OPC (Butt et 
al., 1999). Expression of the Sox10 reporter identifies both OPC and mature 
oligodendrocytes, whereas only mature oligodendrocytes express the PLP reporter 
(Azim and Butt, 2011). Compared with nerves maintained in control culture (n=6), 
the numbers of SOX10-EGFP+ oligodendrocyte lineage cells was increased 
significantly in both lithium (p<0.001, ANOVA, Bonferroni post-hoc test n=6) and 
Wnt3a (p<0.05, ANOVA, n=6), and there was no significant difference between the 
two treatments (Figure 5.1A). In comparison, lithium doubled the number of PLP-
DsRed+ oligodendrocytes compared to control (p<0.001, ANOVA, n=6 in all 
experimental groups) (Figure 5.1Bii, Biv), whereas Wnt3a had no significant effect 
(Figure 5.1Biii, Biv). Interestingly, in the postnatal optic nerve, Wnt3a significantly 
decreased the number of PLP-DsRed+ cells compared to lithium and controls (Azim 
and Butt, 2011). The results demonstrate Wnt signalling persists in the adult optic 
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nerve and indicate its mechanism of action in oligodendrocytes differs than in the 
postnatal nerve.  
Table 5.1 Gene expression of Wnt related genes altered by Lithium compared to 
acute nerves 
Symbol p-value Fold Change Location Type 
WNT4 2.92E-02 -6.936 Extracellular Space cytokine 
FZD2 1.60E-02 -4.736 Plasma Membrane G-protein coupled receptor 
BMP6 4.47E-02 -3.334 Extracellular Space growth factor 
WNT5A 9.90E-03 -3.327 Extracellular Space cytokine 
BMP5 2.36E-02 -3.052 Extracellular Space growth factor 
FZD6 3.54E-02 -2.818 Plasma Membrane G-protein coupled receptor 
WNT7A 3.80E-02 -2.183 Extracellular Space cytokine 
FZD1 2.08E-02 -2.176 Plasma Membrane G-protein coupled receptor 
FZD7 4.34E-02 -1.886 Plasma Membrane G-protein coupled receptor 
133
Figure 5.1 Effects of lithium and Wnt3a on oligodendrocyte lineage cells. (A-B) Representative confocal images of optic nerves from 
Sox10-EGFP and PLP1-DsRed mice maintained in culture for 3DIV, in control medium (Ai, Bi), 20mM lithium (Aii, Bii), or 2µm Wnt3a 
agonist (Aiii, Biii) as indicated; scale bars = 100 m in main panels. Histogram of mean (+SEM) cell counts per constant FOV for Sox10-
EGFP cells (Aiv) and PLP1-DsRed (Biv); tested for significance using ANOVA followed by Bonferroni post-hoc test. Lithium dramatically 
increased the number of SOX10-EGFP+ cells and PLP1-DsRed cells compared to control (P<0.001, n=6). Wnt3a increased SOX10-EGFP+ 
cells compared to control (P<0.001, n=6) to levels comparable to Lithium (P>0.05, n=6); however no statistical difference was observed 
for PLP1-DsRed cells (P>0.05, n=6). 
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5.2.2 Wnt signalling persists in the adult optic nerve 
The effects of Wnt3a provide functional evidence that Wnt/-catenin signalling 
persists and regulates oligodendrocyte differentiation in the adult optic nerve. The 
role of canonical Wnt/-catenin signalling in oligodendrocyte development is well 
accepted, but the exact elements of Wnt signalling in the adult optic nerve are 
unknown. These were analysed by qRT-PCR, using the RT2 profiler WNT signalling 
pathway PCR array (Sabiosciences). Biological replicates were analysed by 
comparing mean Ct values of each genes to the most stable house-keeping gene 
Hsp90ab1. Genes presented are all statistically significant (p<0.05, t-test; n=12 optic 
nerves for each experimental group run in triplicate).  
By comparing the transcriptome of acutely isolated optic nerves with culture 
control we identified a number of Wnt signalling molecules that are present in 
acute nerves but lost in culture (Table 5.2). The endogenous Wnt signalling 
pathways in the adult optic nerve are illustrated in Figure 5.2. Wnt3 signalling is a 
major Wnt in the adult optic nerves, consistent with the results presented above 
(Figure 5.1) and its known function in regulating brain development (Roelink, 2000). 
However, the most abundant Wnt ligands were Wnt6 and Wnt16, which were lost 
in control cultures (p<0.01) and have no clear function in the CNS. Also expressed 
were Wnt10a, which has been shown in the developing zebrafish CNS (Kelly et al., 
1993), and Wnt2b, which has a role in olfactory bulb and optic cup development 
(Ohta et al., 2011; Tsukiyama and Yamaguchi, 2012). Expression of Axin2 (also 
known as Conductin) in the optic nerve is consistent with it being a key component 
of canonical Wnt/-catenin signalling, as is the case for LEF-1 and WIF-1, which are 
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respectively the main target and modulator of the canonical Wnt/-catenin 
pathway. The expression of Sox17 is notable because it was one of the most 
expressed Wnt signalling target molecule in the optic nerve and is necessary for the 
regulation of oligodendrogenesis, directly antagonising Wnt/-catenin to suppress 
cell proliferation and drive OPC maturation (Chew et al., 2011; Moll et al., 2013; 
Sohn et al., 2006). In contrast, Prickle1 (Prk1) belongs to the molecules regulating 
the noncanonical PCP pathway and is expressed in neurons and glia embryonically 
(Liu et al., 2013; Okuda et al., 2007).   
Culture conditions dramatically increased the expression of the WNT target Fosl1 
(FOS-like antigen 1, including also known as Fra-1), which is implicated in regulating 
cell proliferation and differentiation (Casalino et al., 2007) and has been shown to 
regulate the expression of MMP9 and interact with SMAD2/3 (Das et al., 2012; 
Sundqvist et al., 2013). Moreover, there was an upregulation of canonical signalling 
molecules Wnt8a, which is essential for normal vertebrate development (Lindsley 
et al., 2006), together with Wnt2 and Wnt7b, which have poorly defined functions 
in the CNS, although Wnt2 may interact with PDGF signalling (Miller et al., 2012). 
Wnt1 and WISP1 (Wnt1 inducible signalling pathway protein 1) were both 
significantly upregulated in culture, and have been implicated in microglia (Shang et 
al., 2012) and Wnt1 has an important developmental role in ventral midbrain 
dopaminergic neurons (Moreno-Bravo et al., 2012). Similarly, upregulation of Myc is 
consistent with its role in promoting OPC proliferation and inhibiting their 
differentiation in mature oligodendrocytes (Magri et al., 2014), whereas Jun 
expression is increased by PDGF administration in oligodendrocytes in vitro (Hart et 
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al., 1992) and is implicated in reactive astrogliosis and the inflammation response 
(Albanito et al., 2011). Foxn1 and Dab2 were also upregulated, but have no 
reported function in glia, although Dab2 is implicated in CNS embryonic 
development (Cheung et al., 2008). 
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Table 5.2  Wnt-signalling transcripts in adult mouse optic nerve that were regulated 
by organotypic culture for 3DIV. Data obtained by q-PCR analysis of 3 biological 
replicates of Acutely isolated optic nerves compared to optic nerves cultured for 
3DIV. Statistical analysis was performed by volcano plot (unrelated t-test P<0.05; 
FC>2.0). 
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Figure 5.2  Wnt signalling genes present in acutely isolated nerves and altered by 
culture condition. A complement system pathway generated by IPA. Proteins with 
increased expression are marked in red proteins with decreased expression are 
marked in green. Further information on the IPA legend is shown in Figure 4.5.
139
5.2.3  Effects of lithium and Wnt3a on the Wnt signalling pathway  
qRT-PCR was used to determine the effects of lithium and the Wnt3a agonist on 
expression of Wnt pathway transcripts compared to control optic nerves (Table 5.3 
and Figure 5.3); all nerves were maintained in culture, hence any differences 
between the treatments is due to the effects of lithium or Wnt3a. A key feature was 
that both lithium and Wnt3a down-regulated Wnt signalling (Figure 5.3), but to a 
far greater degree in Wnt3a and the majority of elements differed between the two 
treatments (Table 5.3). Notably, Wnt8a, which was upregulated by culture 
(FC=+69), was completely rectified by Wnt3a (FC=-78), but only partly 
downregulated by lithium (FC=-12). The other Wnt ligands were specific to one 
treatment or the other: Wnt16, Wnt8b and Wnt5a in lithium, and Wnt2, Wnt4, 
Wnt6, Wnt7b and Wnt9a in Wnt3a. Fewer Fzd receptors were altered, with Fzd2 
being downregulated in both lithium and Wnt3a, whereas Fzd8 and Fzd9 were 
downregulated specifically in Wnt3a. A major effect of lithium was on Sfrp2 and 
Sfrp4, which are inhibitory to Wnt signalling and were not affected in control 
culture, but were lost after lithium treatment. Notably, Wnt16 and Wif1 were 
strongly expressed in acute nerves and were respectively ablated by lithium and 
Wnt3a. Wnt signalling is proposed to negatively regulate oligodendrocyte 
differentiation and so its downregulation in both lithium and Wnt3a is consistent 
with both factors acting via this pathway to promote the observed 
oligodendrogenesis in the adult optic nerve, although the specific mechanisms may 
differ. 
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Table 5.3  Wnt-signalling transcripts in adult mouse optic nerve that were regulated 
by lithium and Wnt3a in organotypic culture for 3DIV. Data obtained by q-PCR 
analysis of 3 biological replicates of Acutely isolated optic nerves compared to optic 
nerves cultured for 3DIV. Statistical analysis was performed by volcano plot 
(unrelated t-test P<0.05; FC>2.0). 
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 Figure 5.3 Wnt signalling genes altered by Lithium. A complement system pathway 
generated by IPA. Proteins with increased expression are marked in red proteins 
with decreased expression are marked in green. The IPA legend is shown in Figure 
4.5.
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Figure 5.4 Wnt signalling genes altered by Wnt3a. A complement system pathway 
generated by IPA. Proteins with increased expression are marked in red proteins 
with decreased expression are marked in green. The IPA legend is shown in Figure 
4.5.
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5.2.4 Key oligodendrocyte pathways regulated in lithium  
The similar effects of Wnt3a and lithium are consistent with the latter being used as 
a mimetic for canonical Wnt/-catenin signalling, due to its GSK3 inhibitory action. 
However, lithium acts on multiple pathways that may regulate oligodendrogenesis, 
and these were investigated by comparing the microarray datasets of lithium 
compared to acute nerves (n=12 optic nerves for each experimental groups, run in 
triplicate). Key interrelated pathways that were regulated by lithium were PTEN, 
STAT, BMP and ID2/ID4. 
5.2.4.1 PTEN signalling 
Lithium dramatically altered the PTEN pathway (Figure 5.5), with the pathway 
predictor software indicating an activation of PI3K/Akt. The most altered gene in 
this pathway is P21Cip1, also known as Cdkn1a, which was one of the most 
upregulated genes in lithium and inhibits cell proliferation and promotes cell 
differentiation (Lin et al., 2007; Porlan et al., 2013). PTEN is a tumour suppressor 
protein that is regulated by multiple signalling factors, including BMP (see below), 
PDGF and IGF-1. PTEN antagonises the PI3K signalling pathway (Funamoto et al., 
2002) and deletion of PTEN results in the over-expression of Akt and its 
downstream targets, such as mTOR, which leads to the regulation of cell growth 
(Harrington et al., 2010). Furthermore, PTEN accumulation inhibits nuclear 
translocation of cyclin D1, resulting in cell cycle arrest (Radu et al., 2003). 
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5.2.4.2 STAT signalling 
Lithium significantly altered multiple elements that are predicted to result in a 
down-regulation of the STAT3 signalling pathway (Figure 5.6).  STAT3 is activated by 
a plethora of cytokines and growth factors, including BMP (see below), and a key 
effect of lithium was on Myc, which was one of the most upregulated genes in 
lithium and regulates cell cycle progression during oligodendrocyte progression 
(Magri et al., 2014). 
5.2.4.3 The BMP pathway 
BMPs have been shown to play a critical role in cell fate determination in the 
developing CNS, through the downstream effectors SMAD1/5/8 and STAT3 (Rajan 
et al., 2003). Lithium exerted a powerful downregulation of Bmp4, Bmp5, Bmp7 and 
Bmp15, whereas Bmp1 and Bmp2 were upregulated in both lithium and Wnt3a 
(Figure 5.7). The key effects were on BMP4, which was significantly downregulated 
in both lithium (FC>-12) and Wnt3a (FC>-8), and on BMP2, which was significantly 
upregulated in both lithium (FC>3) and Wnt3a (FC>2) (Table 5.4). Moreover, the 
BMP effectors Smad1/5/8 were upregulated, as were the downstream targets JUN 
and CREB.  The increased expression of CREB promoted by lithium is consistent with 
that reported in the literature (Grimes and Jope, 2001a).  
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5.2.4.4 ID2/4 
HDACs are key regulators of Notch, Wnt and BMP signalling, acting to inhibit key 
molecules, including Hes5, ID2/4, TCF4, Egr1 and Sox11 (Swiss et al., 2011). Notch1, 
HDAC1/2, and TCF4 were unaltered in lithium and Wnt3a, whereas Sox11 and Hes5 
were called absent or barely present in the optic nerve, and although Egr1 was 
upregulated, this appeared to be a culture effect (Table 5.4). In contrast, lithium 
strongly downregulated ID4 (p<0.05, ANOVA, Benjamini-Hoechberg FDR, FC>2.0), 
but not ID2, whereas Wnt3a decreased both ID2 and ID4 (p<0.05, ANOVA, 
Benjamini-Hoechberg FDR), although these were marginal effects (FC<1.5) (Table 
5.4). YY1, which suppresses TCF4 and ID4 via HDAC1, was unaltered by treatments 
(Table 5.4). The results suggest that Wnt and BMP signalling via ID2/4 may be 
important in the divergent effects of lithium and Wnt3a on mature 
oligodendrocytes. 
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 Figure 5.5  PTEN signalling genes altered by Lithium. A complement system 
pathway generated by IPA. Proteins with increased expression are marked in red 
proteins with decreased expression are marked in green. The IPA legend is shown in 
Figure 4.5.
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Figure 5.6  Stat3 signalling genes altered by Lithium. A complement system pathway 
generated by IPA. Proteins with increased expression are marked in red proteins 
with decreased expression are marked in green. The IPA legend is shown in Figure 
4.5.
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Figure 5.7  BMP signalling genes altered by Lithium. A complement system pathway 
generated by IPA. Proteins with increased expression are marked in red proteins 
with decreased expression are marked in green. The IPA legend is shown in Figure 
4.5.
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5.2.5  Effects of lithium and Wnt3a on key oligodendrocyte genes   
The main oligodendrocyte genes were not different (FC>1.5) between the 
experimental groups (Table 5.4), and the key differences are illustrated in Figure 
5.8. For example, myelin genes were equivalent in lithium and Wnt3a (e.g. MBP, 
PLP1, CNPase, MOG, and MAG). Similarly, genes that define the oligodendrocyte 
lineage - Sox10 and Olig2  were not altered in lithium and Wnt3a (Table 5.4), 
whereas genes that define OPCs - Pdgfra, Cspg4, and Nkx2.2 - were differentially 
altered in lithium and Wnt3a; Cspg4 was not altered in either treatment, whereas 
Nkx2.2 was downregulated in both, and notably Pdgfra was significantly and 
specifically downregulated in lithium (FC>3). This key finding was confirmed by 
western blot and qRT-PCR, which demonstrated an almost complete loss of 
PDGFR in lithium (Figure 5.9A, B; n=12 optic nerves for each experimental group, 
run in triplicate for the qRT-PCR and western blot), and also confirmed that Olig2 
and Sox10 were unaltered (Figure 5.9C; n=12 optic nerves for each experimental 
group, run once). A range of transcription factors that are important for 
oligodendrocyte differentiation were unaltered by lithium and Wnt3a (e.g. Sox5, 
Sox6, and Sox9), but both Olig1 and Sox17 were downregulated in both treatments 
(FC>2.0). In addition, a number of growth factors and their receptors that regulate 
oligodendrocyte differentiation were altered in lithium and Wnt3a, and notable 
findings were the profound upregulation of Cxcl1 (FC>160 in lithium) and LIF (FC>50 
in lithium), both of which were significantly greater in lithium than Wnt3a (Table 
5.4). In addition, there was a downregulation of GPR17, which was greater in 
lithium (FC>-13). Figure 5.8 illustrates the main oligodendrocyte genes altered by 
lithium and Wnt3a, most of which were regulated in an equivalent manner, with 
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the notable exceptions of Igf1, Bmp2, Lif and Cxl1, which were differentially 
regulated. 
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Table 5.4  Comparison of major oligodendrocyte genes in lithium and Wnt. Data 
obtained by analysing the microarray datasets generated for acutely isolated optic 
nerves, control, Lithium and Wnt3a treated for 3DIV. Statistical analysis was 
performed as ANOVA followed by TukeyHSD post-hoc test. P values were FDR  
corrected. 
 Gene Symbol Acute Control Lithium Wnt3a  
Cnp 1302 1302 1371 1975 
Mag 940 690 569 746 
Plp1 2298 1700 1807 1889 
Mbp 2977 2343 2470 1996 
Mobp 2939 2292 2531 2398 
Mog 2007 1244 1268 1402 
Ugt8a 1813 999 954 982 
Cspg4 62 13 68 79 
Pdgfra 576 522 182 375 
Pdgfa 290 356 428 373 
Nkx2-2 231 178 149 113 
Nkx6-2 363 228 289 346 
Olig1 689 245 260 337 
Olig2 307 171 297 204 
Sox5 19 13 17 13 
Sox6  185 177 192 256 
Sox9 578 820 825 583 
Sox10 958 640 678 1005 
Sox17 26 14 9 13 
Fgf2 10 16 10 14 
Egr1 517 1086 1031 1040 
Sox11 5 15 8 4 
Fgfr1  177 129 250 418 
Fgfr2 1212 658 718 646 
Fgfr3 144 162 99 182 
Igf1 37 82 29 165 
Igf1r 243 153 98 61 
Lif 8 306 411 115 
Lifr 8 17 18 29 
Cxcl1 9 883 1500 670 
Cxcl12 370 261 58 154 
Cxcr2 1 2 2 2 
Cxcr4 348 252 182 141 
Notch1 373 395 376 300 
Yy1 674 804 766 593 
Tcf4 800 712 618 512 
Hdac1 309 331 293 335 
Hdac2 190 248 237 158 
Bmp2 123 440  426 262 
Bmp4 172 22 14 21 
Id2 549 759 643 560 
Id4 396 259 130 225 
Lef1 106 60 24 20 
Gpr17 221 30 17 28 
Ccnd1 1189 1250 1321 1186 
Cdk2 31 28 26 10 
Cdk4 314 535 442 423 
Cdk6 23 59 40 50 
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Figure 5.8 Comparison of major oligodendrocyte genes that are markedly altered in 
lithium and Wnt. Data obtained by analysing the microarray datasets generated for 
acutely isolated optic nerves, control, Lithium and Wnt3a treated for 3DIV. 
Statistical analysis was performed as ANOVA followed by TukeyHSD post-hoc test. P 
















Figure 5.9 Expression of common oligodendrocyte markers. Relative quantification 
(q-PCR) of the expression of Pdgfra in acutely isolated optic nerves, control and 
Lithium (A). q-PCR data illustrate the general decline of Pdgfra transcript level in 
culture condition. (B) Proteomic analysis confirms a general decline of PDGFR-a 
level at 2DIV concomitant with the biological effect observed in Lithium treated 
optic nerves. Olig2 and Sox-10 indicates that the expression of oligodendrocyte 
lineage cells markers is preserved. 
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5.3  DISCUSSION 
Wnt signalling is a potent negative regulator of oligodendrocyte differentiation and 
myelination in the developing brain (Azim and Butt, 2011; Fancy et al., 2009). A key 
finding of this section was that Wnt signalling persists in the adult optic nerve and 
regulates oligodendrogenesis. Both lithium and Wnt3a increased oligodendrocytes 
in the adult optic nerve, which contrasts with the developing CNS, where Wnt 
inhibits oligodendrocyte differentiation (Azim and Butt, 2011; Fancy et al., 2009), 
indicating an important difference in Wnt signalling between adult and postnatal 
OPCs. A major effect of lithium and Wnt3a was to downregulate multiple aspects of 
Wnt signalling, including Wnt8a and Fzd2, which were amongst the most highly 
regulated Wnt ligands and receptors in both groups. In addition, differential effects 
were identified, such as Wnt16, which was the most strongly regulated in lithium. A 
key target of lithium treatment was downregulation of BMP and ID4 signalling, 
which are potent negative regulators of oligodendrocyte differentiation and 
myelination. Moreover, lithium specifically resulted in a marked loss of the OPC 
marker PDGFR, but not SOX-10 or OLIG2, suggesting the increase in 
oligodendrocytes in lithium may have depleted the pool of OPCs. In general, lithium 
and Wnt3 altered similar pathways that negatively and positively regulate 
oligodendrocyte differentiation, notable exceptions being Igf1, Bmp2, Lif and Cxl1, 
which were differentially altered in lithium and Wnt3a, and may underlie 
differences in their effects on mature oligodendrocytes. 
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5.3.1 Canonical Wnt/-catenin promotes oligodendrogenesis in adult optic nerve 
Lithium and Wnt3a equally increased oligodendrocyte lineage cells expressing the 
SOX-10 reporter, which comprise OPC and mature oligodendrocytes. Lithium also 
doubled cells expressing the PLP1 reporter, which are considered to be mature 
oligodendrocytes, whereas Wnt3a did not significantly alter the numbers of these 
cells. The effects of lithium are equivalent to those reported during development 
and are consistent with its GSK3 inhibitory effects (Azim and Butt, 2011). However, 
in the adult nerve the loss of PDGFR in lithium indicates the pool of adult OPCs 
was depleted by generating new oligodendrocytes, whereas this was not observed 
in the developing forebrain, where the SVZ provides a renewable source of OPCs 
under the control of Wnt and other factors (Azim et al., 2014a; Azim et al., 2014b). 
In contrast to lithium, Wnt has differential effects on the developing and adult 
nerve. In the postnatal nerve, there was ongoing differentiation of 
oligodendrocytes from a large population of OPCs, and Wnt increased the 
proliferation of Sox10+ OPCs, but inhibited their differentiation into PLP+ 
oligodendrocytes (Azim and Butt, 2011; Azim et al., 2014b). The results of this 
section indicate Wnt increased OPCs as it does during development, but did not 
inhibit their differentiation into oligodendrocytes, which were also increased, not 
significantly different from lithium, albeit not significantly different to controls 
either. The concentration of Wnt3a used in this study was based on that used 
previously (Azim and Butt, 2011; Feigenson et al., 2011), but further experiments 
are required to determine whether the differences between lithium and Wnt3a are 
concentration-dependent. In addition, this section identified multiple Wnt ligands 
and Fzd receptors are active in the optic nerve in addition to Wnt3a, which merits 
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further examination. Nonetheless, OPCs are the source of oligodendrocytes in both 
the developing and adult optic nerve, hence the effects of Wnt3a to respectively 
increase and decrease PLP+ oligodendrocytes in the adult and postnatal nerves 
indicates a fundamental difference in Wnt signalling in adult and postnatal OPCs. 
Moreover, lithium and Wnt3a differentially altered elements of FGF-2 and BMP 
signalling, which can modify the response of precursor cells to Wnt (Duncan et al., 
2005; Feigenson et al., 2011; Israsena et al., 2004; Jamora et al., 2003). Thus, the 
interplay between these different pathways may underlie the differential effects of 
lithium and Wnt3 on oligodendrocytes in the adult and postnatal nerves and merits 
further study. 
5.3.2  Wnt signalling persists in the adult optic nerve 
Microarray and qRT-PCR analysis of the transcriptome of acutely isolated optic 
nerves compared to cultured nerves identified the expression of diverse Wnt-
related genes that have never previously been reported in the adult optic nerve. 
The Wnt superfamily consists of at least 19 secreted glycoproteins that act via a 
number of membrane-spanning FZD receptors to activate either the canonical 
Wnt/-catenin pathway or the non canonical -catenin independent pathway 
(Malaterre et al., 2007). In the canonical pathway, Wnt signalling inhibits GSK3, 
which allows the nuclear translocation of non-ubiquitinated -catenin to the 
nucleus, where it interacts with TCF/LEF transcription factors to regulate 
proliferation and differentiation during oligodendrocyte development (Adachi et al., 
2007; Azim and Butt, 2011; Azim et al., 2014a; Fancy et al., 2009). The non 
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canonical Wnt/calcium pathway is involved in the mobilization of intracellular 
calcium, although its downstream targets are poorly understood (Saneyoshi et al., 
2002; Sheldahl et al., 2003), whereas the non canonical planar polarity pathway 
involves the regulation of cell polarity. In addition, there is complex regulation of 
Wnt signalling, such as by the secreted inhibitory frizzled receptor proteins (SFRPs), 
Wnt inhibitory factor 1 (WIF-1) and Dickkopf WNT signalling pathway inhibitor 
(DKK) proteins. Many of these elements were identified in the adult optic nerve and 
indicated specific mechanisms of Wnt signalling are active in the nerve, presumably 
acting as signalling molecules between glia and other cellular elements, such as the 
vasculature.   
Expression of Wnt3 amongst the top 10 Wnt genes in the optic nerve is consistent 
with the effects of Wnt3a on oligodendrocytes and has been shown to regulate 
oligodendrocyte differentiation and neurogenesis, without inhibiting cell 
differentiation (David et al., 2010; Feigenson et al., 2011; Langseth et al., 2010; 
Roelink, 2000). However, the most highly expressed Wnt ligand in the nerve was 
Wnt6, which has no reported function in the CNS or glia. However, Wnt6 has been 
shown to regulate macrophage polarisation toward an M2 phenotype in lungs 
(Schaale et al., 2013), and therefore may play similar role in optic nerve microglia, 
which display a M2 phenotype (Section 4). In addition, ectopic expression of Wnt6 
induces embryonic epithelialisation (Krawetz and Kelly, 2008; Schmidt et al., 2004), 
suggesting it may be important in remodelling glia. Another notable observation 
was the expression of Wnt16, which has been shown to be expressed in the brain, 
but its function in the CNS is unresolved (McWhirter et al., 1999; Nygren et al., 
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2009). Outside the CNS, Wnt16 inhibits osteoblast differentiation, while promoting 
keratinogenesis (Jiang et al., 2002; Teh et al., 2007), which has a resonance with the 
microarray findings in Section 4, which identified a hitherto unrecognised 
expression of genes associated with osteobalst differentiation and keratinogenesis 
in the adult optic nerve. Similarly, Wnt10a has not been reported in the mammalian 
CNS, but is expressed in the developing CNS of zebrafish (Kelly et al., 1993), and in 
mammals has been reported in epidermis, liver and kidney and regulates 
adipogenesis of mesenchymal cells in vitro (Cawthorn et al.; Kirikoshi et al., 2001; 
Wang and Shackleford, 1996). Notably, Wnt2b and its receptor Fzd4 have not been 
reported in the optic nerve previously, but are expressed in the optic cup and 
olfactory bulb where they have a potential role in differentiation (Tsukiyama and 
Yamaguchi, 2012). 
A number of different targets of canonical and non-canonical Wnt signalling were 
identfiied in the optic nerve. The expression of LEF-1 is consistent with its role as a 
target for canonical Wnt/-catenin signalling in oligodenrogenesis (Azim et al., 
2014a; Fancy et al., 2014) and its function in regulating proliferation of stem cells 
and endothelial cells (Huang and Qin, 2010; Jamora et al., 2003; Petersson et al., 
2011). Axin2 (also known as Conductin) is another component of canonical Wnt/-
catenin signalling and has recently been shown to be important for myelination and 
remyelination in vivo (Fancy et al., 2011), as well as maintenance of adult NSC 
(Bowman et al., 2013; Yan et al., 2009).  We also identified expression of a class of 
molecules known to regulate Wnt signalling, including Sox17 and Wif1. Sox17 
antagonises Wnt/-catenin directly to suppress proliferation of OPCs and drive 
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their maturation into myelinating oligodendrocytes (Chew et al., 2011; Moll et al., 
2013; Sohn et al., 2006). Sox17 was downregulated in culture and may in part be 
related to the observed decrease in oligodendrocytes in control cultured nerves 
(Section 3). Wif1 is another important inhibitor of Wnt signalling that is regulated 
by SMAD1 and its upstream activator BMP (Hu et al., 2008; Xu et al., 2011), both of 
which are regulated by lithium (see below). In contrast, Prickle-1 belongs to the 
molecules involved in the noncanonical PCP pathway, and is involved in axonal 
maturation and morphogenesis in the developing brain and retina (Liu et al., 2013). 
The data demonstrate the activity of both canonical and noncanonical Wnt 
signalling, many aspects of which were downregulated in culture. However, culture 
conditions dramatically increased the expression of the Wnt target Fosl1 (also 
known as Fra-1), which is implicated in regulating cell proliferation and 
differentiation (Casalino et al., 2007) and has been shown to regulate the 
expression of MMP9 and interact with SMAD2/3 (Das et al., 2012; Sundqvist et al., 
2013). In addition, there was an upregulation of Wnt8a, which is essential for 
normal vertebrate development (Lindsley et al., 2006), together with Wnt2, Wnt7b 
and Wnt1. Wnt2 and Wnt7b interact with PDGF to regulate the development of 
endodermal organs (Miller et al., 2012), suggesting they may have a similar role in 
OPCs. Furthermore, Wnt2 modulates the stabilisation and localisation of -catenin 
in adherens junctions (Wang et al., 2013), consistent with a structural  function for 
Wnt2/-catenin signalling. In contrast, Myc has a known function in OPCs and 
promotes their proliferation and inhibit their differentiation (Magri et al., 2014), 
suggesting upregulation of Myc in culture may be important in the decreased 
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capacity for OPCs to generate oligodendrocytes. C-Jun expression is increased by 
PDGF administration in oligodendrocytes in vitro (Hart et al., 1992), and has been 
implicated with reactive astrogliosis and inflammation response in the cerebellum 
(Albanito et al., 2011).  
5.3.3  Wnt signalling is a key target of lithium and Wnt3a in the adult optic nerve  
Microarray and qRT-PCR demonstrated that treatment with lithium and Wnt3a 
generally downregulated Wnt signalling in the adult optic nerve. This may seem 
counterintuitive, since lithium and Wnt3a activate canonical Wnt/-catenin 
signalling, but the results are consistent with negative feedback mechanisms 
preventing long-term Wnt activation (Ueno et al., 2007). Interestingly, this was not 
related to an activation of known negative regulators of Wnts, such as the Sfrp2 
and 4, which were ablated by lithium, and Wif1, which was strongly expressed in 
acute nerves and ablated by Wnt3a. Notably, Wnt16 was specifically 
downregulated in lithium, whereas Wnt8a was upregulated by culture and 
downregulated by both lithium and Wnt3a, although the effect of Wnt3a was 
greater. As noted above, Wnt16 and Wnt8a have no reported function in the brain 
or in glia, although Wnt8a is involved in embryonic neural development (Erter et al., 
2001; Fear et al., 2000). In addition, Fzd2 was downregulated in both lithium and 
Wnt3a, whereas the ligand Wnt5a was specifically downregulated by lithium. 
Wnt5a/Fzd2 are downregulated in many neurodegenerative diseases, including ALS 
(Li et al., 2013). In the optic nerve, Wnt3a generally decreased expression of more 
Wnt ligands and Fzd receptors than lithium, specifically Wnt2, Wnt4, Wnt6, Wnt7b, 
Wnt9a, Fzd8 and Fzd9; with the exception of Wnt2, none of these have not been 
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noted in glia and have no clear functions in the adult CNS. Interestingly, Wnt2 is a 
reported target of antidepressants (Okamoto et al., 2010), but has not been noted 
in glia.  Notwithstanding these uncertainties, the downregulation of Wnt signalling 
in lithium and Wnt3a is consistent with both factors acting via this pathway to 
promote the observed oligodendrogenesis in the adult optic nerve, as it does in the 
developing forebrain (Azim et al., 2014a; Azim et al., 2014b), although the specific 
mechanisms may differ. 
5.3.4 Lithium alters PTEN and STAT signalling 
In addition to Wnt signalling, IPA analysis highlighted a number of pathways that 
may underlie the profound effect of lithium on increasing oligodendrocytes in the 
adult nerve and can be tested pharmacologically and genetically in future studies. 
Lithium significantly altered the PTEN and STAT pathways compared to acutely 
dissected nerves. PTEN is a tumour suppressor gene that is tightly regulated by 
BMP, PDGF and IGF-1, which were also altered by lithium. PTEN acts by 
counteracting the PI3K pathway (Funamoto et al., 2002) and genetic deletion of 
PTEN in oligodendrocytes results in over activation of Akt and its downstream 
target mTOR, which leads to increased cell growth (Flores et al., 2008; Harrington et 
al., 2010; Narayanan et al., 2009). Our results indicate that lithium activated the 
PI3k-Akt pathway without decreasing Pten levels. Furthermore, PTEN accumulation 
inhibits nuclear translocation of cyclin D1 resulting in cell cycle arrest (Radu et al., 
2003). Lithium also altered the STAT pathway, which like PTEN is regulated by BMP. 
STAT3 has been shown to be an important regulator of astrogliosis after injury 
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(Herrmann et al., 2008). Moreover, STAT3 conditional knock out in astrocytes had 
deleterious effects on myelination, suggesting it mediates interplay between 
astrocytes and oligodendrocytes, possibly involving BMP (Nobuta et al., 2012). A 
recent study showed that lithium directly inhibits STAT3 expression in NSC during 
development through a GSK-independent pathway (Zhu et al., 2011b). We also 
identified that lithium treatment increased Cdkn1a (also known as P21) and Myc, 
downstream targets of PTEN and STAT. Cdkn1a has been shown to provide 
apoptosis resistance, inhibit cell proliferation and promote cell differentiation (Lin 
et al., 2007; Porlan et al., 2013).  Cdkn1a and Myc were the most up-regulated 
genes in our analysis further indicating an effect of lithium on PTEN and STAT 
pathways, which would provide a potential mechanism by which lithium increases 
oligodendrocytes in the optic nerve.  
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5.3.5  BMP and ID4 signalling are downregulated in lithium 
The results indicate BMP signalling is prominent in the adult optic nerve and that a 
major effect of lithium is to directly or indirectly decrease the expression of BMP-4, 
-5, -7 and -15, but not BMP-1 or -2. BMPs play a critical role in cell fate 
determination in the developing CNS through the crosstalk between the 
downstream effectors Smad1/5/8 and STAT3 (Rajan et al., 2003). CREB is a 
downstream target of BMP signalling and was upregulated in lithium, which is 
consistent with findings in the postnatal optic nerve (Azim and Butt, 2011; Grimes 
and Jope, 2001a) and evidence that CREB promotes myelination, as well as axonal 
growth (Afshari et al., 2001; Gao et al., 2004). In particular, lithium strongly 
downregulated BMP-4, which acts via ID4 to inhibit oligodendrogenesis and 
myelination by complexing with OLIG1 and OLIG2 (Samanta and Kessler, 2004; Wu 
et al., 2012). Like BMP-4, lithium downregulated ID4 and decreased levels of ID4 
have been shown to enhance oligodendrocyte differentiation (Samanta and Kessler, 
2004). 
Wnt and BMP regulate HDAC expression to inhibit oligodendrocyte differentiation 
and promote the expansion of OPC population during development (Marin-
Husstege et al., 2002; Ye et al., 2009). The canonical Wnt/-catenin pathway 
increases proliferation in OPCs by promoting cell cycle re-entry and inhibits their 
differentiation during development by increased expression of ID2/4 (Swiss et al., 
2011). When Wnt/-catenin is activated, ID2/4 is phosphorylated, resulting in a 
cascade of events that initiates OPC proliferation (Chen et al., 2012a). ID2/4 directly 
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interacts with Olig1/2 and inhibits Cdkn1a expression (Chen et al., 2012b; Samanta 
and Kessler, 2004). ID4 is essential in OPCs, whereas ID2 is less so (Chen et al., 
2012a; Kondo and Raff, 2000; Samanta and Kessler, 2004), which is consistent with 
the effects of lithium, which strongly decreased ID4 but not ID2. In addition, Olig1 
was downregulated in lithium and Wnt3a, whereas Olig2 was maintained, which 
supports a recent study showing that Olig2 is essential for oligodendrocyte 
differentiation, whereas Olig1 plays a minor role and is non-essential (Paes de Faria 
et al., 2014). Overall, the results provide evidence that lithium represses inhibition 
of OPC differentiation to promote the expansion of oligodendrocytes in adult as it 
does in development (Azim and Butt, 2011). Furthermore, Wnt3a had a marginal 
effect on ID4, suggesting a further difference in the actions of lithium and Wnt3a 
that may be important in their effects on mature PLP+ oligodendrocytes.  
5.4  SUMMARY AND CONCLUSIONS 
This section shows that lithium and Wnt3a act in a similar manner to increase 
oligodendrocytes in the adult optic nerve. Comparison of the effects of lithium and 
Wnt3a on optic nerve genes and pathways strongly suggests that lithium is acting 
primarily as a Wnt mimetic to downregulate Wnt and BMP signalling, which are 
potent negative regulators of oligodendrocyte differentiation, acting at least in part 
via ID4. However, lithium was more potent than Wnt3a in mature PLP+ 
oligodendrocytes, and a number of possible targets were identified that may 
underlie this differential effect. Notably, Cxcl1 and LIF, which are expressed by 
astrocytes and stimulate myelination (Kadi et al., 2006; Ishibashi et al., 2009), were 
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most highly upregulated in lithium compared to Wnt3a, and barely detectable in 
acute nerves. In comparison, IGF1, which is a key regulator of oligodendrocyte 
differentiation and myelination, was most upregulated in Wnt3a. These results 
identify a number of signalling pathways that are expressed in the adult optic nerve 
and are regulated by lithium/Wnt. Further studies are required to identify the 
specific cell types expressing the various ligands, receptors and intracellular targets, 
using immunohistochemistry, in situ hybridization and possibly single cell RT-PCR, 
together with genetic and pharmacological approaches to determine their functions 
in regulating oligodendrocyte differentiation in the adult optic nerve. 
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Section 6
Lithium and Wnt differentially 
regulate astrogliogenesis in the 
adult mouse optic nerve
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6.1  INTRODUCTION AND AIMS 
In Sections 3, I demonstrated a striking effect of lithium on astrogliosis, which is the 
classic astrocyte response to any CNS insult. Reactive astrocytes participate in the 
formation of the glial scar that protects underlying tissue from the site of damage, 
but is an inhibitory chemicophysical barrier to axon growth and is a primary reason 
why CNS axons do not regenerate (Barnett and Linington, 2013; Eddleston and 
Mucke, 1993; Sandvig et al., 2004; Sofroniew, 2009). Lithium has been shown to 
induce astrogliogenesis in vivo and to reduce the response to LPS induced 
inflammation (Beurel and Jope, 2010; Jope et al., 2007; Rocha et al., 1998). The 
mechanisms by which lithium regulates astrogliosis are unclear, but Section 5 
identified multiple aspects of Wnt signalling that persist in acute nerves that are 
regulated by lithium in oligodendrocytes, consistent with the GSK3 inhibitory action 
of lithium (Detera-Wadleigh, 2001; Williams and Harwood, 2000). Wnt signalling is 
implicated in reactive astrocytes in a number of pathologies, including injury, PD, 
ALS, AD and autism (Chen et al., 2012b; Gonzalez-Fernandez et al., 2013; L'Episcopo 
et al., 2011; Miyashita et al., 2009; Toledo and Inestrosa, 2009), and regulates 
astrocyte differentiation from NSC during development (Cai et al., 2006; Coyle-Rink 
et al., 2002; Kalani et al., 2008; Kasai et al., 2005). Therefore, the aim of this section 
was to compare the effects of lithium and Wnt on astrocytes and examine their 
mechanisms of action in the adult optic nerve. 
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6.2  RESULTS 
6.2.1 Lithium and Wnt3a induce astrogliogenesis in the adult optic nerve 
The effects of lithium and activation of the canonical Wnt/-catenin pathway were 
compared directly using the Wnt3a agonist in adult optic nerves maintained in 
organotypic culture ex vivo for 3DIV, as described in Section 3. After 3DIV, 
compared to control cultures (Figure 6.1A), lithium induced a marked astrogliosis 
compared to controls (Fig. 6.1B; p<0.001 ANOVA, and post-hoc Bonferroni tests), as 
reported in Section 3. Wnt3a also resulted in a significant increase in astrocytes 
compared to control (Figure 6C; p<0.001 ANOVA, and post-hoc Bonferroni tests), 
but significantly less than observed in lithium (Figure 6.1D; p<0.01 ANOVA, and 
post-hoc Bonferroni tests). 
169 
Figure 6.1 Effects of lithium and Wnt3a on astrocytes in the adult optic nerve. (A-C) 
Representative confocal images of optic nerves from GFAP-EGFP mice maintained 
in culture for 3DIV in control medium (A), lithium (B) or Wnt3a (C), as indicated; 
scale bar in C = 20 m in all panels. (D) Histogram of mean (+SEM) cell counts per 
constant FOV; tested for significance ANOVA followed by Bonferroni post-hoc test. 
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6.2.2 Lithium and Wnt3a have divergent effects on astrocyte morphology 
Astrocytes in the adult optic nerve have heterogeneous morphologies (Figure 6.2), 
but can be broadly classified into two morphological phenotypes  stellate process 
arborisation (Figure 6.2, large arrow) and transverse orientation (Figure 6.2, small 
arrow), as characterised in detail previously (Butt et al., 1994a; Butt et al., 1994b).  
A key finding is that lithium and Wnt3a had divergent morphogenic effects on 
astrocytes (Figure 6.3). In control culture, astrocytes maintained their characteristic 
stellate and transverse phenotypes (Figure 6.3A, B). In comparison, Wnt3a induced 
the generation of astrocytes with a simple stellate morphology (Figure 6.3C), 
together with transverse astrocytes with three or more long smooth processes 
(Figure 6.3D). Notably, the stellate astrocytes in Wnt3a were distinct from those in 
control nerves and had short, fine bifurcating processes that extended for a short 
distance from a centrally located cell body (Figures 6.3C and 6.4Bi). In contrast, 
lithium induced the generation of astrocytes with a distinct bipolar morphology, 
extending long, fine processes that were smooth and rarely branched, and 
traversed the radius of the optic nerve (Figures 6.3E and 6.4Ai). In addition, 
transverse and stellate astrocytes in lithium and Wnt3a formed distinct clones 
(Figure 6.3D, inset, and 6.3F), consistent with clonal proliferation observed in vivo
(Bardehle et al., 2013). Clones were rarely observed in control and acute nerves, 
where astrocytes had discrete domains (Figures 6.2 and 6.3A, B). Cell counts 
confirmed that compared to control, lithium (p<0.001, ANOVA, Bonferroni) and 
Wnt3a (p<0.01, ANOVA, Bonferroni) significantly increased transverse astrocytes, 
but not the number of stellate astrocytes (Figure 6.3G). 
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Figure 6.2 Astrocyte morphology in the adult optic nerve from GFAP-EGFP mice. 
Astrocytes displayed stellate and transversely oriented process arborisations. Inset 
illustrates the typical branching processes. Scale bars = 20  m.
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Figure 6.3 Effects of Wnt3a and lithium on astrocyte morphology in the adult optic nerve. 
(A-F) Representative confocal images of optic nerves astrocytes maintained in culture for 
3DIV in Control (A, B), Wnt3a (C, D) or Lithium (E, F) from GFAP-EGFP mice, as indicated. 
Astrocytes appeared as clones in Wnt3a (inset in D) and lithium (F), but not controls (B). 
Scale bar = 20 m. (G) Histogram of mean (+SEM) cell counts per constant FOV of 
astrocytes with stellate and transverse morphology, tested for significance by ANOVA 
followed by Bonferroni post-hoc test; **p<0.01, ***p<0.001. 
6.2.3  Analysis of astrocyte genes altered in lithium and Wnt3a  
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Although lithium and Wnt3a both induced astrogliosis, lithium- and Wnt3a-
astrocytes appeared markedly different (Figure 6.4Ai, Bi), indicating that they acted 
via divergent mechanisms. To characterize the transcript profile of lithium- and 
Wnt3a-astrocytes, we compared the transcriptome obtained for control, lithium 
and Wnt3a with the database of genes whose expression is enriched in astrocytes 
(Cahoy et al., 2008). Approximately 90% of astrocyte entities were expressed in the 
treatment groups (4790 in Wnt3a and 4800 in lithium), with 95 and 80 entities 
being found in lithium or Wnt3a, but not controls (Figure 6.4Aii, Bii). Statistical 
analysis was performed on datasets obtained by Volcano Plot (p<0.05, moderated t-
test and Benjamini-Hoechberg FDR), in which genes were filtered for FC>2.0 and 
absolute value E>200, which indicated that more entities were downregulated than 
upregulated in both treatments, and the effect was more marked in lithium (Figure 
6.4 Aiii, Biii). One approach to examine the divergent effects of lithium and Wnt3a 
on astrocytes would be to focus on the genes that are differentially regulated. 
However, such an analysis would miss key genes, since the differences between the 
treatment groups were not absolute, whereby stellate and transverse astrocytes 
were found to a greater or lesser extent in all groups (Figures 6.2 and 6.3); indeed, 
only 16 entities differentially regulated in lithium and Wnt3a had FC>2.0/E>200, 
and all of these were FC<2.04 and appeared undistinguished (not illustrated). The 
most informative approach is to compare all genes within the astrocyte database in 
each treatment group as illustrated in the Volcano plots (Figure 6.4 Aiii, Biii). 
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Figure 6.4 Astrocyte transcripts altered by Wnt3a and lithium. Photomicrographs (left panels) illustrate that lithium (Ai) and Wnt3a 
(Bi) induce the development of divergent astrocyte morphological phenotypes. Venn diagrams (middle panels) illustrate the astrocyte 
genes enriched in lithium (Aii) and Wnt3a (Bii), compared to control culture, using a generally adopted astrocyte database (Cahoy et 
al., 2008). Entities were selectively filtered by Volcano Plot (right panels) to illustrate altered genes with FC>2.0 (p<0.05, moderated t-
test Benjamini-Hoechberg FDR) in lithium (Aiii) and Wnt3a (Biii). 
Ai 
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6.2.4  Astrocyte genes commonly regulated in both lithium and Wnt3a 
Analysis of the top astrocyte entities regulated by Wnt3a or lithium (filtered for 
FC>2.0 and E>200) identified Gas1 (growth arrest-specific 1) as being regulated by 
both lithium and Wnt3a (Table 6.1). Gas1 was strongly expressed in acute nerves 
and was not markedly altered in control culture, but was downregulated in both 
lithium and Wnt3a (E<<200) by >4-fold compared to acute nerves. This is of interest 
because Gas1 is abundant in astrocytes and blocks the effects of growth factors to 
induce cell-cycle arrest (Zarco et al., 2013). The downregulation of Gas1 in both 
lithium and Wnt3a indicates it is a common mechanism by which lithium and 
Wnt3a act via canonical Wnt/-catenin signalling to promote astrogliogenesis. In 
comparison, the remaining top regulated genes in lithium and Wnt3a were specific 
for one or either treatment and, as noted above, lithium generally induced a 
greater FC than Wnt3a. 
Table 6.1  Astrocyte genes most statistically altered both by lithium and Wnt3a (FC>2.0 



































Gas1 1.48 -5.81 -4.00 -3.93 -2.71 -1.45 406 279 70 103 
176 
6.2.5  Specific effects of Wnt3a on astrocyte genes
The top astrocyte genes regulated by Wnt3a are given in Table 6.2, and a few stand 
out as being differentially regulated in Wnt3a and lithium, suggesting they may be 
key factors in the different morphogenic effects of lithium and Wnt3a on 
astrocytes. Significant features were that two of the top 20 genes regulated by 
Wnt3a were involved in regulating planar cell polarity (Ctnnd1 and Cpne1), and a 
further two in phosphoinositide metabolism (Pld2 and Plcd4). Ctnnd1 (catenin 
(cadherin associated protein) delta 1) and Cpne1 (Copine-1) were downregulated in 
Wnt3a, but not lithium. Pld2 (Phospholipase D2) and Plcd4 (Phospholipase C, delta 
4) were upregulated in Wnt3a, but downregulated in lithium. In addition, Mertk (C-
mer proto-oncogene tyrosine kinase) was upregulated in Wnt3a alone, higher than 
lithium and control levels, and is a receptor tyrosine kinase for the ligand growth 
arrest-specific protein 6  (Gas6), which is increased in astrocytes in MS lesions 
(Weinger et al., 2009). Vcam1 (Vascular cell adhesion molecule-1) was upregulated 
in culture and rectified by Wnt3a, and to a lesser extent lithium, and is of interest 
because it acts as an environmental sensor in the SVZ and disruption of VCAM1 in 
vivo causes proliferation and depletion of the normally quiescent astrocyte-like 
NSC, or Type B cells (Kokovay et al., 2012). Most of the remaining genes have been 
discussed elsewhere, e.g. P2rx7, Id2, and Fzd7, or did not stand out as having major 
importance in generating novel astrocytes in Wnt3a, because they were expressed 
at equivalent levels in acute and Wnt3a nerves, e.g. Bcl10, Masp1, Ugdh, Psph, Mcc, 
B4galt7, Tor1aip2, and Hmgb2. 
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Table 6.2  Astrocyte genes most significantly altered in Wnt3a. 
Gene 
Symbol
p (Corr) FC Wnt 
vs. Acute










Ctnnd1 0.031135 -2.35 -2.80 355 431 390 153 
Cpne1 0.01217 -1.56 -2.79 132 240 194 86 
Gas1 5.34E-04 -4.00 -2.71 406 279 70 103 
P2rx7 0.030018 -2.23 -2.68 250 306 278 114 
Serpinh1 0.004924 -1.27 -2.59 268 559 457 215 
Bcl10 0.02998 -1.42 -2.51 227 409 405 162 
Id2 0.021669 -1.02 -2.38 188 448 344 187 
Plcd4 0.006015 1.26 2.37 225 122 94 288 
Pld2 0.005209 1.36 2.36 180 106 89 248 
Masp1 0.019958 1.18 2.30 172 90 126 205 
Ugdh 0.004007 -1.08 -2.29 275 591 317 257 
Psph 7.27E-04 -1.17 -2.27 126 249 461 109 
Mcc 0.034056 -1.60 -2.22 145 204 149 91 
B4galt7 0.014986 1.24 -2.21 114 317 218 143 
Fzd7 0.020264 -1.37 -2.19 345 561 293 255 
Tor1aip2 0.023708 -1.12 -2.13 136 265 244 124 
Vcam1 4.14E-05 3.96 -2.09 55 461 339 220 
Hmgb2 5.48E-04 2.27 -2.07 62 295 150 142 
Mertk 0.016806 1.97 2.05 130 127 138 259 
Plxnb1 0.009361 -1.08 2.05 308 142 163 290 
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6.2.6  Specific effects of lithium on astrocyte genes
As noted above, astrocyte genes regulated by lithium were altered to a far greater 
extent than in Wnt3a (Table 6.3). Notably, the top 3 were also identified in Section 
4 as the genes most altered by lithium overall, namely Car3, Lox and Cdsn (Table 
6.3); Car3 and Cdsn were barely present in acute nerves (E<50) and were 
upregulated over 20-fold in lithium, whereas Lox was strongly expressed in acute 
nerves and almost completely abolished in lithium. Moreover, these effects were 
specific to lithium and were not observed in controls or Wnt3a (Table 6.3). Of the 
remaining genes, most were similarly expressed in lithium and two or more of the 
other groups, such as Hhatl and Alcam, and brief examination in the literature 
suggests they may not be key factors in the generation of novel transverse 
astrocytes in lithium. However, a number stood out. 
Klf4 (Kruppel-like factor 4) is upregulated in lithium and downregulated in Wnt3a, 
so may be important in their divergent effects on astrocytes. Klf4 is upregulated in 
astrocytes following ischemic injury (Park et al., 2014), and its expression, together 
with c-myc or Oct4, results in the reprogramming of somatic cells into pluripotent 
stem cells (Kim et al., 2009a; Kim et al., 2009b; Kim et al., 2008). 
Gpr56 (G-protein coupled receptor 56) is upregulated in lithium and is involved in 
cell adhesion and cell-cell interactions, specifically in the maintenance of the pial 
basement membrane integrity and regulating NP migration (Singer et al., 2012). 
GPR56 is present in abundance in radial glial endfeet and loss of Gpr56 in mice 
results in a defective pial basement membrane (BM) and neuronal ectopia in the 
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cerebral cortex, and in humans to a specific human brain malformation called 
bilateral frontoparietal polymicrogyria (BFPP) (Jin et al., 2009b; Li et al., 2008).  
Per1 (Period1) is a clock gene that is upregulated in lithium and is associated with 
the regulation of neuroinflammation through the NF-kB-JNK-IL-6 pathway in 
astrocytes (Sugimoto et al., 2014). Interestingly, daily rhythms of Per1 and other 
clock genes regulate circadian ATP release in astrocytes (Marpegan et al., 2011), 
and ATP signalling is a prominent feature of optic nerve astrocytes (Hamilton et al., 
2008). 
Fstl1 (Follistatin-like 1) is downregulated in lithium  and is  involved in the inhibition 
of BMP signalling (Xu et al., 2012).  
Pacrg (Parkin Co-Regulated Gene) was upregulated in lithium, but not Wnt3a, 
completely rectifying the downregulation observed in controls to recover acute 
levels, and stands out because it is expressed by ependymal glia (Wilson et al., 
2010). 
Cntf (ciliary neurotrophic factor) is of interest because it is an astrocyte-derived 
factor that has multiple autocrine and paracrine effects. CNTF and its receptors are 
constitutively expressed in astrocytes (Dallner et al., 2002) and promotes 
astrogliosis and hypertrophy (Escartin et al., 2006; Hudgins and Levison, 1998). In 
addition, CNTF promotes oligodendrocyte survival and axon regeneration (Barres et 
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al., 1993; Muller et al., 2009), and stimulates astrocytes to release trophic factors, 
such as CXCL10, that more than doubles the number of OPCs within 48h and 
promote myelination (Albrecht et al., 2007; Barres et al., 1993; Nash et al., 2011). 
Furthermore, CNTF regulates the differentiation of bipotential OPCs to generate 
astrocytes (Raff and Lillien, 1988). Thus, CNTF may be involved in all the major 
effects of lithium in the optic nerve.  
181 
Table 6.3  Astrocyte genes most significantly altered by lithium. 













Car3 1.28E-05 24.55 10.47 40 95 976 62
Lox 0.001294 -3.78 -9.96 204 546 54 406
Cdsn 9.82E-07 30.32 5.84 13 71 407 106
Gas1 5.34E-04 -5.81 -3.93 406 279 70 103
Fstl1 7.47E-05 -2.49 -2.73 624 696 251 443
Pacrg 3.38E-04 -1.09 2.57 231 84 213 146
Il13ra1 0.032208 -1.35 -2.43 203 373 151 229
Alcam 2.98E-05 -4.74 2.42 539 281 114 202
Cntf 0.001198 1.53 2.31 260 175 398 198
Klf4 3.79E-04 1.74 2.27 131 103 229 66
Per1 0.001993 3.92 2.25 66 118 260 144
Hhatl 2.47E-04 -1.06 2.24 348 150 330 242
Gpr56 5.49E-04 1.73 2.22 167 133 289 151
Ctsc 3.96E-05 1.33 -2.22 160 482 213 281
Tpx2 0.001227 1.40 -2.10 69 207 97 158
Gas2l1 0.00495 1.36 2.02 204 140 277 251
Inhbb 6.03E-04 4.72 -2.01 43 415 203 185
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6.2.7 Lithium and Wnt3a regulate  axon growth pathways 
In light of the results above showing lithium and Wnt promote astrogliosis, and the 
astroglial scar being the primary reason why CNS axons do not regenerate, it is 
noteworthy that the axonal guidance pathway was the third most altered pathway 
in lithium. Lithium showed a gross inactivation of the inhibitory parts of the axonal 
guidance pathway (Figure 6.5). In particular, lithium exerted a strong 
downregulation of integrin-mediated adhesion and the genes involved in axon 
repulsion, notably the Eph and Sema3 pathways (Figures 6.5), together with 
multiple effects on the Sema4/5/6/7, Slit/Robo, Netrin, Nogo/Mag, NGF/Lingo, 
NGF/Trk, Rhoa/Rock, Wnt, BMP and Shh signalling pathways (Figure 6.6). On the 
other hand, eIF4E (eukaryotic translation initiation factor 4E) was the most 
upregulated gene in the Sema3 pathway (Figure 6.5) and netrin pathway (Figure 
6.6), and complexes with the homeoprotein Emx2, which together promote axon 
growth (Li et al., 2004; Nedelec et al., 2004; Zheng et al., 2001). The Rho family 
GTPase 1 (Rnd1) is also strongly upregulated by lithium (FC>28) and is a key factor 
in Sema3 (Figure 6.5) and Sema4 (Figure 6.6), and promotes axon outgrowth by 
antagonising growth cone collapse induced by Sema3 (Li et al., 2009; Zanata et al., 
2002). The downregulation of Sema 3 and upregulation of Rnd1 in lithium (Figure 
6.5) suggests this a key mechanism by which lithium may regulate astrocyte-
mediated control of axon growth in the optic nerve. Moreover, lithium increased 
the expression of NGF (Figure 6.6), which is known to enhance axonal regeneration 
by inhibiting GSK3 (Lindsay, 1988; Zhou et al., 2004). Remarkably, Wnt3a had the 
exact same effect as lithium on the Eph and Sema3 pathways, but with less potency 
(not illustrated), and with only subtle differences on the other axon 
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growth/guidance pathways (Figure 6.7). The results indicate lithium is a potent 
regulator of axon growth/guidance pathways in the adult CNS via GSK3-dependent 
canonical Wnt/-catenin signalling.  Moreover, the results indicate that astrocytes 
generated in lithium and Wnt3a are not equivalent to reactive astrocytes formed in 
response to CNS injury, which is consistent with the microarray data described in 
Section 4.  
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Figure 6.5  Effects of lithium on the Eph and Sema3 axonal growth and guidance pathways. A complement system pathway generated 
by IPA. Proteins with increased expression are marked in red proteins with decreased expression are marked in green. The IPA legend 
is shown in The IPA legend is shown in Figure 4.5
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Figure 6.6  Effects of lithium on axon growth and guidance pathways. A complement system pathway generated by IPA. Proteins with 
increased expression are marked in red proteins with decreased expression are marked in green. The IPA legend is shown in The IPA 
legend is shown in Figure 4.5
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Figure 6.7  Effects of Wnt3a on axon growth and guidance pathways. A complement system pathway generated by IPA. Proteins with 
increased expression are marked in red proteins with decreased expression are marked in green. The IPA legend is shown in The IPA 
legend is shown in Figure 4.5
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6.2.8 Lox mediates novel morphogenic effects on astrocytes 
I have identified Lox (lysyl oxidase) and Cdsn (corneodesmosin) as two novel genes 
that are amongst the most regulated by lithium, overall (Section 4), and the top 
genes specifically in astrocytes (Table 6.3). Notably, Lox regulates cell-cell adhesion 
via the non-canonical function of -catenin (Giampuzzi et al., 2003; Sanchez-
Morgan et al., 2011), and corneodesmosin is specific to desmosomes, which form 
strong cell-cell adhesion bonds (Leclerc et al., 2009; Oji et al., 2010). Lox and Cdsn 
are have never previously been reported as expressed in the normal CNS, and this 
was confirmed by qRT-PCR, comparing mean Ct values of each gene to the most 
stable house-keeping gene Hsp90ab1 (Figure 6.8; n=12 optic nerves for each 
experimental group run in triplicate). Cdsn was not expressed in the brain or 
acutely dissected optic nerves (Figure 6.8A). In contrast, Lox was strongly expressed 
in acutely isolated nerve, but not in the forebrain or cerebellum (Figure 6.8B). 
Significantly (p<0.05, t-tests), lithium dramatically increased the expression of Cdsn 
(Figure 6.8A) and decreased the expression of Lox (Figure 6.8B). 
The qRT-PCR confirms that Lox and Cdsn are major targets of lithium in the optic 
nerve, providing supporting evidence that they may be involved in the morphogenic 
effects of lithium on astrocytes, through their functions in cell-cell interactions. To 
assess the potential involvement of corneodesmosin, immunostaining was 
performed on optic nerves cultured for 3DIV in lithium and control medium (Figure 
6.9). Corneodesmosin was not expressed in acute nerves (Figure 6.9A), but was 
expressed to a low extent in control cultures (Figure 6.9B) and was markedly 
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upregulated in lithium (Figure 6.9C). Corneodesmosin immunolabelling was 
localised to astrocyte somata and transverse processes (some indicated by arrows 
in Figure 6.9B, C). The results confirm the qRT-PCR results that corneodesmosin is 
upregulated in lithium and demonstrate expression is localised to astrocytes. 
The effects of Lox on astrocytes were tested directly, using the Lox inhibitor -
aminopropionitrile (BAPN, 4mM, Sigma) and Lox activator Suramin (6mM, Sigma); 
BAPN irreversibly inhibits Lox (Lucero et al., 2011; Lucero et al., 2008; Tang et al., 
1983), whilst Suramin profoundly upregulates Lox (Buchinger et al., 2008). 
Sufficient adult GFAP-EGFP mice were not available at the time for these 
experiments, so they were performed on optic nerves from P10 GFAP-EGFP mice 
maintained in culture for 3DIV, which respond in the same way to lithium and 
allowed me to use age-matched mice from the same litter to compare the effects of 
lithium, BAPN and suramin (Figure 6.10). The Lox activator suramin did not result in 
astrogliosis and was not significantly different from controls (Figure 6.10A, B, G). In 
contrast, inhibition of Lox with BAPN, to mimic the effects of lithium on Lox 
downregulation, dramatically increased the number of astrocytes (Figure 6.10C, G; 
p<0.001, ANOVA, Bonferroni), not significantly different than in lithium and with a 
similar morphogenic effect (Figure 6.10D, G). However, astrocytes in BAPN were 
less uniform than in lithium, which induced the generation of highly polarised 
transverse astrocytes, as observed in the adult (Figure 6.10C, D, G; p<0.001, 
ANOVA, Bonferroni), and similar to those described above in Wnt3a (Figures 6.1 
and 6.3). The results demonstrate Lox is functional in the optic nerve, confirming 
the qRT-PCR results. Moreover, the lack of further effects of suramin and the 
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explosion of astrogliosis in BAPN indicates endogenous levels of Lox are sufficient 
and necessary for maintaining astrocyte numbers and morphology. 
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Figure 6.8  qRT-PCR analysis of cornedesmosin (Cdsn) and lysyl oxidase (Lox) transcripts in 




Figure 6.9 Corneodesmosin expression in optic nerve astrocytes. Optic nerves from 
adult GFAP-EGFP mice acutely dissected (A), or cultured for 3DIV in control 
medium (B) or lithium (C). Representative confocal photomicraphs immunolabelled 
for corneodesmosin and arrows indicate co-expession with GFAP-EGFP. Scale bar = 
20m. 
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Fig. 6.10 Effects of Lox on optic nerve astrocytes. Optic nerves from P10 GFAP-EGFP 
mice were maintained ex vivo for 3DIV in control medium (A), the Lox activator 
suramin (B), Lox inhibitor BAPN (C) or lithium (D). (A-D) Representative confocal 
images of whole mounted optic nerves; scale bar = 100 m. (E) Histogram of mean 
(+SEM) cell counts per constant FOV; ***p<0.001, ANOVA followed by Bonferroni 
post-hoc test. 
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6.3  DISCUSSION 
In this section, I report for the first time that lithium and Wnt3a promote the 
generation of novel astrocytes in the adult CNS. Furthermore, lithium and Wnt3a 
had differential effects on astrocytes, whereby Wnt3a induced formation of simple 
stellate astrocytes and lithium induced highly polarised transverse astrocytes, 
although these differences were not absolute and appeared to represent extremes 
of a morphological continuum. These effects are consistent with microarray 
analyses which demonstrated a major effect on activation of the Planar Cell 
Polarity, Cdc42, and genes involved in the remodelling of cytoskeleton and 
extracellular matrix, such as PLCd4 and PLD. In addition, axon growth and guidance 
was one of the top pathways regulated by lithium and Wnt, with a general 
downregulation of axonal repulsive cues, such as the ephrins and semaphorins, and 
upregulation of genes implicated in chemoattraction, notably Rnd1 and eIF4E. 
Microarray analysis identified Cdsn and Lox, which have cell-cell adhesion functions, 
as two of the most important genes in lithium. qRT-PCR demonstrated Cdsn is 
absent in the brain and optic nerve, but is massively upregulated by lithium and 
immunostaining provided evidence Cdsn is localised to astrocyte somata and 
processes. Lox is also absent in the brain, but is enriched in the optic nerve and 
abolished by lithium. Direct inhibition of Lox in optic nerves to mimic the effects of 
lithium increased astrogliogenesis and induced polarised astrocytes similar to 
observed in lithium and Wnt. The results provide evidence that lithium induces the 
generation of novel astrocytes through a mechanism that involves Wnt signalling, at 
least in part mediated by the downregulation of Lox and upregulation of 
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corneodesmosin. Moreover, lithium and Wnt do not mediate a classic reactive 
astrogliosis that is characteristic of CNS injury, since the astrocytes do not have a 
reactive phenotype and are not axon growth inhibitory. 
6.3.1  Lithium and Wnt promote astrogliosis  
Lithium and Wnt3a both increased astrocytes, suggesting they have a shared 
mechanism in promoting astrogliosis, consistent with their effects on 
downregulating Wnt signalling and on oligodendrogenesis discussed in Section 5.  
Results of the present section provide the first direct evidence that Wnt regulates 
astrogliogenesis in the adult CNS, as described for astrocyte differentiation from 
NSC during development (Cai et al., 2006; Coyle-Rink et al., 2002; Kalani et al., 
2008; Kasai et al., 2005). It is thought that astrocytes actively migrate and 
proliferate clonally in response to CNS insults (Bardehle et al., 2013; Sofroniew, 
2009), and numerous cytokines and growth factors have been shown to promote 
proliferation of astrocytes in vitro (Selmaj et al., 1990). Furthermore, GSK3 in 
astrocytes has been shown to be inhibited in an in vitro scratch-assay of injury, 
resulting in stabilisation of -catenin at the leading edge of astrocyte migration 
(Etienne-Manneville and Hall, 2003). Notably, stabilisation of -catenin resulted in a 
change of astrocyte polarity through the phosphorylation of GSK3 mediated by 
Cdc42 and the mitotic role of PLK (Etienne-Manneville and Hall, 2003). Cdc42 is 
highly expressed in the optic nerve (E>1000 in all experimental groups), and when 
genetically knocked out in vivo reduces cell proliferation and polarisation in 
response to injury (Bardehle et al., 2013; Etienne-Manneville and Hall, 2003), which 
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has resonance with the effects of lithium on optic nerve astrocytes and the PLK 
pathway. Furthermore, in nerves treated with Wnt3a, we identified the novel 
expression of Copine 1 (Cpne1), which is involved in intracellular calcium and 
known to interact with Cdc42 (Creutz et al., 1998; Tomsig et al., 2003). 
Consistent with the astrogliogenic effects of lithium and Wnt3a, the microarray 
analyses demonstrated an overall upregulation of genes involved in cell growth and 
proliferation (1955 genes), together with cell movement, remodelling of 
cytoskeleton and polarisation, as summarised in Table 6.4. As noted in Section 4, 
cell cycle control in lithium involves the PLK and RAN pathways (Table 4.6C) and 
multiple growth factors (Table 4.6D), and future studies should examine their roles 
in regulating gliogenesis in the adult nerve (Hudgins and Levison, 1998; Lopez-Casas 
et al., 2002; Lopez-Casas et al., 2003; McKimmie and Graham, 2010; Raivich et al., 
1999; Wang and Gao, 2005). Interestingly, the current section identified Gas1 as 
abundant in acute nerves, consistent with it being highly expressed in quiescent 
cells, where it blocks the effects of growth factors and induces cell-cycle arrest 
(Zarco et al., 2013). Gas1 enhances AP-1 and inhibits NFB and c-myc (Lee et al., 
2001), and its downregulation in lithium and Wnt3a suggests it is a common 
mechanism by which canonical Wnt/-catenin signalling promotes astrogliogenesis.  
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Table 6.4 Summary of Disease and Function annotations regulated in lithium 
6.3.2  Does Wnt/b-catenin signalling regulate OPC fate in the adult optic nerve?  
The results indicate clonal expansion of astrocytes, as described in vivo (Bardehle et 
al., 2013), and this was particularly prominent in lithium. However, 
immunolabelling in Section 3 suggested OPC may also be a source of newly 
generated astrocytes in response to GSK3 inhibition. Moreover, the stellate GFAP-
EGFP astrocytes generated in Wnt3a were characterised by very short, fine primary 
processes with complex branching, which is unlike astrocytes described in the 
normal or injured nerve (Butt and Colquhoun, 1996; Butt et al., 1994b), and is 
highly reminiscent of NG2+ OPC (Butt et al., 1999). We have previously reported 
NG2+ OPC express the GFAP-EGFP reporter ex vivo in cerebellar slice cultures (Leoni 
et al., 2009), and the current section indicates that  canonical Wnt/-catenin 
signalling regulates their fate decision in the non-neurogenic niche of the optic 
nerve, as it does in the SVZ during development (Cai et al., 2006; Coyle-Rink et al., 
2002; Kalani et al., 2008; Kasai et al., 2005). It is significant, therefore, that lithium 
increased expression of CNTF, which Raff and colleagues showed regulates the 
differentiation of bipotential OPCs from the optic nerve to generate astrocytes (Raff 
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and Lillien, 1988). Moreover, lithium also upregulated Klf4 (Kruppel-like factor 3), 
which together with c-myc results in the reprogramming of cells into pluripotent 
stem cells (Kim et al., 2009a; Kim et al., 2009b; Kim et al., 2008). A recent study has 
shown that Klf4 is up-regulated in astrocytes following ischemic injury (Park et al., 
2014). A combination of live cell imaging, fate mapping and genetic techniques are 
required to test the possibility that canonical Wnt/-catenin signalling regulates 
fate decision of OPCs and their differentiation into astrocytes in the adult optic 
nerve. 
6.3.3  Astrocytes genes regulated y Wnt signalling 
Microarray analysis identified a number of genes and pathways altered specifically 
by Wnt3a, which may underlie its effects on astrocytes. Wnt3a upregulated PLCd4 
and the astrocyte specific PLD2, which are associated with growth factor signalling 
and cytoskeleton remodelling (Fukami et al., 2008; Fukami et al., 2000; Zhang et al., 
2004). Phosphoinositide metabolism is a reported target of lithium and these 
effects of Wnt3a suggest lithium mediates its actions via Wnt/-catenin signalling. 
Phosphoinositides are involved in a plethora of cell functions including growth 
factor signalling, membrane trafficking, cytoskeleton remodelling and transduction 
of neurotransmitters (Fukami et al., 2008; Fukami et al., 2000). Genetic deletion of 
Plcd1 or 3 results in epidermal hyperplasia and inflammation, while deletion of 
Plcd4 results in reduced fertility caused by abnormal acrosome reaction by 
impaired intracellular Ca2+ (Fukami et al., 2008). PLD has been associated with 
many signal transduction pathway, and Pld1 is expressed by neurons, while Pld2 is 
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expressed by astrocytes (Zhang et al., 2004). Moreover, Pld expression is increased 
in differentiating cells in response to retinoic acid administration (Rujano et al., 
2004). 
Another target of Wnt3a was Mertk, which was upregulated, and Mertk expression 
has been shown to be elevated in astrocytes and oligodendrocytes in MS lesions 
(Weinger et al., 2009). Moreover, Mertk/Axl have been shown to mediate 
phagocytosis in the retina (Finnemann and Nandrot, 2006; Nandrot et al., 2007). 
Mertk, together with Axl and Tyro3, is a receptor tyrosine kinase that mediates the 
actions of Gas6 and Mertk/Axl can reduce Gas6 level by sequestration (Weinger et 
al., 2009). On face value, the results might suggest that activation of Wnt/-catenin  
upregulates Mertk, but overall Wnt signalling was downregulated in Wnt3a by a 
negative feedback mechanism (Section 5), indicating that Wnt signalling may 
negatively regulate Mertk/Gas6 signalling in the optic nerve, which has relevance to 
remyelination in MS. 
Plexin B1 (Plxnb1) was upregulated by Wnt3a and is a receptor for semaphorins, 
which not only induce growth cone collapse in axons, but are also are involved in 
cell migration and cytoskeletal dynamics (Barberis et al., 2004). Moreover, 
Semaphorin 4D activates the MAPK pathway through Plexin B1 (Aurandt et al., 
2006). Interestingly, Wnt3a also downregulated the expression of catenin (cadherin 
associated protein) delta 1 (Ctnnd1), which together with -catenin has been 
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shown to be important in the regulation of planar cell polarity, morphogenesis and 
cell-cell adhesion (Chacon-Heszele et al., 2012; Kurley et al., 2012; Ouyang et al., 
2013). Copines (Cpne1) are a class of protein that are involved in intracellular 
calcium that has never been shown expressed in the optic nerve (Creutz et al., 
1998). Interestingly, Cpne1 interacts with MEK1 and Cdc42 and therefore is 
assumed to have a role in planar cell polarity (Tomsig et al., 2003). Serpinh1 was 
also downregulated in response to Wnt3a and is essential for folding of type 1 
collagen (Ishida et al., 2006). Moreover, Serpinh1 depletion inhibits the expression 
of type 1 collagen and scar formation (Wang and Li, 2008), supporting the evidence 
that the astrocytes induced in Wnt3a does not represent a classic reactive 
astrogliosis and scar formation. 
6.3.4  Novel astrocyte genes regulated y Lithium 
Lithium increased the expression of genes that have never been reported to have 
functional roles in astrocytes. Lithium dramatically increased the expression of 
CAIII, which is involved in the regulation of cellular homeostasis and pH regulation 
(Riihonen et al., 2007; Supuran, 2011; Winum et al., 2003). CAIV and not CAIII is 
normally expressed in astrocytes (Svichar et al., 2006), and CAIII is implicated in 
seizure susceptibility, AD, PD and BD (Lafon-Cazal et al., 2003; Staunton et al., 2012; 
Winum et al., 2003). Interestingly, a number of astrocyte genes regulated by lithium 
are implicated in ependymal cell and stem cell function. Gpr56 is present in 
abundance in radial glia (Jin et al., 2009b; Li et al., 2008), Pacrg is expressed in 
ependymal cells lining the ventricles (Brody et al., 2008; McClintock et al., 2008; 
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Wilson et al., 2009), and Klf4 is known to reprogramme somatic cells into 
pluripotent stem cells (Kim et al., 2009a; Kim et al., 2009b; Kim et al., 2008). Hence, 
the genotype of astrocytes in lithium has similarities with ependymal astrocyte-like 
neural stem cells. 
6.3.5  Wnt and lithium regulate genes that promote axon growth 
Lithium and Wnt3a showed a remarkable down-regulation of the chemo-repulsive 
molecules and inducers of growth cone collapse, such as the Wnt5a, Wnt7a, 
Ephrins and the semaphorins. On the other hand, lithium, and to a less extent 
Wnt3a, greatly increased the expression of eIF4E, Rnd1 and NGF. eIF4E has been 
shown to be expressed in the regenerating axons of the olfactory bulb in vivo and 
the regenerating sensory axons in vitro (Li et al., 2004; Nedelec et al., 2004; Zheng 
et al., 2001). Rnd1 antagonises the growth cone collapse caused by Sema3 and 
promotes axon outgrowth (Li et al., 2009; Zanata et al., 2002). Moreover, its over-
expression in neurons causes the formation of multiple axons (Li et al., 2009). NGF 
is known to enhance axonal regeneration by inhibiting GSK3 (Lindsay, 1988; Zhou et 
al., 2004). The effects of lithium and Wnt3a indicate that inhibition of GSK3 and 
activation of Wnt/-catenin promotes a general regenerative capacity, by inhibiting 
reactive astrogliosis and inducing astrocytes that are morphologically and 
biochemically permissible for axon regeneration. 
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6.3.6  Lox is central to the effects of lithium 
Lithium exerted profound changes in Lysis oxidase (Lox) and corneodesmosin (Cdsn) 
compared to all the other conditions. We confirmed the absence of Lox and Cdsn in 
the forebrain and cerebellum by q-PCR, and demonstrated their expression and 
regulation by lithium in the optic nerve. In addition, I demonstrated that 
pharmacological inhbition of Lox mimicked the effects of lithium and Wtnt3a, 
causing a profound astrogliosis and morphogenic effect. The results support a 
central role for Lox in mediating the effects of lithium and Wnt on astrocytes, and 
the likely mechaism is through the disruption of -catenin localisation at the plasma 
membrane level, which may involve corneodesmosin.  
Lox is involved in many pathologies and cellular activities, such as control of 
differentiation and oncogenic transformation (Dimaculangan et al., 1994; Hajnal et 
al., 1993), and is important for the oxidation of cell surface proteins and the 
chemotactic response in vitro (Lucero et al., 2011; Lucero et al., 2008). Notably, Lox 
regulates cell-cell adhesion by its interaction with -catenin, leading to an up-
regulation of the down-stream activator Cyclin D1 (Giampuzzi et al., 2003; Sanchez-
Morgan et al., 2011). Lox sequesters -catenin from the cytoplasm to the plasma 
membrane, antagonising Wnt translocation of nuclear -catenin (Giampuzzi et al., 
2003; Sanchez-Morgan et al., 2011). Moreover, Lox has great affinity with 
fibronectin and collagen and causes polarisation of epithelial cells (Fogelgren et al., 
2005; Jansen and Csiszar, 2007 Kagan and Li, 2003). Corneodesmosin is specifically 
upregulated in astrocyte by lithium and, like Lox, is involved in cell-cell adhesion 
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(Leclerc et al., 2009; Oji et al., 2010). The expression of Cdsn has never previously 
been reported in glia or the CNS, but lithium induces its expression in astrocyte 
transverse processes and somata. The function of corneodesmosin in astrocytes is 
unknown, but we can assume that it is involved in the formation of adherens 
junctions and that this is important for the morphogenic effects of lithium on 
astrocytes, which is mediated in part by Lox. Corneodesmosin is considered to be 
specific to desmosomes in the epithelium (Leclerc et al., 2009; Oji et al., 2010), 
where it is essential for the correct formation of cell-cell adhesion bonds, and its 
dysregulation has been linked with psoriasis and perinatal death due to epidermal 
tearing (Leclerc et al., 2009; Oji et al., 2010). Notably, Cdsn has been identified as a 
risk gene in MS (Calleja et al., 2006; Hafler et al., 2007; Leclerc et al., 2009; Oji et al., 
2010), and the results of this section indicate this may involve Wnt-mediated 
effects on astrocytes. 
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6.4  SUMMARY AND CONCLUSIONS 
In this section, I demonstrated for the first time that Wnt and its mimetic lithium 
promote astrogenesis in the optic nerve, without causing reactive astrogliosis. 
Lithium and Wnt3a may regulate the same pathways to promote astrocyte 
proliferation, but act via very different mechanisms to differentially affect astrocyte 
morphogenesis. The results indicate the highly polarising effect of lithium on 
astrocytes is through a noncanonical Wnt/-catenin pathway, with a central role for 
Lox sequestrating cytosolic -catenin to the plasma membrane and promoting cell-
cell adhesion via adherens junctions involving a unique role for corneodesmosin in 
the CNS. These effects of lithium on astrocytes, and to a lesser extent Wnt, provide 
a permissive environment for myelination and axon regeneration. The results 
demonstrate for the first time that Wnt signalling regulates astrocytes in the adult 
CNS and suggest lithium is a potential therapy for regulating astrocyte scar 





7.1 Summary of Key Findings 
In this study, I have examined the effect of lithium and Wnt signalling on glial cells 
of the adult mouse optic nerve. To achieve this, an optic nerve ex vivo model was 
developed that preserved structural and cellular integrity for up to 7DIV. Microarray 
analysis confirmed that the major oligodendrocyte and astrocyte genes were 
unaltered ex vivo, although there was some evidence of upregulation of genes 
associated with activation of astrocytes and microglia, consistent with tissue repair 
mechanisms.  
A key finding was that addition of lithium to the culture medium promoted both 
oligodendrogliogenesis and astrogliogenesis in the adult nerve. Comparison with a 
specific GSK3 inhibitor and Wnt3a agonist indicated the gliogenic actions of lithium 
were via its GSK inhibitory action and activation of the canonical Wnt/-catenin 
pathway. Genomic analysis demonstrated that lithium had a general anti-
inflammatory effect on genes upregulated by culture, with prominent novel targets 
including Arginase-1, Saa1 and the PPAR pathway. In addition, lithium treatment is 
shown to be a potent regulator of genes involved in the cell cycle initiation, growth 
and cellular remodelling. A major effect of lithium was on Wnt signalling and the 
results demonstrated for the first time endogenous Wnt signalling in adult white 
matter and that it regulates gliogenesis. In OPCs, lithium acts primarily as a Wnt 
mimetic to downregulate Wnt and BMP signalling, which are potent negative 
regulators of oligodendrocyte differentiation, acting at least in part via ID4. 
However, lithium also acted on mature PLP+ oligodendrocytes via a non-Wnt 
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mechanism, and microarray analysis identified Cxcl1 and LIF, which are released by 
astrocytes to stimulate myelination, as the most highly upregulated in lithium.  
Perhaps the most striking finding was that lithium and Wnt induced the generation 
of novel kinds of astrocyte not previously observed in the adult optic nerve. 
Moreover, the newly generated astrocytes were morphologically and genotypically 
distinct in lithium and Wnt, whereby Wnt3a induced formation of simple stellate 
astrocytes and lithium induced highly polarised transverse astrocytes. Astrocytes 
were generated by clonal cell division, but there was immunohistochemical and 
microarray evidence that astrocytes may also be derived from OPC. Significantly, 
astrocytes in lithium and Wnt were not reactive and expressed genes associated 
with supporting axon growth and guidance, with a general downregulation of 
axonal repulsive cues, such as the ephrins and semaphorins, and upregulation of 
genes implicated in chemoattraction, notably Rnd1 and eIF4E. Furthermore, a 
number of genes were identified that have not been reported in the optic nerve or 
astrocytes, and in some cases have no known function in the CNS. Most notable 
were Lox and corneodesmosin which are shown to be the most regulated astrocyte 
transcripts in lithium. Lox is barely expressed in the brain, but is enriched in the 
optic nerve and almost completely ablated by lithium. Direct pharmacological 
inhibition of Lox provided evidence it is the mechanism by which lithium induces 
astrocyte polarisation, involving cell-cell adhesion via adherens junctions involving a 
unique role for corneodesmosin that is massively upregulated by lithium. Overall, 
the results of this project identify novel effects of lithium and Wnt on 
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oligodendrocytes and astrocytes in the adult CNS, which are relevant to 
neurodegenerative and demyelinating diseases. 
7.2 The optic nerve organotypic culture model 
In this study, I devised a new model for the study of gliogenesis in adult white 
matter. Previously, most studies focussed on organotypic culture of developing 
tissue as the adult loses its integrity (Gahwiler et al., 1997; Stoppini et al., 1991). 
Azim and Butt (2011) showed that GSK3 inhibition promoted oligodendrogenesis in 
the developing optic nerve. However, oligodendrogenesis is ongoing in the 
developing optic nerve, whereas little or no proliferation occurs in the adult optic 
nerve (Butt and Ransom, 1993; Kang et al., 2010). Furthermore, astrocytes in the 
developing CNS are immature and are highly responsive (Jarlestedt et al., 2010). To 
successfully maintain tissue integrity, it was necessary to take great care in 
preserving cells within the tissue and alleviate degenerative changes in axons and 
myelin, which would otherwise induce a reactive astrogliosis response. This was 
achieved by keeping the retina intact and therefore maintaining the axons of retinal 
ganglion cells that pass through the optic nerve. Immunohistochemical analysis 
confirmed the persistence of axons and myelin, and this was confirmed by 
microarray, where interestingly Nefl was robustly expressed. However, there was 
some tissue disruption, denoted by a slight decrease in oligodendrocytes and 
disruption of their arrangement in rows. In addition, there was an increase in 
astrocytes in cultured nerves, but no evidence of cellular hypertrophy, consistent 
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with a limited isomorphic astrogliosis, which is considered to be tissue protective  
(Sofroniew, 2009). 
Microarray confirmed there were no major changes in macroglial genes in culture, 
although there was a microglial response toward the M2 state and an upregulation 
of genes involved in inflammation, brain injury and the astrocyte injury response, 
including MMP3, CSF3, LCN2 and Serpina3, together with chemokines released by 
reactive astrocytes, such as CXCL1, CXCL3 and CXCL6 (Hua et al., 2011; Neria et al., 
2013). This is further indication of injury and perhaps longer studies may reveal 
further degenerative changes in axons and myelin, full activation of microglia and 
the formation of a glial scar. We also identified a number of genes never previously 
reported in the optic nerve. Amongst these were genes involved in keratin 
metabolism such as OMD, Keratin 6A and mimecan, which have no known function 
in mammalian glia, but reactive astrocytes produce keratins (Sofroniew, 2009), and 
by extension it seems likely these novel genes are involved in the glial responses to 
tissue damage and are worthy of further study. In this respect, it is interesting that 
astrocytes in culture also upregulate corneodesmosin, which interacts with keratins 
to regulate desmosomes (Kitajima, 2013), and both desmosomes and cytokeratins 
are features of primitive astroglia, such as mammalian ependymal cells (Kasper, 
1992; Kawano et al., 2001) and fish optic nerve astrocytes (Scholes, 1991). Culture 
conditions also altered a number of pathways, such as the peroxisome proliferator-
activated receptor pathway (PPAR), IL-17F and the HIF1 pathways, which are all 
associated with microglial activation and brain injury and downregulated by lithium. 
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The anti-inflammatory role of lithium is not new (Goldstein et al., 2009; Nahman et 
al., 2012; Quiroz et al., 2010). Interestingly, we observed a general rectification of 
expression of most genes altered by culture condition. Notable amongst these were 
Saa1, one of the most downregulated genes in lithium. Saa1 was barely detectable 
in acute nerves, but its expression was massively induced by culture. Saa1 is one of 
the top genes associated with amyloidosis and chronic inflammatory diseases, 
including atherosclerosis, rheumatoid arthritis, Crohn's and AD (Tucker and Sack, 
2001). Lithium completely ablated the expression of Saa1 identifying this as a major 
target of lithium that has relevance to the diseases mentioned above, in which Saa1 
levels are increased. Interestingly, Lox is also ablated by lithium and, like Saa1, is 
involved in atherosclerosis and vascular fibril deposition, and colocalises with A
accumulation in brain vessel walls in AD (Wilhelmus et al., 2013). 
7.3 Lithium and Wnt signalling in the adult optic nerve 
Wnt signalling has been shown to have a prominent role in NSC proliferation and in 
oligodendrogenesis in the developing brain (Adachi et al., 2007; Azim and Butt, 
2011; Das et al., 2006; Feigenson et al., 2009; Kim et al., 2009c; Lie et al., 2005; 
Shimizu et al., 2008; Umehara et al., 2007). In this study we demonstrated qRT-PCR 
evidence that Wnt/-catenin signalling persists in the adult optic nerve and showed 
that activation with lithium and Wnt induce the proliferation of OPCs and their 
differentiation into oligodendrocytes, as observed during development (Azim and 
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Butt, 2011; Azim et al., 2014a; Azim et al., 2014b). Furthermore, a number of Wnt 
related genes were identified that have no known function in the CNS, such as 
Wnt6 and Wnt16. We also demonstrated the expression of Sox17, which is crucial 
for Wnt-mediated regulation of oligodendrogenesis (Chew et al., 2011; Moll et al., 
2013; Sohn et al., 2006). Studies on the developing CNS have shown that Wnt/-
catenin promoted proliferation of OPCs, but inhibited their differentiation into 
mature oligodendrocytes (Azim and Butt, 2011; Fancy et al., 2009; Feigenson et al., 
2009). More specifically, Azim and Butt showed that Wnt3a promotes OPC 
expansion and inhibits oligodendrocyte maturation in the developing optic nerve, 
whereas lithium induces both (Azim and Butt, 2011). In contrast, Wnt3a did not 
decrease in oligodendrocytes in the adult optic nerve, indicating a major difference 
in Wnt (Ueno et al., 2007). The effect of lithium on OPCs and oligodendrocytes can 
be attributed to its downregulation Wnt, BMP and ID4, which negatively regulate 
oligodendrocyte differentiation by decreasing HDAC1/2, which are required for 
oligodendrocyte differentiation (Chen et al., 2012a; Samanta and Kessler, 2004; Ye 
et al., 2009). Furthermore, lithium almost completely ablated PDGFR which 
maintain OPCs in a proliferative state and inhibit their differentiation (Bansal, 
2002).  Cell cycle progression in OPCs is tightly regulated by the Cdks and their 
inhibitors, which were regulated in lithium, but the PLK pathway was the most 
regulated, indicating future studies should examine its role in gliogenesis. Cell cycle 
exit is essential for OPC differentiation and is regulated by YY1 and Sox17 that 
interact to inhibit cell cycle re-entry (Chew et al., 2011; Rylski et al., 2008a; Rylski et 
al., 2008b; Sohn et al., 2006). YY1 interacts specifically with the inhibitor of myelin 
expression TCF4/LEF1 and ID4 by recruiting HDAC1/2 to their promoter during OPC 
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differentiation (Chen et al., 2012a; Du and Yip, 2011; Marin-Husstege et al., 2002; 
Swiss et al., 2011). Interestingly, lithium upregulated astrocyte-derived factors that 
affect oligodendrocytes, including CXCL1, which is released by astrocytes and its 
overexpression promotes remyelination in EAE (Omari et al., 2009), and CNTF, 
which stimulates astrocytes to release trophic factors, such as CXCL10, which more 
than doubles the number of OPCs within 48h and promote myelination (Albrecht et 
al., 2007; Barres et al., 1993; Nash et al., 2011), similar to the effects of lithium in 
the optic nerve. This illustrates the difficulty in working in the intact tissue, since 
although it is a true scenario, it is difficult to dissect direct and indirect effects. 
Nonetheless, the effects of CXL1, CNTF, BMP and other factors can be studied in 
this model, and it should be possible to dissect their precise mechanisms of action 
pharmacologically and using genetic techniques. Furthermore, longitudinal studies 
would throw some light on the precise mechanisms by which lithium and Wnt 
promote the generation of adult OPCs, which is important because decreased 
capacity for oligodendrogenesis is a feature of MS and AD.  
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7.4  Lithium and Wnt promote astrogliogenesis in the adult optic nerve 
The effects of Lithium and Wnt3a on gliogenesis were not restricted to 
oligodendrocytes and this PhD provides the first evidence that lithium and Wnt3a 
induce astrogliogenesis in the adult optic nerve. Notably, lithium and Wnt also 
induced the generation of novel astrocyte phenotypes, indicating divergent 
mechanisms of action. In lithium, astrocytes were characterised by an accentuated 
polarity which is consistent with the observed activation of noncanonical PCP 
signalling (Ciani and Salinas, 2005; Etienne-Manneville and Hall, 2003; Jang et al., 
2013; Jansen and Csiszar, 2007; Jin et al., 2009a; Liu et al., 2013; Zhou et al., 2004). 
Microarray analysis demonstrated a large number of genes associated with 
cytoskeleton remodelling were altered by lithium. Prominent amongst these was 
Lox, which is strongly expressed in acute nerves and essentially ablated by lithium. 
Lox is involved in the stabilisation of -catenin for the correct formation of cell 
adhesion. Moreover, we confirmed pharmacologically that direct inhibition of Lox 
promoted astrocyte polarisation. 
The source of newly generated astrocytes in the adult CNS is a matter of hot 
debate. The adult optic nerve contains little or no proliferation and the only 
proliferating cells are a small number of OPCs (Butt et al., 1999; Butt and Ransom, 
1993; Kang et al., 2010; Psachoulia et al., 2009; Young et al., 2013). However, 
lithium promoted a massive expansion of glial cells in the optic nerve. The doubling 
of Sox10+ cells can be attributed to their differentiation from OPCs, but there was 
an equivalent increase in GFAP+ cells between DIV2 and DIV3. Recent studies 
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showed that only a small population of astrocytes can proliferate in response to 
injury and the=is occurs over days (Bardehle et al., 2013). An in vivo study has 
shown that GSK3 inhibition can induce the proliferation of NG2+ cells and 
astrocytes in response to injury (White et al., 2009). Furthermore, NG2+ cells can 
differentiate in astrocyte in vitro, which could explain our immunohistochemical 
results. Nonetheless, astrocytes can be reprogrammed into proliferative 
neuroblasts that differentiate in neurons in vivo (Niu et al., 2013), and GSK3 
inhibition has been shown to play a major role in stem cell pluripotency (Huang and 
Qin, 2010; Sato et al., 2004; Umehara et al., 2007). The possible reprogramming of 
adult astrocytes in lithium is consistent with the increase in Klf4, which is associated 
with astrogliogenesis and is one of 2 genes that is essential for the induction of 
pluripotency (Kim et al., 2009a; Kim et al., 2009b; Kim et al., 2008; Park et al., 2014). 
Another point of interest was the presence of genes associated with ciliogenesis, 
such as Rfx2 and Pacrg. This is a characteristic of astrocyte-like stem cells, radial 
glia, and ependymal cells, which are also interconnected by complex cell-cell 
junctions, consistent with the upregulation of corneodesmosin in lithium. 
Moreover, it is difficult to ignore the striking resemblance of polarised astrocytes in 
lithium with radial glia. This is certainly a possibility that requires further attention. 
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7.5 Conclusions 
In conclusion, this PhD has given evidence for the first time that lithium and Wnt 
induce gliogenesis in the adult optic nerve. We developed a novel ex-vivo model to 
study glia in the white matter that allows easier manipulation of cell signalling than 
any in-vivo models. We identified that lithium induces the differentiation of 
oligodendrocytes by inhibition of BMP and ID2/4. Furthermore Lithium stimulates 
astrogliogenesis through the Wnt pathway and induces astrocyte polarisation 
through the inhibition of Lox. We identified novel genes whose expression was 
promoted by Lithium such as corneodesmosin which is worth of further study. 
Lithium showed novel interactions with pathways such as the Polo-like kinase 
pathway, Ran pathway and Stat pathway that has never been reported in the 
literature previously.  Lithium is used in a number of neurological disorders and is 
suggested as a potential therapy in many others, including AD and MS. Thus, my 
results confirm that glial cells are potential targets of lithium treatment, which 
promotes repair by stimulating oligodendrocyte generation and remodelling 
astrocytes to a phenotype that supports axon growth.  
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